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Introduction 
 
This report presents an analysis of the validity of US patent 5,301,105  (`105), asserted by 
Allcare Health Management systems, Inc. (“Allcare”), the plaintiff in a civil action 
number 1:02CV756-A.  According to the abstract, the ‘105 patent relates to "A Fully 
Integrated and Comprehensive Health Care System ... ".  The description provided with 
the Figures call it a "Wellness Health Management System", and the claims have 
preambles that refer to "A Comprehensive Health Care Management System" (63 times), 
"An Integrated Health Care Management System" (10 times) and omit the qualification in 
the remaining claims. The report subsequently compares the claimed features of the `105 
patent with the systems operated by the defendants, a Claims Reimbursement System.   
 
In my opinion, the `105 patent is seriously flawed. If the `105 patent would be upheld, 
then it would still not be infringed by the defendants’ systems.  Because of the errors and 
vagueness in the `105 patent, the claims do not serve as notice of what is within and 
without the scope.  The basis and opinions presented in Section 1 of this report, namely 
Patent Invalidity, hence arise also in Section 2, Non-infringement. 
 
The 102 claims in the `105 patent specify much narrower systems than the specifications 
preceding them (See also Section 5.5.2). The 102 claims all relate to automating control 
of reimbursement based on patient complaints and medical history, although the 
preambles of the claims often state that such a system represents a comprehensive health 
care system (See Section 3.12).  The specifications, primarily in the major section 
Preferred Embodiment, describe an implementation never realized anywhere, neither by 
the plaintiff, nor by the defendant, nor by any other organization or government. The 
confusion between description, claims, and feasibility becomes clear when perusing 
reports presented by the plaintiff, say, [Singer:2000], as indicated in Section 5.4 . The 
plaintiff’s experts link the `105 claims to carefully selected items of the specification in a 
fashion that implicates systems in a way very different from the technology actually 
described in the `105 patent. 
 
Of course, the idea of an all-encompassing health care system is not new. In Section 4.3.1 
we cite the long-term view, published in 1984, of an expert actually building Health Care 
Systems [Halverson:1984].  Halverson recognizes that eventually we will need smart, 
artificial intelligence systems. He did not patent that vision because he did not know how 
to build such a system either.  Research to achieve that vision had been ongoing for many 
years and continues to make slow progress [Wiener: 1960].  If the claims of the `105 
were to be construed as asserted by Plaintiff, then there is nothing to distinguish the claim 
coverage from most of health care data processing, including manual, paper, phone, fax 
and computer-based, past and present.  The coverage would extend to systems built in the 
past and systems built after the patent was issued, as well as to systems one might build 
in the future, including results of ongoing research. 
   8
The vagueness of the patent requires that we present a Section 3, Definitions. The text in 
this report uses these definitions throughout. Our definitions hew closely to widely 
accepted standards in the health care systems community.  Since questions of originality 
have been raised, we also provide in Section 4 some brief reviews of systems that carry 
out similar functions as those claimed in the `105 patent.  In Section 5 we analyze and 
rebut some of the testimonies provided by the plaintiff. A list of further references closes 
the body of this report.   
 
Appendices expand on the following topics: 
A.  My vitae and a reduced biography  
B.  Symptoms Misused as Diagnoses in Plaintiff Testimony  
C.  Definitions of Medical Terms used in the report and in relevant testimonies 
D.  Claims clusters to structure the `105 patent 
E.  Materials made available and reviewed.   9
 
1. The `105 Patent is Invalid. 
This section sets forth issues that we have with the granting of the patent in the first 
place. 
 
This patent was granted without verification that critical concepts implied in its claims 
and in its specification were enabled or even understood by the patent applicant. In each 
of the claims, there is an assumption that a `smart system' can fill a gap in the process that 
is required to perform the recited functions and methods.  The term `smart system' 
appears in Figures 1 and 6 and seven times in the preferred embodiment section of the 
specification (See Section 1.5), but no further indication of the construction, technology, 
or the methods that might be used to build such a `smart system' is provided.  It is 
infeasible to implement the claims as stated.  Implementing the specified vision is 
similarly infeasible. 
 
Since even today, 12 years later, no `smart systems’ nor other systems exist that can carry 
out the scope of the tasks envisioned by the `smart systems' of the `105 patent, it is 
neither possible to operate within the scope of the patent nor to show prior art to 
demonstrate the features claimed in the `105 patent.  The patent applicant did not claim to 
have invented such a ‘smart system’ either. He simply states that he believes that such a 
smart system is possible, or that it can be obtained from public sources, see Section 5.1.4. 
 
In summary, the error made in granting the `105 patent is the failure to recognize that it is 
infeasible as the specification is not sufficient to enable one of ordinary skill in the art to 
practice the invention without undue experimentation, if at all. We understand that 
Allcare has asserted that a ‘smart system’ according to the ‘105 patent need not exhibit 
the afore referenced capacity and have, therefore, assumed a construction as asserted by 
Allcare for the purpose of comparison of the claims to the prior art. 
 
Now on to the specifics.  
1.1 Discontinuity in the Linkage from Symptoms to Treatment 
The `105 patent depends for its effectiveness on automatically making correct decisions 
about appropriate treatment based on patient symptoms " ... input of data through said 
input means symbolic of symptoms of one of said predetermined plurality of persons for 
tentatively identifying a proposed mode of treatment ... " [`105: claim 1(d)]. Those 
symptoms (see Definition 3.1) are to be entered by the physician (claims 1, 2, 4, 16, 17, 
19, 34, 52, 67, 70, and 102 and their associated dependent claims) or sometimes (claim 
85 and the associated dependent claims) are to be available as part of a Medical History 
(see Definition 3.7). 
 
Symptoms are the external manifestations of a possible disease presented by a patient to a 
health care provider. The most common symptom presented by a patient is pain 
[Blois:1984]. It is up to the physician, using education and experience, to further examine 
the patient and arrive at a diagnosis (see Definition 3.3). Kaliski, a computer science   10
expert examining the `105 patent, consistently equates symptoms to diagnoses  
[Kaliski:2002, p.18, and footnote 18 on page 32], taking [Holland:2002] as the authority 
(see also Section 1.1.3). However, Holland, in justifying the equivalence, avoids citing 
applicable literature and instead relies on a misleading example (see Section 5.6). The 
fallacy of equating symptoms to diagnoses is addressed in detail in Sections 5.5.4 and 
5.7, but should be obvious to any one who has presented clear symptoms to a doctor and 
watched the often tedious process of arriving at a diagnosis.  
 
The patent specifications do not make that error.  The `105 patent provides ‘smart 
systems' and ‘expert systems' to make that transformation (see Section 1.1.1).  
 
Figure 1, label 21: Smart system, drugs, and diagnostics 
 
Figure 6: "An expert system that compares diagnostics test - line attendance based 
on physician goal and patient history" 
 
Column 2, line 34: "physician interaction via smart system" 
 
Column 5, line 10: smart system (diagnosis and drugs) 
 
Column 6, lines 55-70: "In accordance with the "Smart System" characteristics of 
the invention, Physician File 44 preferably will include an identification of the 
most commonly encountered diseases and other ailments, together with symptoms 
usually associated therewith. Accordingly, if symptoms are entered into the 
system terminal (e.g., one of terminals 11a-11c), and an identification of the 
corresponding illness is requested from the Processing System 10, the physician's 
file is interrogated, and the system prepares a list of the most likely medical 
condition corresponding to such symptoms, together with the generally approved 
and/or recommended treatment protocols. It also contemplates the identification 
within Physician File 44 of those procedures for which Utilization Review and/or 
Second Opinion 34 is deemed necessary or desirable. " 
 
Column 9, lines 53-65: "By this is contemplated the entry of symptoms and other 
data which can assist in making a diagnosis and identifying the aforementioned 
recommended treatment protocols. Thus, the physician is assisted in correlating 
the observed patient symptoms and test results so as to identify the most likely 
causes of the health problem, complete his diagnosis, and prescribe the most 
appropriate treatment protocols." 
 
Column 10, starting at line 24:"An Expert System that Compares Diagnostic 
Testline Attendance Based on Physician goal and Patient History." Thus, the 
physician is able to determine the testing options based on conditions and the 
condition of the body that each test was designed to report on. In addition, the 
physician is given the cost of each testing procedure including those that are 
laboratory or radiology based. If requested, the system will allow the physician to   11
select through a triage process to determine what test would yield the best data for 
diagnosis of the presenting problem. " 
 
The fact that the patent does not say how the process of inferring diagnoses from 
symptoms might work does not mean that symptoms are to be confused with diagnoses.  
The author of the `105 patent himself has stated that the two concepts are distinct (See 
Section 5.1.2). 
 
Treatments (see Definition 3.5) are the means to cure diseases.  The intent of the 
mechanisms and methods described in the `105 claims in general is to prevent payment 
for treatments that are not warranted for the patients presenting certain symptoms. 
 
The mechanisms and methods presented in the `105 patent claims fail to make a clear and 
implementable connection from symptoms to treatments. Making such a connection 
automatically is well beyond the state of the art, and hence presents a serious 
discontinuity in the `105 patent.  Elaboration on this issue is set forth in Section 3 of this 
report. 
 
   12
 
In defending the validity of the `105 patent, Allcare has presented three distinct 
arguments: 
 
1.  Smart systems were available at the time that the `105 patent was applied for that 
could bridge the discontinuity automatically 
2.  The `105 patent allows human experts to intercede and bridge the discontinuities 
that cannot be handled by computer programs. 
3.  What is actually entered by the physicians are diagnoses, and not symptoms. 
 
These three arguments do not complement each other.   We will discuss them distinctly. 
 
1.1.1  Automatic Diagnosis and Treatment from Symptoms.  
When faced with the challenge of linking symptoms to treatments during earlier 
depositions, [Cummings II:2000, p. 186, l. 17-21] [Cummings II:2000, p. 218 l. 24-25] 
[Cummings II:2000, p. 219, l. 1-7], Cummings claimed that a `smart system' can bridge 
such a discontinuity, without citing any actual ‘smart system’ that did or could perform 
that task. I expand on the lacunae in Section 5.1.3  As a reference for his belief, 
Cummings cites a Health Risk Assessment system developed within his organization, but 
not by him [Cummings:2002, p.145] (see Section 3.26 for a definition) Cummings also 
claimed in those depositions that a routine statistical procedure, namely factor analysis, 
could provide the parameters needed by such a `smart system'. We also present an 
analysis of the inadequacy of factor analysis for this task in that section.  Since 
‘wellness’, rather than management of disease has been the primary interest of the patent 
holder, he uses his experience with Health Risk Assessments (HRA) as a model for 
disease management in a Comprehensive Health Care System without considering the 
problems of moving into a domain with a much larger scope and risks, a domain that 
demands medical certification.  
 
The fallacy of the possible existence of such a `smart system' is that it requires 
automation of the physician's art. While such an advance is imaginable, it has not been 
achieved, it has not been shown that it is achievable, and has certainly not been achieved 
by the plaintiff.   
 
That this patent has been granted is likely due to two factors: 
1.  The lack of an explicit `smart system' step in the claims appears to have led to the 
patent examiner ignoring the failure of the specification to teach how to make and 
use any such system, i.e., the existence of a gap in the process.  It is hard for an 
examiner to find fault with issues that have not been described.  
2.  The specification does not set forth sufficient information about medicine and 
medical diagnostic techniques to have alerted the patent examiner to the 
unfeasibility of the approach. 
  
The issuance and attempt to enforce the `105 patent against Defendants on the basis of 
automation of the diagnostic process is analogous to patenting passenger flights to Mars 
and enforcing the resulting patent against airlines operating domestic passenger service.    13
1.  There have been earlier science fiction stories and projections about flights to Mars. 
2.  Others have made experimental flights to the moon. 
3.  A patent application discloses the concept of planetary travel, describing the process 
of boarding and disembarking, and flying above the surface of a planet, and indicate that 
a smart vehicle can make the trip, without specifying it in detail or having ever flown to 
Mars.  
4.  Since all travel above the surface of one planet is included in that concept, the 
patentee can now collect licensing fees from all airlines.  
 
The strategy of extracting license fees has been explicitly stated in a letter by Charles 
Singer to Robert Shelton and Halden Conners [Singer:2000D, exhibit 20 (AHM 
02578/AHM0334634)]: 
"Bradley .. felt that United Healthcare might fight this on principle, as opposed to 
just paying the fee. ... the strategy of going for the weaker and smaller 
organizations as licensees to add validity looks like it is still the best."  
and [ibid, exhibit 21, AHM 02800/AHM034687] 
"Their web sites are www.HBOC.com and www.epicsys.com. You can see from 
their web sites that they have broad portfolios of applications and customers, and 
their claims are right on target as dream infringers." 
Nowhere in that correspondence is there any indication of a beneficial deliverable to be 
provided to the potential licensees.  
 
1.1.2 Manual Diagnosis and Treatment from Symptoms.  
Diagnosing a patient's disease from symptoms, signs and a medical history by human 
experts is feasible.  That is what clinicians are trained to do, and do quite well after many 
years of training. However, if we allow the patent to cover manual process steps as well 
as automated process steps, there is a wealth of prior art that is applicable and has not 
been cited. All the prior art cited in the `105 patent and prosecution history describes 
fully automated systems (see Section  5). We summarize the patents brought forth as 
prior art briefly in Section 5.10 to 5.17. 
 
The specification does mention "physician interaction via smart systems", [`105: c. 2 l. 
34] but in the specific section of interest (see also this Report, Section 1.2) the `105 
patent states specifically:  
 
Accordingly, if symptoms are entered into the system terminal (e.g., one of 
terminals 11a-11c), and an identification of the corresponding illness is requested 
from the Processing System 10, the physician's file is interrogated, and the system 
prepares a list of the most likely medical condition corresponding to such 
symptoms, together with the generally approved and/or recommended treatment 
protocols. [`105: c. 6 l. 59-67]     
 
The author of the `105 patent, in a deposition, states that he believes that the `105 patent 
also covers arbitrary replacement of automation by manual processing steps. For 
instance, in [Cummings I 2000, p. 142, l. 6-24] he states in the context of Claim 1 of the 
patent that :   14
 
Well, I think if you read through it, it also says it could be manual. So there is 
manual capabilities, as well as automated capabilities.   
Q: Okay, Well --  
A: Or automated --  
Q: So Claim 1, to you, covers both manual systems and automated systems, 
correct?  
A: Right.  
Q: Okay. And a manual system does not have electronic communications between 
the patient, health care provider, bank or other financial institution, insurance 
company, utilization reviewer and employer, correct?  
A: I think it's -- that's a technical decision I think that, you know, the telephone is 
a manual system, but it can be utilized with some automated properties. So it can 
be technically -- so I’d say that with that qualification, fax, telephone, those 
require certain manual -- whereas a computer's all automated.  
 
on page 143, lines 24-25: 
  
In the [`105] patent process, there is data sending and there is human intervention.  
 
on page 145 lines 2-4 in responding to: 
 
Q: do you envision that possibly being done with people talking to each other on 
the phone:  
A: In a primitive situation if necessary. Could be. I don't really -- the vision is to 
get all electronic  
 
This latter statement even implies that the `105 patent could cover 100% manual 
processing of healthcare and claims reimbursements. By that definition, the `105 patent 
covers all existing prior art, since before computers (“BC” being about 1950), all such 
processing was being performed manually, on paper and by telephonic communication.  
Even today there is a work force of humans that look at the claims (CHIPS and TRIMED 
staff for example) within a reimbursement claims workflow system which is made up of a 
combination of automated computational and human-based manual processing. 
Singer performed a search for prior art, which ignored any system that was not fully 
automated. His recent depositions have been consistent with that view. For instance, 
Singer has stated  (see Section 5.3.3), that the OPTIMED system does not constitute prior 
art, because it employs phone conversations, rather than  "electronic communication 
means as required by the patent" [Singer:2000,  p. 12].  
 
Also, "in the 105 patent .. communication of this [patient] data to the UR [(Utilization 
Review)] firm is clearly intended to occur as computerized data." [ibid, page 11]. 
 
The steps of paramount concern regarding the substitution of human experts where the 
`105 patent cannot show that automation was achievable are: 
   15
Diagnosis:  Establishing a diagnosis is the first step required when selecting a 
treatment based on patient symptoms. That task is central to the art of medicine.  
Establishing a diagnosis (see Definition 3.3), takes into account many factors that 
go beyond the symptoms presented by the patient.  Physicians have had to 
diagnose patients based on presented symptoms since Aesculapius: Ad sanitatem 
gradus est novisse morbum (The first step toward cure is to know what the disease 
is).  We analyze the patent specifications and claims in regard to that step in detail 
in the subsequent Section 1.1.  Simply stated, an automated system is not 
currently available. 
 
Adjudication: Deciding if a treatment is appropriate requires commensurate 
knowledge. In the `105 process this step is specific to the payment process. Since 
adjudication of reimbursement claims requires medical insight, professionals with 
medical degrees are employed to make the final decision. Simple eligibility rules 
are automated, routine and low cost treatments are not scrutinized, medications 
may be substituted, but any questionable cases (at TRIGON still a very large 
proportion) are handled manually, and often require telephonic interaction with 
the requesting health care provider. Automation of this step would be 
irresponsible, causing worthy patients to be denied treatment, while others that are 
able to game the system would be able to receive more treatment than is 
warranted. 
 
Many expert's reports submitted for this case follow a generalization which allows 
physicians to convert symptoms manually to diagnoses and treatment recommendations. 
They also allow TRIGON's medical directors to make telephone calls to physicians' 
offices to obtain medical records, history information, and the like, all within the scope of 
the `105 patent. Their extrapolations of the claims as written are either due to lack of 
knowledge of health care [e.g., Kaliski:2002], or an excess of knowledge. If an expert 
assumes that the patent is valid because the question posed is one of infringement, then 
the expert will impose his or her knowledge upon the system, and, for instance, consider 
that `diagnosis' is meant where `symptom' was written [e.g., Holland:2002].     
 
The `105 patent cannot allow the substitution of automated, computer-based processing 
by manual handling, carried out by medical or nursing staff.  For instance, when 
discussing telephonic communication as an alternative by a provider with a ‘Utilization 
Review Company’ to obtain permission for an inpatient admission [Singer I:2000, p.82]: 
  
was the normal mode at the time this patent was written and so to specify a 
system like that would make no sense, because that, in fact, was what they were 
trying to fix. [p. 82 1.14-15]  
 
 If substitution by manual processing at any step of the `105 process were allowed, the 
entire house of cards that is the ‘105 patent would fall because there would be no 
distinction between the whole gamut of prior art.  Indeed, such manual operations have 
been ongoing for many years in healthcare.  Predecessors of TRIGON had to validate 
eligibility for reimbursement for decades, ever since health care insurance was instituted   16
[MetropolitianLife:1985].  The prior art cited in the prosecution history of the patent 
deals only with automated systems, systems in which there are no intermediary manual 
processes.  We could not locate in the prosecution history any reference to manual 
processes.  The citation of only fully automated prior art indicates that both the applicant 
and the Examiner, at the time of examination, contemplated only fully automated 
systems.. 
 
 
 
1.1.3. Symptoms are NOT Equal to Diagnoses.   
 
Plaintiff’s Experts fall into the trap of making assumptions that would allow resolution of 
the problem that this patent presents. The most common trap is that symptoms are the 
same as diagnoses. We will first cite evidence and testimony that symptoms are not equal 
to diagnoses, and then show why the arguments that equate them are false. 
 
Symptoms are not equal to diagnoses. Dictionaries, the patent itself, the author of the 
`105 patent, and the healthcare expert at Allcare all distinguish symptoms and diagnoses: 
  
First we refer to the definitions in Section 3.1 and 3.3 of this report, taken from general as 
well as from medical dictionaries that clearly distinguish the two, symptoms being 
complaints presented by the patient to a health care provider, and diagnoses being 
determined by a health care provider based on reported symptoms, signs observed by the 
physician or through clinical testing (see Definition 3.2), and the patients medical history 
(see Definition 3.7). 
 
Dependent Claims 13, 28, and 44 of the `105 patent introduce a databank to provide 
information for the processing of symptoms to obtain diagnoses: 
 
Claim 13. A comprehensive health care management system according to claim 2 
in which one of said databank memories includes identification of symptoms for 
diagnosis of each of a predetermined plurality of illnesses.  
 
If symptoms were equal to diagnoses no such databank would be required. Claims 64 and 
70 access such a databank to retrieve symptoms to aid in obtaining a diagnosis: 
 
Claim 64. A method of managing a health care management system according to 
claim 55 further including the step of accessing one of said databank memories to 
identify symptoms for diagnosis of each of a predetermined plurality of illnesses. 
 
If symptoms were equal to diagnoses no such processing would be required; and finally, 
Claim 94 provides for entering of symptoms for diagnosis. 
 
Claim 94. A method of managing a health care management system according to 
claim 85 including the step of entering into said data bank memory an   17
identification of symptoms for diagnosis of each of a predetermined plurality of 
illnesses.  
 
If symptoms were equal to diagnoses none of these claim steps would be required. 
 
In the specification of the `105 patent the physician file is described as being this 
symptom-diagnosis databank referred to in the claims: 
 
In accordance with the "smart system" characteristics of the invention, Physician 
File 44 preferably will include an identification of the most commonly 
encountered diseases and other ailments, together with symptoms usually 
associated therewith. [`105: c. 6 l. 55-59]. 
 
If symptoms were equal to diagnoses no such information would be required in the 
physician file. Finally, the difficulty of translating symptoms to diagnoses is emphasized 
in this sentence as being associated with the `smart system' characteristics of the `105 
patent.  We discussed those aspects in Section 1.1.1. Obviously no `smart system' would 
be required to help in this task if symptoms were equal to diagnoses. 
 
[Cummings II.:2000, p. 182  l. 22-23] is initially also fairly clear that there is a 
difference. 
Symbolic of symptoms does not mean symbolic of diseases.  
 
(For further supporting statements in this testimony see Section 5.1.2) .  
But, later, when faced with the problem in the Claims, Cummings backpedals: 
 
Q: ... what's the difference between data symbolic of symptoms and symptoms for 
diagnosis?  
A: They're similar.  
Q: Are the same thing? 
A: Could be the same thing but not all - yeah. 
[Cummings III: 2000, p. 311 l. 17-21] 
 
[Singer:2000D, p. 73] considers that an expert system might be able to translate 
symptoms to diagnoses, but also that such a capability would be fairly rare: 
 
Q: And where you would actually tell the system, `Here are the symptoms. Here's 
what the patient is presenting to us,' and the system would actually make 
suggestions about `Here are possible diagnoses'?   
A: That form of system is rare, but some people have attempted that.  
Q: And had some people attempted that prior to 1990?   
A: I believe so.  
[Singer:2000D, p. 73] 
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Research in this area includes Jack Mayer's work, starting actually around 1970 (See 
Section 4.6.2: The Internist System).  It is the difficulty of making diagnoses that makes 
such systems rare, a difficulty that would not exist if symptoms were equal to diagnoses. 
  
Symptoms are equal to Diagnoses. Well-meaning experts resolve the problem of the 
`105 patent in various ways: For instance, Kaliski, being a computer scientist, simply 
equates symptoms with diagnosis, ignoring the `105 specification and claims where the 
smart system performs the inferential step, and cites [Holland:2002] as the authority (see 
Section 5.5.4).  
 
Holland [Holland:2002]  mixes symptoms and diagnoses, in creative, but unjustifiable 
ways to resolve the problem of the patent containing tasks that cannot be carried 
automatically (see Section 5.6.2 for the required detail).  All of the symptoms that 
Holland cites as also being diagnoses are not, and would never be acceptable as the basis 
for a reimbursement claim, the objective of delivering such information to Trigon (We 
provide information on every single one in Appendix B. Only a few pathognomonic 
symptoms determine diseases, and these are so rare that one certainly would not base a 
Comprehensive Health Care Systems on them.  
  
Singer [Singer:2000, pp. 75-77] simply misreads the patent and assumes that the 
physician enters treatments, and the system suggests alternative treatments: 
 ... my interpretation of this is that the physician or the person providing 
the care is entering the proposed mode of treatment.  ....  the system might 
respond by saying, `Well you might want to also do these other things.' 
Now the problem is solved by ignoring symptoms altogether. More detail about this 
interpretation is given in Section 5.6.2. but note that it conflicts with Singer's 
understanding that expert systems might translate symptoms to diagnosis, cited above. 
 
If even the plaintiff's experts come up with such different interpretations of how the `105 
patent is to be implemented, we must conclude that the `105 patent did not provide notice 
to a person of ordinary skill to determine what is within the scope of the claims 
 
The plaintiff's experts were not concerned with the validity of the `105 patent. By 
constructing feasible systems, for instance, systems where diagnoses instead of symptoms 
are entered, the novelty of the `105 patent is lost, since claims reimbursement based on 
diagnoses submitted by the providers has been in existence for a long time. 
 
1.1.4 Summary.   
 
No solution resolving the discontinuity in the linkage from symptoms to treatment is 
enabled.   
 
1.  Inferring diagnoses or treatments needed from symptoms presented by the patient 
cannot be performed automatically by processes specified or even implied in the `105 
patent. No such technology available to the patent holder.   19
2.  The lack of references to prior art disallows substitution of automation by manual or 
alternative operations. Health care staff performing diagnosis and adjudication functions 
cannot be covered by the patent.  
 
My personal opinion is that we might have systems that correspond to the patent holder’s 
vision in the far future. The vision has been developed and expounded since the 1960's. 
We are not there in 2002, and I don't expect we will be before 2044.  At that point 
physicians would only be managers of medical knowledge, and all direct interaction with 
patients could cease. Fortunately, Trigon has a less ambitious role, validating payment 
requests for medical treatments to help in keeping our health care system solvent.  Paying 
license fees for unjustified claims of inventions that do not contribute one whit to our 
knowledge or capabilities does not help our society. 
 
Most of the remaining points in Section 1 of this report contribute detail to this argument, 
although some of them are sufficiently strong to demolish the ‘105 patent or many of its 
individual claims.  We will now refine the issues.  Some key definitions are provided in 
Section 3. 
 
 
1.2 Lack of Available Technologies for Automation 
The crucial `smart system' step required is buried within individual functions recited in 
the claims of the `105 patent.  We will cite the entry from Claim 1, and emphasize the 
issue in boldface: 
 
(d) means in communication with said input means responsive to input of data 
through said input means symbolic of symptoms of one of said predetermined 
plurality of persons for tentatively identifying a proposed mode of treatment 
for said one of said predetermined plurality of persons and, when said proposed 
mode of treatment includes one of said predetermined procedures requiring 
utilization review, for producing indicia indicative thereof and for preventing 
payment therefor by said payment means until said utilization review has been 
obtained and data indicative thereof has been entered in said system.  
 
The essential phrase: "means responsive to input data symbolic of symptoms for 
tentatively identifying a proposed mode of treatment" appears in Claim 1(d), Claim 2, 
Claim 4, Claim 16, Claim 17, Claim 19(e), Claim 34, Claim 52(c), Claim 53, Claim 54, 
Claim 55(d), Claim 65, Claim 66, Claim 67(e), Claim 70(f), Claim 85(e), and, implicitly, 
in their dependent Claims 2-3, 5, 7-12, 17-18, 20-27, 35-46, 56-66, 68-69, 71-81, and 86-
96.  A similar phrase "input of patients' symptoms for displaying recommended 
treatments, for identifying recommended treatments" occurs in Claims 47 and 97, 
affecting their dependent Claims 48-51 and Claims 98-101. The few remaining claims: 
82-85 and 102 perform similar tasks depending on a medical history and a personal 
health profile and will be addressed in Section 1.4. 
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The structure to perform the function of the ‘means' claims supporting the process in the 
`105 patent of establishing treatment on the basis of symptoms presented by the patients, 
is omitted from the claims, but can be inferred from the specification and is described 
further in the deposition testimony as being implemented via: 
 
1)  file tables ("the physician's file is interrogated, and the system prepares a list of the 
most likely medical condition corresponding to such symptoms, together with the 
generally approved and/or recommended treatment protocols") [`105: c. 6 l. 63-67],  
2)  as being achieved through a `smart system'  [Cummings II:2000, p. 186 l. 17-21 pp. 
218 l. 24-25 pp. 219 l. 1-9]  
3)  achieved through an Expert System  [`105: Figure 6 Box 123][`105: c. 10 l. 24],  and 
4)  based on factor-analysis [Cummings II:2000, p. 206 p. 207 p. 208 l. 4-7].  These 
technologies differ in data requirements, functional specification, structure, and 
nature of results. 
 
Each candidate technology is inadequate to bridge the discontinuity indicated in Section 
1.1: 
1.  Tables cannot be effectively constructed for combinations of multiple symptoms, 
and fail when required symptoms have not been entered (see Definition  3.20). 
The contents required for such tables require knowledge that is not available. 
2.  Smart systems do not represent a specific technology (see Definition  3.15) and a 
wide variety of suggestions appear in the author of the `105 patent’s deposition 
and expert testimony by others.  We deal with that issue in Section 1.5 below. 
3.  Expert Systems, defined in the materials as using Rule-based technology (see 
Definitions 3.17  and 3.19) could not cope with the complexity of the required 
medical reasoning at the time the patent was granted - and still can not do so.(see 
Section 1.6 and our review of the state of the art (Section 4.6) , Kaliski review at 
5.5).  
4.  Factor analysis over the entire domain of medicine requires data volumes that 
exceed globally available resources  (see Definition 3.21)  Cummings can only 
provide some generalities, although he admits that is difficult and risky: 
 
Q: Okay. How do you actually take symptoms and come up with a proposed 
mode of treatment? How is that actually done?  
A: Through pattern analysis.  
Q: How is pattern analysis done?  
A: Basically, when you have the outcomes from an experience of employees 
(sic) and you are able to factor-analyze what are the best outcomes for treating 
various conditions.  
Q: And you knew about pattern analysis when you filed the application?  
A: Pattern analysis?  
Q. Yes. A: It is a statistical concept. [Cummings II:2000, p. 206 l. 3-16]. 
 
His experience was limited, and even in about 1996 had not progressed beyond the 
scope of a Health Risk Advice system. 
   21
"HRA has somewhere over 40 variables." [Cummings III: p. 344] while 
symptoms encodings number over 8000. (see Definition 3.1) 
 
Any computing technology needs input in order to generate results. Nowhere in the 
patent are their interfaces defined, other than by arrows in the Figures, indicating 
communication lines.  As described in Section 5.5.1 of this report, Kaliski uses his 
expertise to fill in technological gaps without addressing the problems presented in the 
discontinuity defined in Section 1.1.  The design, engineering, and construction of the 
required technologies and their interfaces would be a feat requiring more than the 
ordinary skill and could not be accomplished without undue experimentation  and true 
inventiveness.  As the `105 patent is described, these technologies are in conflict with 
each other. 
 
Filling the gaps with manual processing, specifically physicians diagnosing patients in 
their offices and medical directors at an insurance company performing adjudication of 
claims, is an arbitrary and inappropriate extrapolation (see Section 1.1.2).  
 
1.3 Utilization Review  
Utilization Review is a means to assure quality of care. The patent specification and the 
claims use the term inconsistently. That inconsistency fatally effects the reports and 
depositions presented by the plaintiff. We provide the commonly agreed upon definition 
in Section 3.9 below.  We use the term cost-effectiveness review for the task of 
identifying treatments that have costs that are not warranted by the medical benefits they 
provide, see Definition 3.10.  Singer confirms that distinction [Singer:2000D, p. 15], see 
also Section 5.4. 
 
In the specification of the `105 patent [`105: c. 1 l. 41-42], `utilization review' is shown as 
an example of obtaining second opinions.  That appears to be erroneous.  In the summary 
of the specification of the `105 patent [`105: c. 1 l. 57], a `utilization reviewer' seems to 
be equated with a case manager (see Definition of Second Opinion in Section 3.6).   
 
The use of `utilization review' in the object and function section of the specification of 
the `105 patent [`105: c. 2 l. 15-18] implies the traditional usage (See Definition 3.9) 
since recommendations include both treatments to be given and to be avoided for certain 
diagnoses. In the same section [`105: c. 2 l. 28-34] inappropriate utilization, presumably 
as defined 3 sentences earlier, is to be facilitated by a `smart system'. 
 
However, as used in Claims 1 (and its dependent Claims 2 and 3), 4 (and its dependent 
claims 5, 7-12), 47 (and its dependent Claims 48-51), 50, 55, 97 (and  its dependent 
Claims 98-101), and 102, the term `utilization review' only refers to denial of 
reimbursement, and hence only performs cost-effectiveness review. In Claims 50 and 51, 
obtaining a second opinion is included in the utilization review. Since a committee 
normally carries out utilization review, the implication that the claims refer to cost-
effectiveness review, as we define it, is further strengthened. 
   22
In reference to the claim construction, this confusion is exacerbated.  Allcare cites a 
definition of `utilization review' that is close to the traditional meaning, i.e., our 
Definition 3.9, while  TRIGON, as an insurance carrier, defines `Utilization review'  in 
sense of cost-effectiveness review (our Definition 3.10). However, when Allcare argues 
infringement by TRIGON, it appears that they too, use the concept as defined by us as 
cost-effectiveness review. 
 
This inconsistency has effected the depositions taken. While the author of the `105 
patent, Cummings  considers that utilization reviews exist to improve health care quality, 
he has made mixed statements: 
 
... the  patent application basically points out there are payment systems out there 
and there were magnetic payment systems and those kinds of things happening in 
the world, and really the significance of the patent was that it integrated the 
totality and especially added the whole utilization management, utilization 
review, second opinion, all the medical management components, where largely 
all we had was financial management [Cummings:2002, p.85  l. 8-16]. 
 
versus 
 
"Q: so the payer, typically, sets the rules for the predetermined procedures 
requiring utilization review 
 A: Right" [Cummings I :2000 p.163 l .14-15]. 
 
Many of the Allcare experts, when supporting infringement, use the term in the limited 
sense of Cost-effectiveness Review. For instance, Holland, having focused on financial 
controls for much of his professional life, frequently uses the term `Utilization 
Management' when Claims Reimbursement Cost-effectiveness Review is intended 
[Holland:2002, pp.35-38, 66-76].  On page [Holland:2002, p. 152], it becomes clear that 
the focus of the `smart system' aspects of the claim and the needs for `utilization 
management' differ. [Singer:2000D, pp.59-61 distinguishes getting pre-authorization and 
utilization review, but when comparing the ‘105 patent to the services provided by 
OptiMed refers to that process as utilization review [idid, pp. 81-83]. 
 
There is no trustworthy basis for the applicability of the patent because of the 
inconsistencies in the use of the term utilization review. 
1.4 Medical History.  
 
The medical history is the major element of the patient's chart (see Definition 3.7). One 
of Allcare's experts agree that the `105 system needs a reasonably complete record of the 
patient's medical and insurance history [Singer:2000], see Section 5.4. The named author 
of the `105 patent of the patent describes in his deposition the many elements that were 
available in the chart at his hospital in 1990 [Cummings I:2000, pp. 82-84].  The term 
`Medical History' does not appear in the specification, but frequently in the claims of the 
`105 patent. It is unclear in the `105 patent what the `Medical History' contains, where its   23
contents originates and how its contents is entered.  We are hence forced to infer 
guidance indirectly, using the figures, the claims, common references, and the expected 
knowledge of a `person familiar with the art'.  Unfortunately, the results are inconsistent, 
particularly in light of Allcare’s insistence that a Reimbursement Claims History (see 
Definition 3.8) is a Medical History. 
 
Figure 1 shows a Physician File (44) and a Claims File (20).  Figure 3 shows a Physician 
File attached to the Physician's Office Microcomputer. In Figures 5, 6, and 7 various 
patient visit processes take place that are based in the physician's office, including 
accessing the patient's chart/record (105 in Fig.5). We hence see that the medical history 
is accessed at the Physician's office microcomputer. The `105 patent "contemplate(s) the 
physical location of such data in other sites as well as, or in addition to, files at the 
physician's location." [‘105: c. 6 l. 51-54]. Note that access to the full physician chart by 
insurance companies is inappropriate.  Selected items that may be accessed by insurance 
companies for a limited time are shown in [MIB:2002].  An HMO, being a provider of 
healthcare, may keep such data, but should not reveal them to an insurance company 
unless needed for adjudication of a specific reimbursement claim.  
 
In the `105 patent, reimbursement claims are transmitted to a central computer (200 of  
Fig. 8) and presumably stored in the Claims File (20 of Fig.1).  "There is stored detailed 
information covering relevant items of interest in ensuring accurate administration of 
claims in accordance with applicable criteria." [`105: c. 5 l. 3-6], as defined in (see 
Definition. 3.8). Claim adjudication and reimbursement follow. These are activities 
particular to an insurance carrier or its service organization.   
 
The actual `105 claims use the term `Predetermined Items of Medical History'.  A 
physician's chart should not be constrained to predetermined items, since patients present 
a broad variety of symptoms and diseases. This wording makes it likely that a 
reimbursement claims history is intended. 
  
a.  In Claims 4 and its dependent Claims 5, 7-12, Claim 19 and its dependent 
Claims 20, 22-27, Claim 31, Claim 57 (dependent on Claim 55) and its 
dependent Claims 62 and 63 (in turn dependent on Claim 55), Claim 70 and its 
dependent claims 72-81, Claims 82, 83,84, the processes include determination 
of appropriateness of payment and are hence based in the insurance company, 
implying that the term refers to Reimbursement Claims data and possibly other 
permitted data, although it is never stated where any other data might be 
obtained.  
 
b.  Claim 47 and its dependent Claims 48-51, and Claim 97 and its dependent 
Claims 98-101 require utilization review (see Definition. 3.9) and hence outside 
access is required. Here we have an interaction with the inconsistency of the 
term `Utilization Review' in patent `105 (see Section 1.3). If the meaning is 
according to the accepted medical definition (see Definition 3.9), then the 
outside access is by an institutional review board that has legitimate access to the 
full chart (see Definition 3.7)  If the meaning is the restricted meaning often   24
implied in the `105 patent, namely cost-effectiveness review performed at an 
insurance company (see Definition 3.10), then only access to the Claims History 
should be provided. 
 
c.  In Claims 32, Claim 34 and its dependent Claims 35, 37-46, Claim 82, Claim 83, 
Claim 84, Claim 85 and its dependent Claims 86-94, the operation can be 
performed within the Physician's office, and hence can refer to a true `Medical 
History'.  
 
d.  In Claims 5, 20, 35, 71, 86 and 97(c)  `Physical Profiles' are made available as 
part of the Medical History.  Since Physical Profiles should not be made 
routinely available to an insurance carrier, they should not appear in 
Reimbursement Claims History (see Definition 3.8).  However, Claims 5 and 20 
depend on claims that involve reimbursement, and hence imply that a claims 
history is intended when the term `Medical History' is used. 
 
e.  Claim 97 already has the inconsistency due to the term `Utilization Review'.   
The use of `Physical Profile' in Claims 35 and 86 strengthens the assumption that 
a true Medical History (Definition 3.7) is intended for Claim 34 and its 
dependent Claims 35, 37-46, as well as for Claim 85 and its dependent Claims 
86-94. 
 
f.  For most of the tasks to be accomplished in the various claims of the `105 patent, 
a comprehensive medical history, (as defined in Definition3.7), is essential. A 
patient would not want to receive advice from a physician regarding "mode of 
treatment") based on a Reimbursement Claims History as proposed in (Claims 
1,2, 4 and its dependent Claims 5, 7-12, Claim16 and its dependent Claims 17 
and 18, Claim 19 and its dependent Claims 20, 22-27, Claim 34 and its 
dependent Claims 35, 37-46, Claim 52 and Claim 55 and its dependent Claims 
56 to 66, specifically Claims 65 and 66, Claim 67 and its dependent Claims 68 
and 69, Claim  70 and its dependent Claims 72-81, and Claim 85 and its 
dependent Claims 86-94). 
 
g.  Neither would patients want to have "ancillary services", including their 
medications being prescribed based on a Reimbursement Claims History (Claim 
2, Claim 17, Claim 34 and its dependent Claims 35, 37-46, Claim 47 and its 
dependent Claims 48-51, Claim 53, Claim 68, Claim 85 and Claim 97 and  its 
dependent Claims 98-101). 
 
h.  It would be equally unwise to direct a patient's "preventive health routines for 
addressing each of any identified plurality of potentially health-destructive 
conditions including excessive weight, high blood pressure, smoking, and 
insufficient exercises "based on a Reimbursement Claims History (Claim 3, 
Claim 18, Claim 41, Claim 47 and its dependent Claims 48-51, Claim 54, Claim 
69, Claim 91, and Claim 95). 
   25
The effect of the inconsistencies a. to h. above is that an interpretation of the term 
`Medical History', and the legitimate and actual contents of a `Medical History Data 
Bank' will differ depending on which claim is being asserted and defended.  We find such 
confusion intolerable. It results in inconsistent interpretations and, therefore, the claim 
term is not susceptible of definite construction.  In addition, Allcare's urged construction 
is simply arbitrary.  Plainly, the claims do not provide sufficient notice to permit one of 
ordinary skill in the art to ascertain what is within and without the scope of the claims.  It 
also disables any reliable guidance towards implementation by anyone, experts or mere 
programmers.  Notwithstanding this, points e, f, g and h make it clear that use of a patient  
Chart rather than a Reimbursement Claims History is a more appropriate interpretation of 
Medical History. 
 
We also analyzed the data flow for the contents of the `Medical History' as described in 
the processes of the claims. Instead of obtaining clarification, the specification revealed 
more discontinuity. 
 
a.  In Claim 4 and its dependent claims 5, 7-12, Claim 19 and its dependent claims 
20, 22-27, Claim 34 and its dependent claims 35, 37-46, Claim 70 and its 
dependent claims 72-81, claims 82, 83,84, Claim 85 and its dependent Claims 
86, 91-96, and Claim 97 and its dependent claims 98-101, there exists a databank 
for medical history without a means for entering data and retrieving results. The 
data being entered either from a card or manually in Claims 11, 12, 26, 27, 92 
and 93 would not comprise a medical history. The data entered in Claims 7, 22, 
37 are restricted to patient identification. The data being entered in Claims 94, 
95,and 96 are not patient-specific and hence cannot serve a medical history.   
 
b.  Claims 6, 21, and 71 do specify an input terminal for medical history, clearly 
showing that an input means is needed unless only legacy historical information 
is to be stored.  
 
c.  In Claims 72 and its dependent 77 and 78, the medical history is being accessed. 
Here only legacy historical data are available as part of the medical history. This 
observation is made as well by [Kaliski:2002, p. 47], (see Section 5.3.2).  Past 
information alone is clearly inadequate for making current decisions about 
requested patient treatments.  
 
d.  In all other claims of the `105 patent, the potentially costly existence of a 
historical medical history database is merely for beauty and comprehensiveness, 
since data is neither entered nor taken out.   
 
This patent obviously does not provide adequate guidance to anyone steeped in the art of 
construction of health care systems to implement consistently the important medical 
record component and its functions that appears in the majority of the claims of the `105 
patent.  This becomes obvious in [Holland:2002] discussion, see Section 5.6.1. The 
resulting systems would differ a great deal.  It does provide an opportunity for experts to 
improperly read their experience into the intent of the `105 patent.  The efforts by Allcare   26
to assert the theories of infringement are based on an interpretation of the language that is 
inconsistent with many of the claims and, as such, is arbitrary and not supportable. 
  
1.5 Smart Systems 
The concept of `Smart Systems' appears several times in the figures and specification of 
the `105 patent but is not further defined. For the systems and methods according to the 
claims to be operative, such ‘smart systems' are needed to bridge the gap shown in 
Section 1.1.  Even the plaintiff's expert reports recognize that their abilities are essential 
to the validity of the patent  [Kaliski:2002], (see Section 5.5.3).  Since there is no 
consistency to their requirements, also recognized by [Kaliski:2002], we address each of 
these occurrences one by one, before summarizing our understanding. 
1.  Figure 1, label 21: Smart system, drugs, and diagnostics: is explained in Column 
5, line 10: Cylinder 21: smart system (diagnosis and drugs) does not state what is 
being accomplished, only that it is "contemplated by several of the following 
operations including ... "Utilization Review/Second Opinion/Procedure 
Approval".  Since the diagnosis is an input parameter, we must conclude that 
having a `smart system' facilitates reviewing prescribed drugs during Utilization 
Review.  I could not locate the promised "ensuing description" which made this 
portion of the system "very versatile", since this is the only occurrence of the term 
"versatile" in the `105 patent. 
2.  Figure 5, the transition from the box labeled 111 "Input reason for visit and tests 
ordered" to box 112 "Access Patterns of treatment Protocols" requires a smart 
system, as stated in [Cummings:2000, pp. 161-162] "In accordance with the smart 
system characteristics of the invention, physician file 44 preferably will include 
an identification of the most commonly encountered diseases and other ailments, 
together with symptoms usually associated therein. Accordingly, if symptoms are 
entered into the terminal, an identification of the corresponding illness and so 
forth that are most likely to that medical condition and recommended treatment"  
Q: so the system of Claim 1 is a smart system, correct?" [Cummings I :2000, page 
161]: "Right". 
3.  Column 2, line 34: As the second basic (non-optional) feature "The invention" 
provides an "integrated service [..]  thus reducing time, direct cost, and indirect 
cost often incurred through duplication of tests, excessive paperwork and 
inappropriate utilization, thus enhancing the ability of the system to provide 
quality health care through case management and physician interaction via smart 
system". These services are broad, and recognizing inappropriate utilization is 
indeed a task requiring smarts. This task could well be termed `utilization review', 
but that would then not be based in a specific physician's office. Case 
management is not defined either.  
4.  Column 5, line 10: "Figure 1 reveals the inclusion of a smart system 21 including 
parameters dealing with diagnosis and drugs (as hereafter described)". The figure 
depicts a file or databank, although the smart system is described as being a 
processing system.  Later references to drugs are limited to wellness management 
and drug profile reporting.  The claims never mention drugs in either sense, but   27
we could assume that treatments, medical history, and ancillary services may have 
components including prescribed drugs. The lack of precision allows a variety of 
inferences about the `105 patent's  intent, disabling a definite implementation. 
5.  Column 6, lines 55-70: "In accordance with the 'Smart System' characteristics of 
the invention, Physician File 44 preferably will include an identification of the 
most commonly encountered diseases and other ailments, together with symptoms 
usually associated therewith [Smart System (3)]. Accordingly, if symptoms are 
entered into the system terminal (e.g., one of terminals 11a-11c), and an 
identification of the corresponding illness is requested from the Processing 
System 10, the physician's file is interrogated, and the system prepares a list of the 
most likely medical condition corresponding to such symptoms, together with the 
generally approved and/or recommended treatment protocols. It also contemplates 
the identification within Physician File 44 of those procedures for which 
Utilization Review (see Definition 3.9) and/or Second Opinion 34 (see Definition 
3.6) are deemed necessary or desirable. " 
6.  Column 9, lines 53-65 (describing rectangle 110): "By this is contemplated the 
entry of symptoms and other data which can assist in making a diagnosis and 
identifying the aforementioned recommended treatment protocols. Thus, the 
physician is assisted in correlating the observed patient symptoms and test results 
so as to identify the most likely causes of the health problem, complete his 
diagnosis, and prescribe the most appropriate treatment protocols."  This `smart 
system' instance describes concepts that were under research and development at 
the time (see for instance Section 4.6.2 - the Internist system). Today some 
software tools are available to practicing physicians (for example see Section 
4.6.7 on Ovid), but not in the integrated form contemplated in the vision 
presented.  They typically address sub-problems, i.e., cases where the physician 
has made at least a preliminary diagnosis and wishes to refine it, or get a list of 
treatment choices, perhaps with statistics of the cost and success of these choices 
on similar patient populations.  
All references in the `105 patent refer to the smart system being available to the 
physician at his or her office.  Any assertion made by the plaintiffs that the `105 
patent also intended to cover services at an insurance company is an 
extrapolation.  We know of no systems that infer diagnoses or treatment from 
symptoms that are connected to Claims Reimbursement Systems. 
7.  The functions allocated to smart systems in points 1-6 above relate to what is 
referred to as an `expert system' in Fig.6 of the `105 patent. See Section 1.6 for an 
analysis of that concept. 
The patent does not explicitly claim ‘smart systems’ as an element.  It does include 
means plus function limitations whose functions require such ‘smart systems.’  The 
referenced ‘smart system’ is provided in order to miraculously solve problems that 
conventional, algorithmic (see Definition 3.16) computing can not solve.  Integration of 
smart concepts into the real world has always been the vision of the many competent 
people who actually researched, developed, and invented precursors to ‘smart systems’ 
intended to perform as described in the ‘105 patent.  No one, including the ‘105 patent,   28
has described the structure of such a system in a manner sufficient to permit one of 
ordinary skill in the art to make and use such a system in a practical health care setting. 
1.6 Expert System.  
Figure 6, rectangle 123 shows "An Expert System that compares Diagnostic Testline 
Attendance Based on Physician Goal and Patient History".  The related text at col.2, lines 
18-34 explains:  
 
In addition to the foregoing, the System also includes provision for further 
diagnostic support. This is indicated by rectangle 122 `Is diagnostic Suport (sic) 
Needed'. 
 
If the answer is "No", then the system continues on as indicated. However, if the answer 
is "Yes", then the system invokes such additional assistance as indicated by rectangle 123 
"An Expert System that Compares Diagnostic Testline Attendance Based on Physician 
goal and Patient History." Thus, the physician is able to determine the testing options 
based on conditions and the condition of the body that each test was designed to report 
on. In addition, the physician is given the cost of each testing procedure, including those 
that are laboratory or radiology based. If requested, the system will allow the physician to 
select through a "triage process to determine what test would yield the best data for 
diagnosis of the presenting problem."  
 
We provide the commonly accepted definition of `Expert System' in Section 3.17 and 
note that `Expert Systems' are considered to be a specific type of `smart system`, as used 
in the context of this patent. Unfortunately, here we cannot understand what the system 
does. We are at a loss to understand the term "testline". It does not appear in our medical 
dictionaries or in the 20-volume set of [OED:2002]. The associated text does not help 
much, and various people `familiar with the art' would arrive at differing conclusions, if 
any, about what is intended here. The term `triage' is misused here as well. Triage means 
selecting from a set of patients those that (1) can benefit from treatment, and ignoring 
those (2) too ill to benefit from scarce resources and those (3) well enough to survive by 
themselves.  
 
We are also not informed about the expert technology to be used here. In his deposition 
[Cummings I :2000, p.161], see Sect.5.1, he refers to an expert system as being an 
artificial intelligence system that is both rule-based and can learn. We do not know of any 
rule-based system that can learn, although systems that can learn comprise the holy grail 
of artificial intelligence.   
 
This is the only place where the term `expert system' is used in `105. It does not appear in 
the claims. Given the vagueness and the author of the `105 patent's poor understanding 
shown in the deposition, we conclude that the use of the term `expert system' in the patent 
was due to its attractiveness in marketing and is not a valid technical specification.     29
1.7 Lack of Originality in Composition 
The specification, as the author of the `105 patent himself has stated [Cummings 2002, 
p.69  l. 1-4, p. 128  l. 20-25] represents a vision of  a comprehensive health care system. 
All of the many features described in the specification of the `105 patent had been 
available in a variety of systems. We refer to the prior art summaries in Section 
4.3,4.4,4.5, and 4.6. 
 
The actual claims of `105 focus on a subset, namely Healthcare Reimbursement System.  
The specification is not coordinated with the claims of the ‘105 patent.   
 
We address in this section the features cited in the specification. We address each feature 
distinctly.  We also note that all of the features that are mentioned in the claims have had 
examples in prior art.  The compositions presented do not express originality, they are 
samples selected from a menu of choices, and often not even consistently (see Section 
1.4, Medical History, for instance)  
 
 
 
 
  Feature in 
specification 
claim USC 
[Brian:1981] 
AAMRS 
[Wiederhold: 
1975] 
Next Three 
Generations of 
Healthcare 
Information Systems 
[Halverson:1984] 
precursors 
1 integrated 
wellness 
missing dietary, 
discharge care 
plans  
yes  yes, "from womb to 
tomb" 
Kaiser 
1a integrated 
service  via a 
smart system 
missing integrated, 
patient 
diagnosis and 
order profile 
integrated 
medical and 
financial 
yes, AI, expert sytems  OncoCyn 
2 customized 
wellness re-
commendations 
3,18, 41, 
47,54,69, 
91,97 
dietary, 
discharge care 
plans, 
yes  yes, "from womb to 
tomb" 
Kaiser, 
Regenstrief 
3 group  health 
management 
82,83 discharge  care 
plans with 
patient chart 
could be, 
follow ups 
combined with 
patient chart 
yes, analyze health care 
protocols to determine 
standards and norms 
Kaiser, HCHP @ 
MGH 
4 integration  of  in- 
and outpatient 
records 
missing yes  yes  yes  Kaiser,  MGH 
5 inclusion  of 
ancillary 
services 
2,17,34, 
47,53,68, 
85,97 
yes yes yes  TDS,  HCHP, 
ARAMIS 
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  Feature    claim  USC [  AAMRS    Next 3 Gen's of HIS   precursors 
6 workman's 
compensation 
capability 
33, 84  medicare, 
insurance 
billing 
multiple 
insurance 
carriers 
yes, includes standard 
insurance 
Technekron 
7 precertification  9,10,24, 
35,40, 
47-51,60, 
61,75,76, 
89 
utilization 
review, 
reports, 
treatment 
plans, 
admission and   
transfers 
(ADT) 
referrals, 
follow-ups, 
triage, cost 
reviews, 
utilization 
reviews, 
admission and   
transfers  
integrated financial and 
patient management 
with clinical decision 
support systems   
Optimed 
8 patient  discharge 
planning and 
monitoring 
missing discharge  care 
plans  
follow ups, 
patient chart, 
discharge and 
transfers 
integrated financial and 
patient management 
with clinical decision 
support systems   
Help, oncocyn 
 
9 interactive  links 
to cost-benefit 
review 
1,9,47,48, 
52,55,97,9
8 
yes yes integrated  financial  and 
patient management 
with clinical decision 
support systems   
OptiMed 
9a  second opinions  73-76  utilization re 
view,  
treatment 
plans, ADT 
as a form of 
cost reviews 
and utilization 
review, ADT 
integrated financial and 
patient management 
with clinical decision 
support systems   
BankOne 
10 customized  utili-
zation review per 
criteria 
ignored since neither the specifications nor the claims defined what customization is intended. 
11 concurrent  and 
retrospective 
review 
1,4,16,19, 
52,55,102 
utilization 
review, 
reports, 
treatment plans 
yes integrated  financial  and 
patient management 
with clinical decision 
support systems   
OptiMed, 
Lifecard 
12 quality  control 
by cost-benefit 
review 
47, 97  yes  yes  integrated financial and 
patient management 
with clinical decision 
support systems based 
on medical expert 
systems 
Optimed 
13 on-line  test 
results, images, 
in MD offices 
missing yes  yes  yes  Oncocyn 
14 real-time 
connection to  
employers 
missing no  no  no  VA 
14a   payroll linkage  31,37,47,8
2, 83,97 
no no no  Technekron 
15  banks are inte-
grated for EFT 
missing  yes  yes  yes, enhance financial  BankOne 
 
Table 1.7  Features of the `105 patent Specification and Their Anticipation, Continued 
 
Reimbursement systems existed prior to the filing of the patent. (see [BankOne:1989], 
and Singer's correspondence [Singer: 2000D, Exhibit 17] ). 
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[Singer:2000] ) rejects certain prior systems as not being comprehensive. However, the 
prior art addressed by [Singer:2000] operated in association with other subsystems 
serving other aspects of healthcare, even if not in the most elegant fashion.  
 
The ‘105 patent discloses a tight integration (see Definition 3.22) of information flow to 
support all health care functions: We quote from the patent [`105: c. l. 36-51]: 
 
However, such systems have not heretofore featured the total health care function, 
for they have not integrated important elements of total health care such as 
comprehensive preventive health measures, the review of the necessity for 
implementing selected procedures including changes in life styles, the obtaining 
of second opinions, (i.e., utilization review/case management) and other functions 
contemplated by total health management such as ancillary services. Neither have 
they included integration of the active participation by a patient's employer or 
inclusion of a patients' own available cash balances. Accordingly, since these 
missing functions are important ingredients to extend proposals of the prior art to 
fully comprehensive medical care, there has continued to be a need for a system 
which provides full integration of each of the aforementioned activities. 
 
In his deposition, Cummings reinforces that various independent systems must operate 
together [Cummings:2002, p. 8  l. 14-16, p. 9  l. 12 to 25, p. 10  l. 1-10]  
 
Q: What system is that that you use? 
A. We use a variety of systems, so they're integrated together, but our major 
clinical system is SMS." 
Q:  What other kinds of systems are involved? 
A.  There's lab systems such as SunQuest systems. There's picture archiving 
systems for Pac's applications. That would be in the area of radiology. 
Q. Anything else you can think of? 
A. Not -- I mean, there's a whole mapping of all those systems.  There are a 
number of them. 
Q. Do those systems interconnect with each other in any way? 
A. Yes. Not to the degree we would like to have them interconnect, but some of 
them do -- you know, they report information, and we are integrating those all the 
time. That's the Quest. 
Q. Now, these three examples that you gave me, are they part of the SMS?  Are 
they separate from the SMS? 
A. SMS is the one around the clinical, the nursing and the nursing clinical and 
those kinds of things.  The SunQuest system or the lab system would be a system 
they can interface with. 
 Q. Okay.  They also interface with a picture archiving system? 
 A. Yes, they do theoretically.  How well that's deployed or how well that 
executes, we're in the process of implementation, so stay tuned. 
 
It is an open question to what extent the systems have to be tightly integrated, i.e., 
supplied by a single vendor, as the quoted prior art has been, or composed, as we find in 
the practice at the author of the `105 patent's home institution, at the accused sites, and as   32
is and has been a practice in the industry since before the filing of the ‘105 patent.  No 
definition is given, and the practice of computing has not been consistent. The early 
dictionaries define  
"Integration: The combining of diverse elements of hardware and software, often 
acquired from different vendors, into a unified system"; [Webster:1994], 
 
but later editions give up and fail to define this or related terms [Websters:2000]. 
 
The `105 specifications also state: 
 
Thus, as earlier mentioned and as described below, supporting and ancillary 
services are integrated into the System and are effective to provide such ancillary 
services and support as are called for by the attending physician or other 
authorized staff personnel. 
 
Here it appears that other systems may be integrated with the system described in the 
`105 patent.  No further use of the term is made, except that the preambles to Claims 47-
51 and 98-101 state that these claims represent integrated systems. We could not find a 
structural difference between these nine systems and the 92 other system configurations.  
We must conclude that the labeling of systems as being `integrated' or not within the 
scope of the `105 systems is meaningless. 
 
Given this lack of guidance from the `105 patent and the relevant literature, we conclude 
that the patent can not restrict nor demand that systems be constructed as a whole, versus 
being assembled from components. 
 
In table 1.7 we match the features listed in the specification with prior art in individual 
systems.  We find that all of them have existed in prior art, and that all of them, except 
smart systems, have been included as components in larger healthcare systems.  
 
The novelty, if any, set forth in the claims of the ‘105 patent is the addition of a `smart 
system', as described above in Section 1.5 to perform the function of tentatively 
identifying a proposed mode of treatment in response to input of data symbolic of 
symptoms. Note that this capability recapitulates the issue in Section 1.1 of this report, 
namely that there is a "discontinuity".  The `smart system', needed to distinguish the `105 
patent from common understanding and practice, is not described except by use of the 
term itself in the patent specification. It plays an important role in the depositions of the 
author of the `105 patent [Cummings:2000]. 
 
1.8 Obviousness 
As described above, the features described in the `105 patent have been available 
individuality or in various combinations in earlier systems.  Combining them in a 
modular fashion would have been obvious to one of ordinary skill in the art at the time of 
the filing of the ‘105 patent.  The list of over 175 features of HIS, given in 
[Wiederhold:1981] and  [Brian:1981] are prefixed with the advice:   33
The matrices are intended to serve as points of reference for hospital decision-
makers to use in the process of developing system specifications and selecting an 
AHIS. The Hospital/Applications Matrix may be used to identify what types of 
applications are being employed by various sizes of hospitals. The System 
Supplier/Application matrix may be used to match against your hospital's desired 
application profile to determine the likelihood that the configuration desired will 
be available from one or more potential suppliers [AHIS:1981, p. B2]. 
For users of the Automated Hospital Information Systems Workbook [AHIS:1981] the 
choice of which sub-systems to integrate is a cost-benefit tradeoff and does not involve 
any new great intellectual insight.   
 
Technical elements of the descriptions include a listing of the applications offered 
and their mode of operation, the type of user interface equipment used, data 
retention characteristics and development support requirements. These elements 
are designed to be employed by personnel with the technical experience and 
expertise to determine the relevance of these characteristics to the individual 
hospital's desires and requirements [AHIS:1981, p. C1]. 
 
That various combinations of these features will be available in actual systems is made 
clear in the literature. See Section 4.3.2 and 4.3.3. 
 
Being comprehensive, ( i.e., including all features), is an abstract ideal in health care. The 
software is already costly to implement and maintain. But the cost of the software is a 
small fraction of the cost of operating a health care system. Data, as patient's symptoms, 
medical history, diagnoses, physician's and nurse’s notes, treatment records, etc., are 
voluminous and costly to collect and record accurately. A designer of a health care 
system will weigh the costs versus the benefits to be obtained. Even promoters of 
“comprehensive” healthcare systems have stressed the need to proceed gradually, starting 
with a few modules and adding other modules as needs arise and justify the additional 
cost [Barnett:1967] [Barnett:1976] [Barnett:1978] [Barnett:1987].  Selecting modules 
incrementally, as the need for sharing the knowledge that is the basis for the systems 
arises, is also emphasized in Greenes [Greenes:1990].  
 
Since the specification considers all features to be optional, the number of distinct 
`Comprehensive Health Care Systems' covered is huge (well over a million). Since all of 
the features were preexisting [Cummings V:2000, p. 203 l. 17-25] except for the 
augmentation with a `smart system', investigation of prior art not including a `smart 
system', would have required more resources than the patent office could possibly bring 
to bear on the issuance of the patent.  Many preexisting systems contained several of the 
18 features, but none provided the automated diagnosis function.  We deduce hence, that 
the inclusion of a ‘smart system’ that tentatively identifies a proposed mode of treatment 
in response to input of data symbolic of symptoms is indeed the distinguishing feature of 
the ‘105 claims.  
 
The fact that the inclusion of features is not one of invention but merely one of selection 
is clear from the claims section of the patent itself, where claim 4 and its dependent   34
claims 5-12, claim 19 and its dependent claims 20-27, claim 34 and its dependent claims 
35-46, claim 70 and its dependent claims 72-81, claim 85 and its dependent claims 86-96, 
and claim 97 and its dependent claims 98-101, all show a similar structure, as if they 
were mechanically generated.  The intellectual contribution of permuting claims is low, 
and does not reflect inventiveness, but only a desire to profit from the work of others.  
  
1.9 Vagueness in the Patent 
In addition to the crucial discontinuity cited in Section 1.1, there are many other instances 
of vagueness in the patent, that deny the public of reliable notice of what is within and 
without the scope of the claims.  We listed specifically the problems with Utilization 
Review (Section 1.3), Medical History (Section 1.4), smart systems (Section 1.5), and 
Expert Systems (Section 1.6).  There are further instances of vagueness that we address 
below. 
 
1.9.1 Comprehensive is a term both applied to the computer systems and health care 
services.  We provide definitions of both in Definition 3.12 and  3.13. Both of them have 
unattainable, ideal endpoints.   
 
The comprehensiveness of health care computer systems is limited by our ability to build, 
obtain data, maintain, and pay for them. For each candidate feature (see list of `105 
features in Section 1.7) a cost/benefit analysis is required to see if there is a payoff.  
 
The comprehensiveness of health care, providing quality healthcare for everyone 
throughout their life is an even loftier goal, and impacts our national economy and 
political will. It can be aided, but not achieved by having better systems.   
 
Unfortunately, throughout the patent and the ensuing reports the two are not well 
distinguished, leading to confusion and inconsistencies, see Section 5.5 and Section 5.6. 
The confusion gets worse when the term comprehensive is applied to health care payment 
systems, as implemented by TRIGON. (see Section 5.8). 
 
1.9.2 Integrated System: The term, integrated system, is used a few times in the 
specification and in the preambles of 10 of the claims, but is never defined. In general, 
integration is a desirable goal, but the means to achieve it vary greatly.  Tight integration 
typically means a fixed set of services provided by a single vendor. Loose integration 
allows multiple subsystems to inter-operate asynchronously, initiating remote processing 
and communicating data electronically as needed. Since it does not have a fixed meaning 
in the literature [Webster:1994] versus [Webster:2000] it has led to misleading arguments 
as to what the intent of the patent is and what prior art is relevant. We cover the issue in 
more detail in Section 5.4.2 where such an argument arises. 
 
1.9.3 Versatile: It is stated that "the System is very versatile in that it can be tailored to 
include either or both of the Utilization Review and Second Opinion" (6, 20-22).  How 
this versatility is achieved is not stated. Having choices in implementing software 
systems is common. It is unclear if `very versatile' means a simple choice in system   35
feature selection or something that is really uncommon. This appears to be merely a 
marketing term of no technical value, although it is cited as a benefit in some expert 
reports.  
 
1.9.4 Role of the Patient. We recapitulate an observation of [Kaliski:2002, p. 9, footnote 
3] "In fact, although perhaps desirable, nowhere in Figure 1 of the `105 patent is the patient 
even depicted as a participant (unlike, for example, a financial institution), although the 
specification plainly states that Fig. 1 ‘depicts the principal components of the preferred 
system in accordance with the principles of the invention.’ (4:5-7)" The importance of the 
patient as a participant is emphasized in the abstract and a few times in the initial 
specifications. Subsequently, the patient is reduced to a supplier of symptoms and 
provider of insurance or payroll deductions. The only automated participation of patients 
is the access to their available cash balances (1:46).  Marketing of comprehensiveness 
and neglect in execution is known to create unhappiness with the consumers of healthcare 
services, and will also create problems in any system validation. 
 
1.9.5 Patient Data Entry. Only Claim 58 specifies entry of individual patient 
information. However, many of the other claims depend on having such data available, 
 
1.9.6 The Terminal shown is a Point-of-Sale Terminal Phone. The function of the 
input means is performed by the terminal shown in Figure 2, which is clearly a telephone 
with the capability of a swipe card and speed dialing.  It does not include the capabilities 
required for the patent and listed in the `105 specification: 
 
Now turning to FIG. 2, it will be observed that it depicts, in a perspective view, a 
terminal suitable for utilization in the System as identified by symbols 11a-11c in 
FIG. 1. Although as mentioned above, all of the features of the illustrated terminal 
are not required in order to practice the principles of the invention and thus some 
of them are optional, it is deemed apparent that each of the features illustrated are 
attractive and add to the usefulness of the terminal.  
 
The terminal of FIG. 2 includes a main housing 50 having a visual display 
window 51, a card data entry slot 52 having an elongated portion 53 and an 
enlarged portion 54, conventional manual data entry keyboard 55 and 10-key 
numeric calculator 56. It also includes conventional telephone handset cradle 57 
and telephone handset 58. As will be evident from reference to FIG. 2, the 
terminal is operative in accordance with techniques well known in the data 
processing arts. Thus, for example, manual entry of information may be made by 
depressing the appropriate keys on keyboard 55, and information entry may also 
be made by inserting a conventional or special data-containing card (e.g., a "swipe 
card") into data entry slot 52 and moving it laterally there through. Although not 
necessary to the practice of the invention hereof, it is contemplated that the 
terminal will be responsive to data entry through conventional credit cards as well 
as special cards that may be issued for such purpose. It is also contemplated that 
the terminal may be adapted for reading bar codes such as those conventionally   36
employed for identifying merchandise. 
 
1.10 Organizational and Syntax Errors  
The number of errors in the ‘105 patent is such that interpretation and search are 
hampered. 
  
First of all, the description of the preferred embodiment occupies most of the 
specification section.  That preferred embodiment lists so many choices that we cannot 
tell what is actually preferred. It does not indicate any actual implementation, and does 
not show any demonstration of the system, even in one single version.  We are not 
surprised that Allcare and Cummings have never implemented a system according to the 
patent [Kurtyka:2002, p 291-292]. 
 
There are many important features of health care that appear in the specification as 
contribution of the invention, but are not specifically claimed.  For instance `planning', an 
important aspect of developing treatment sequences, is mentioned several times in the 
specification, but never in the claims. No technology for planning is indicated in the `105.  
patent.  Should we now assume that planning is an implied step in any step of any claim 
where planning makes sense? 
 
Including many substantial unclaimed features is confusing to reviewers, who will tend to 
ascribe aspects to claim elements that are not actually there. We see in the expert reports 
for this case that on some topics the discussion focuses on the claims, and on other topics 
on the specification and the preferred embodiment. Since the specification and the claims 
do not match, arguments ensue that should not occur.   
 
1.10.1 In the Specification 
 
•  "several of the following operations" is not followed by any operations [`105: c. 6 
l. 16]  
•  promise of an "ensuing description", which never occurs [`105: c. 6 l. 20] 
•  1-800-4Health - real phone number not associated with Allcare. 
•  The term "Diagnostic Testline Attendance" [`105: box 123] goes undefined. 
•  Wellness Health Management System goes undefined.  
•  Transaction File, Procedure File, and Library file named but not used or defined. 
 
1.10.2 In the Claims 
 
•  In Claim 16b, use of 'option' instead of 'opinion'. 
•  Claim 56 is an incomplete sentence. 
•  Claim 67 clearly shows the direct mapping of symptoms to treatment plan was 
intended to be an automated process.  
 
67(e) accessing said data symbolic of patient symptoms for tentatively identifying 
a proposed mode of treatment and   37
 
This wording clarifies that the appropriate interpretation of “for tentatively 
identifying a proposed mode of  treatment” is as an automated function based on 
symptoms.  While no additional function or mechanism is described that would 
enhance the system in this claim, the use of the term accessing at least implies that 
the data symbolic of patient symptoms has been previously stored so that it could 
be accessed.  Whether or not the system requires prior storage of symptoms does 
not alter the conclusion that the system automatically generates the proposed 
mode of treatment and is not a function performed manually by the provider. 
 
•  In Claim 85 the proposed mode of treatment is based only on the medical history. 
We have first an ambiguity of what is intended here (see Definition 3.7). Even if 
the most liberal definition of Medical History were employed it would be unwise 
not to consider the problem that the patient is currently presenting. 
   
1. If the `data bank memory' is at the physician's office then it might contain a 
proper medical history, but now the `smart system' proposing treatments and 
ancillary services resides in the physician’s offices.  There is no interaction with 
any insurance carrier.   
 
2. If the `data bank memory' is part of the insurance carrier's system then its 
contents are limited to the reimbursed claims history (see Definition 3.8). Any 
claim history that may be held by a carrier would be insufficient to permit a 
system to propose a mode of treatment. 
 
Then procedures are selected before treatments are proposed. There is nothing 
said about payment.  
 
1.11 Human Intervention for Certain Processing Steps 
 
All of the patents cited in the ‘105 patent have one basic flaw that is from input to 
automated computation to output. There is no manual human-based step in the automated 
computational phase. A human may generate input and receive output, but a human does 
not get involved in the automated computational step. 
 
A work flow system is an example of a mix of automated computational and human-
manual intervention. Work is routed in an automated fashion and processed until it lands 
on the desktop (or email box) of a human. The human reads the work items, performs 
some actions, marks the work item as completed, and then the work item again enters the 
automated computational system. 
 
Claims processing when it was all paper based is an example of a 100% human-manual 
process. As computers evolved and claims systems were built, more of the claims system 
got automated, but even today there are a work force of humans that look at the claims 
(CHIPS and TRIMED people for example). It is very important to note that TRIGON   38
uses a claims workflow system with a combination of automated computational and 
human-based manual processing. 
 
If one allows a human-based manual step in the automated computation then every 
system must be allowed, because the human could do anything including another 
computation. 
 
Both Cummings and Kaliski in their deposition describe systems that are both automated 
computational and human-based manual processing. The `105 patent in the claims only 
includes automated computations. The specification talks about both. Their process 
descriptions swap `smart systems' in and out at will.  
 
Thus, if we follow the structure and operation of the claims section of the ‘105 patent, the 
recited embodiment is not enabled and cannot be built.  If the urged construction, 
permitting an undefined mix of automated computational and human-based manual 
processing, is adopted, then there is no distinction between the claimed embodiments and 
principally manual operations of any other claim processing system, even one that was 
100% paper and human-manual.  Because the manual versus automated implementation 
as urged by Allcare is arbitrary, not based on any distinctions described in the 
specification, the necessary result of adoption of the construction urged by Allcare, 
Kaliski and Holland is that any system, including pre-1990 Trigon system, would then 
invalidate the patent. 
 
We do not agree with [Kaliski:2002,  [Kaliski:2002D ] or [Cummings:2002, pp. 23-25] 
that all computer programs are smart, as that interpretation renders the term “smart” 
meaningless. 
 
We also dispute that a proper construction of the ‘105 claims can allow the substitution of 
automated, computer-based processing by manual handling of medical or auxiliary staff 
[Cummings:2000][Cummings:2002].   
Q: You envisioned that the invention would require a patient, a healthcare 
provider, a bank or other financial institution, an insurance company, a utilization 
reviewer, and an employer?  
A:  Yes . .  It can also work with paper, a debit card, manually. ...   
Q: So if were all done on paper that would be within the scope of your invention? 
A: Right. Near time is required.  
Q: `Your invention does not cover retrospective systems'.  
A: `It can',  [abstract of Cummings II: 2000, pp.130  l. 5 – pp.133  l. 5]. 
 
If the claims were to be interpreted that broadly, they would be unsupportable, since 
mixed (automated and manual) operations have been ongoing for many years in 
healthcare. Physicians have had to diagnose patients based on presented symptoms since 
Aesculapius: Ad sanitatem gradus est novisse morbum (The first step toward cure is to 
know what the disease is).  Predecessors of TRIGON had to validate eligibility for 
reimbursement for decades, ever since health care insurance was instituted.  
[MetropolitianLife:1985].  The prior art revealed in the application for the patent deals   39
only with automated systems, systems in which there are no intermediary manual 
processes.  We could not locate in the prosecution history any reference to manual 
processes.  
 
If the ‘105 claims were interpreted as having a physician converting symptoms to 
treatment, then the Bank One system shows all of the claimed features, since it expects a 
physician to make the same conversion, before submitting diagnoses to the insurance 
system for edit an adjudication [Kurtyka:2002, p 37, 38].    
 
None of the prior art cited in `105 and none of the prosecution history mentions manual 
steps other than initial input and final payment. The  claims do not list intermediate 
manual steps either, see Section 4.0 for a rationale. If manual conversions were 
considered by the applicant or the Examiner to be included, prior art showing manual 
steps would have been cited.  That neither the applicant nor the Examiner cited such prior 
art reinforces our conclusion that proper interpretation of the claims requires automated 
and not manual conversions. 
1.12 The Vision of the Patent Invalidates Subsequent Art 
As stated by the author of the `105 patent and many of the experts, the `105 patent 
presents a vision. Many other people had the same vision and talked about it, often 
informally at conference keynotes intended to motivate audiences to perform research 
and development towards the annunciated goal [Barnett:1967] [Barnett:1976] 
[Barnett:1978] [Barnett:1987] [Halverson:1984].  I quote from my own writings; 
[Wiederhold:1981, Databases for Healthcare]: 
 
The fact that data are shared promotes consistency of information for decision-
making and reduces duplicate data collection, A major benefit of databases in 
health care is due to the application of information to the management of services 
and the allocation of resources needed for those services, but communication 
through the shared information among health care providers, and the validation of 
medical care hypotheses from observation on patients are also significant. 
 
Patenting the vision of a system that is not described in a manner sufficient to enable one 
of ordinary skill in the art to make and use the system is a misuse of the patent process. 
Patenting a non-enabled system discourages research and development in that arena, 
since the results of subsequent researchers would be covered by the prior patent and 
hence incur licensing costs, rather than sales or licensing benefits. Hence, in my, non-
legal opinion, this patent violates the intent of the Constitution: 
 
To promote the progress of science and useful arts by securing for limited times to 
authors and inventors the exclusive right to their respective writings and 
discoveries. 
 
because without an enabling disclosure, it does not promote progress.   
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I am disappointed that the applicant has fallen into the trap of pursuing financial gain 
based on the ongoing work of others. Instead of helping to improve the healthcare 
systems, he is forcing the health care industry to defend against this patent, creating costs, 
distractions, discouragement, and reducing available resources by a high multiple of the 
financial gains accruing to the holder of the `105 patent.  
   41
 
2. Non-Infringement 
 
The defendants systems differ in many crucial aspects from the systems described in the 
claims of patent ‘105.  The plaintiff and its experts have urged construction and coverage 
of certain claims of the ‘105 vision that are both unjustifiably broad and vague. 
 
We start by describing elements that occur repeatedly in ‘105 claims that the plaintiff has 
indicated to be infringed.  In Section 2.2, we describe the relevant portions of defendants’ 
systems. In Section 2.3, we go through all the claims asserted by Allcare versus TRIGON 
and match the elements that do not fall within the scope of those claims.  In Section 2.4, 
we list individual system components in TRIGON's operation and indicate which of their 
functions correspond to steps in the `105 claims, and why these TRIGON subsystems 
individually do not infringe.  Finally, in Section 2.5 we briefly cite other issues that 
substantiate non-infringement. 
2.1 Elements that do not read on accused systems 
We list now the elements that Allcare has asserted to be within the scope of one or more 
claims.  
   
2.1.1 No Automatic Denial for Medical Causes 
 
Trigon does not automatically prevent payment for medical reasons. 
 
None of the accused systems prevent or deny payment for treatment automatically for 
patient-specific medical reasons. Payment will be denied for contractual reasons as 
specified by the plan, namely, to people that are not members of the plan or for 
treatments that are specifically excluded in the plan (say psychiatric care). Any further 
denial of payment is made by Medical staff, i.e., trained MDs. 
 
In [Cummings:2000] the author of the `105 patent tries to generalize the vision of the 
`105 patent by including manual processing (see Section 5.1.7). Such a generalization 
would result in a claim interpretation that includes the prior art (see Section 1.2) 
 
The `105 patent, as specified, does not include any structure for manual intervention in 
the payment approval process.  The apparatus description states clearly that all terminal 
devices, printers, monitors, and displays are located in the physician's office, and the 
methods described in the `105 claims do not require any such devices to be located at the 
insurance carrier, inhibiting manual intervention. An expert report [Kaliski:2002] 
attempts to generalize the specification of the patent by stating that since the `105 patent 
describes an instance of a distributed system, and since distributed systems have 
terminals in arbitrary locations, the system described by the `105 patent can have 
terminals anywhere, including at the insurer's, here at TRIGON's site. This is an 
unwarranted extrapolation and generalization and is not supported by the specification. 
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2.1.2 No Automated Processing of Symptoms. 
 
No automated processing of symptoms in the reimbursement claims approval / 
denial process. 
 
No patient symptom data are available for processing. 
Trigon does not process symptoms.   
Trigon does not collect patient symptoms. 
Trigon does not process symptoms automatically. 
 
In the accused system, approval of inpatient reimbursement claim is based on the contract 
and the diagnosis of the patient and, if needed, on information obtained by telephonic 
interaction with medical staff at the hospital. Similarly, in the accused system, approval 
of payment claim for outpatient office visits and referrals is based on the contract and the 
diagnosis reported by the physician.   
 
Symptom information is not encoded in reimbursement claims for payment. It could be 
entered on a text field but is not processed automatically, and not even made available to 
the medical staff associated with the Trimed system.    
 
The ‘105 patent claims require automated processing based on symptoms.  
Trigon does not have more than occasional access to symptoms; those best remain with 
the physician. 
No Trigon systems infringe on that pervasive `105 patent claim in its various forms. 
 
2.1.3 No Automated Processing of the Patient's Medical History. 
 
No automated processing of the patient's medical history in the reimbursement 
claims approval / denial process. 
 
Trigon's databanks do not include predetermined items of medical history. 
Trigon does not store a medical history. 
Trigon does not collect predetermined items of medical history. 
Trigon does not keep a medical history. 
Trigon systems cannot access predetermined items of medical history. 
Trigon does not process medical histories. 
 
Trigon's databanks do not include physical profiles.  
Trigon does not store physical profiles. 
Trigon does not collect physical profiles. 
 
Trigon does not collect a personal health profile. 
 
In the accused system approval of inpatient reimbursement claim is based on the contract 
and the diagnosis of the patient and, if needed, telephonic interaction with medical staff at   43
the hospital. Similarly, in the accused system approval of reimbursement claim for office 
visits and referrals is based on the contract and the diagnosis reported by the physician.   
Only a limited Reimbursement Claims History (see Definition 3.8) is available to the 
adjudication process, and even that reimbursement claims history is not available to the 
automated processes used in TRIGON. 
 
If the Medical Directors (see Definition 3.14) at Trigon need information about the 
patient's Medical History (see Definition 3.7) in order to help in adjudicating a 
reimbursement claim, they resort to calling the patient's primary health care provider's 
office. The patent, in Claims (see Section 1.4) specifies automation in use of a Medical 
History in reimbursement claims processing, since no Terminal is specified that allows 
the Medical Director to interact or view a Medical History (see Section 5.5.1).  While we 
could design such a system, and as Kaliski argues (see Section 5.5.1), a distributed 
system as specified in the specification of the patent might well have terminals at all of its 
sites, such an extension only provides the means, but does not show any intent of the `105 
patent to allow manual processing (see also Section 1.12 on human intervention).  We 
certainly cannot also extend the claims to enlarge the critical function of determining the 
appropriateness of the treatment, and include a second source (the provider's discussion 
of the patient's Medical History) in addition to the Reimbursement Claims History (the 
history collected at TRIGON and made available to the manual adjudication process). If 
such extensions were warranted. 
 
The claim by Holland (see Section 5.6.1) on equivalence of the Patient's Medical History 
with the Reimbursement Claims History is specious. 
 
Since Trigon performs no automated processing of any kind of patient' history, and 
Trigon Medical directors can only use the system manually to access a limited 
reimbursement claims history, the Trigon systems do not infringe on the claims made by 
the plaintiff. 
 
If the interpretation of the `105 patent is to be so broadly construed to include the actual 
Trigon operation, then the issue of validity must be raised, since Trigon's predecessors 
and competitors had access to patient's Reimbursement claim Histories and could call 
providers on the phone to get information from the patient's Medical History.   
 
2.1.4 Smart Systems.   
 
Trigon does not attempt to identify treatment modes based on a medical history 
nor on symptoms. 
 
Here we revisit the issue of the major discontinuity, see Section 1.1. These process steps, 
specified in `105 appear to require the use of a `smart system' or `expert system', as 
mentioned in the specification. The term `smart system` does not appear in the claims and 
only appears in the specification.  The uniqueness of the patented vision relies on using 
smart technology to achieve this goal. Its importance is recognized by the patent holder 
(see Section 5.1.3 and 5.1.4)  and by the plaintiff's experts' reports (see Section 5.5.3).     44
 
 
2.1.5 Trigon does not Practice Medicine.  
 
Trigon does not propose medical treatments. 
Trigon does not identify proposed modes of treatment. 
 
Trigon does not provide for second opinions 
 
TRIGON provides for reimbursement of treatments proposed and performed by a 
physician.  It provides no feedback to the physician about alternative treatments that 
might be more effective. A physician may change his mode of practice based on not 
receiving full or partial reimbursement, how that practice will be altered remains the 
decision of the practitioner. 
 
Differences about treatment are often due to different value systems. For instance, a 
physician may seek a more promising treatment, but the patient has an aversion to risk or 
pain. Sometimes patients have heard about costly or unusual treatments that the physician 
has rejected as having had little or no additional benefit over commonly accepted 
alternatives. 
 
Second opinions are a means for a patient to gain confidence for a proposed treatment. 
Different treatments often reflect different value systems such as aversion to risk, pain, or 
acceptance in common practice. Trigon provides pre-certification of costly treatments 
proposed by a provider, but those are based on cost-effectiveness. Any denial of 
reimbursement for proposed treatment in cases involving medical necessity is made 
manually by Medically certified personnel at TRIMED system, not by any automated 
program.    
 
 
 
2.1.6 Trigon does not determine preventive care based on Symptoms.  
 
Trigon does not identify preventive health routines based on Symptoms. 
Trigon does not propose preventive care based on Symptoms. 
Trigon does not tentatively identify preventive health routines based on Symptoms. 
 
Trigon does not tailor wellness recommendations to specific patients, and certainly 
does not identify nor propose patient-specific preventive health routines or 
preventive health care based on symptoms reported by the patient.  It does not 
have access to such symptoms; those best remain with the physician.  
 
2.1.7 Ancillary Services including Pharmacy 
 
Trigon does not propose ancillary services.     45
Trigon does not provide ancillary services. 
Trigon does not keep a list of predetermined procedures requiring ancillary 
services. 
 
Ancillary services cover a wide range of diagnostic services and treatments (see 
Definition 3.11). In the opinion of the plaintiff's experts, pharmacy services are included 
when the term is used in the `105 patent. Any prescriptions for medication, normally 
presented to a Pharmacy, are passed through by TRIGON to an independent operation, 
MEDCO.  In practice, TRIGON is apt to see very few of those, since most prescriptions 
are brought by the patient to their pharmacies, who then deal with MEDCO or similar 
drug-management services directly. 
 
Other ancillary services, such as physical rehabilitation, are outside of TRIGON's sphere, 
since they again involve medical judgment.  Such services are proposed by physicians 
and provided by appropriate specialized health care facilities.  Such facilities may submit 
bills for reimbursement to TRIGON, and those bills will be dealt with in a manner 
analogous to in-and outpatient billing by hospitals and individual providers, as described 
in Section 2.1.2.  No automatic adjudication of such claims is or should be based on 
symptoms presented by the patient. 
 
TRIGON does not perform activities within the scope of the ‘105 claims that deal with 
preventive care. 
 
2.1.8 Illness 
 
We consider the term illness here ill defined. 
Trigon does not enter identification of symptoms for diagnosis of illnesses. 
Trigon does not enter identification of symptoms for treatment of illnesses. 
 
An illness (see Definition 3.3) is neither a diagnosis nor a treatment procedure. An illness 
represents a condition of the body or the mind that may be the complex interactions of 
many diagnoses manifesting as numerous symptoms.  
 
In the accused systems, approval of an inpatient reimbursement claim is based on the 
contract and the diagnosis of the patient and, if needed, telephonic interaction with the 
medical staff at the hospital. Similarly, in the accused system, approval of a payment 
claim for outpatient office visits and referrals is based on the contract and the diagnosis 
reported by the physician.   
 
Symptom information is not encoded in reimbursement claims for payment. It could be 
entered on a text field but is not processed automatically, and not even made available to 
the medical staff associated with the Trimed system.    
 
The ‘105 patent specification and claims require automated processing based on 
symptoms.  
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2.2 Trigon System 
 
The Trigon Systems, in their aggregate, form a health insurance reimbursement claims 
processing system. A reimbursement claim represents a request for a financial transaction 
on behalf of an individual policyholder and includes diagnosis and treatment information. 
Reimbursement claims are entered into the system where they are then adjudicated, 
resulting in financial transactions. Reimbursement claims may enter the system through 
many avenues, including paper, phone, web clients, or electronic transmission. The 
adjudication process is shared between two main sub-systems. One of the adjudication 
sub-systems resolves reimbursement claims that fall within excepted health insurance 
policy guidelines. The other adjudication sub-system resolve reimbursement claims that 
require additional medical information. The two sub-systems work together in tandem. 
The reimbursement claim may be associated with many adjudication sequences resulting 
in changes to the financial transaction and the reimbursement claim status. An 
explanation of benefits describes the financial transaction and reimbursement claim 
status. While many reimbursement claims are post-treatment, some reimbursement 
claims are pre-treatment to establish a predictable financial transaction outcome and 
status when the post-treatment reimbursement claim is presented.  
 
In addition to the reimbursement claims processing system, there are several other 
systems at Trigon. One such system is an informational web site. Another such system is 
a `Healthy Return' service. Other systems perform data mining of the reimbursement 
claims data in the aggregate to establish cost effectiveness of policy groups. 
 
 
Figure 1: A diagram of Trigon's operations, from the [Kurtyka:2002] expert report.    47
 
 
Figure 1 provides an overview of TRIGON's system architecture as perceived by one of 
the plaintiff's experts. It shows that TRIGON is a loosely integrated system, as per 
Definition 3.22.  The systems architecture sketched here conflicts with the patent 
specification  
"the integrated interconnection and interaction of the patient, health care 
provider, bank or other financial institution, utilization reviewer/case management 
and employer so as to include within a single system each of the essential 
elements to provide patients with complete and comprehensive health care and 
payment therefor. (1 :55-60)."  
This sentence favors a tightly integrated architecture, where all components are at least 
managed by a central authority, even if multiple computers and databanks may be in use. 
Allcare’s experts have been inconsistent in their interpretation.  Most have favored a 
loose coupling or a ‘distributed system’.  However, this is in conflict with Singer, who, 
when dismissing prior art, states that systems having external components means that 
those system are not integrated in the sense required by the `105 patent (see Section 5.4). 
 
Some peripheral elements are missing from Figure 1, as FEP, Claims Reimbursement 
data collection for Federal Employees, processed elsewhere.  
 
Both [Holland:2002] and [Kaliski:2002] give descriptions of the Trigon systems.  They 
also see the TRIGON systems as having a loosely integrated architecture. They believe 
that such an architecture matches the intent of the ‘105 patent. We do not herein endorse 
all aspects of their testimony regarding the Trigon systems.  We find that the Trigon 
systems do not include every element of any asserted claim of the `105 patent. 
 
2.2.1 Overview 
We list here the three principal steps involved in processing reimbursement claims, which 
include all the methods that the plaintiff asserts as being infringed by TRIGON: creation 
and submission, adjudication, and payment remittance. 
 
2.2.1.1 A Reimbursement Claim is Created. 
 
Reimbursement claims may be created and submitted on paper or through a computer 
system.  Paper claims are sent to an internal service component and converted there to 
electronic form.  Trigon also has a web application that is available to certain physician 
offices .  
 
A reimbursement claim may be submitted via electronic transmission to Trigon Open 
Network or MedUnite. Paper based reimbursement claims are entered into the system 
using OCR in the CMS component (box 9). Some reimbursement claims require manual 
entry by a Trigon employee.  
 
Claims for or from Out-of-State members use a clearinghouse (ITS) – box 8.   48
 
All reimbursement claims eventually enter the Claims Management System (CMS – 
box 9). In the CMS, claims are checked for syntax errors, obvious exclusions, and 
scrubbed for consistency. The reimbursement claim is now dispatched to one of many 
adjudication systems: the Comprehensive Health Insurance Processing System 
(CHIPS – box 10), the Federal Employee Program (FEP), the Inter-Plan 
Teleprocessing System (ITS), and the Amisys (box 11). 
 
2.2.1.2 A Reimbursement Claim is Adjudicated.  
 
CHIPS adjudicates reimbursement claims that fall within excepted health insurance 
policy guidelines. CHIPS works in tandem with TRIMED (box 5) when a 
reimbursement claim requires additional medical information. CHIPS validates a member 
and a provider, prices a reimbursement claim based on policy guidelines, and verifies 
pre-authorization, pre-certification, and referral information. Pre-authorization, pre-
certification, and a referral are not a guaranty of future reimbursement claim adjudication. 
A reimbursement claim may be put into the "pend"(ing) status if additional medical 
information is required. This reimbursement claim is now sent to TRIMED for medical-
based adjudication.  
 
FEP reimbursement claims are sent off-site to a federal government system for 
adjudication, then back to COS (unnumbered box ).  
 
ITS reimbursement claims happen when a policyholder of one Blue-Cross system uses 
another Blue-Cross system for treatment. ITS handles the case when a Trigon member 
uses another Blue-Cross system and the case when another Blue-Cross member uses a 
provider under the Trigon system.  
 
Amisys reimbursement claims are processed by a vendor purchased product and handle 
the HMO portion of Trigon's business. Reimbursement claims are processed based on 
managed care arrangements with fixed fees.  
 
All adjudicated reimbursement claims are sent to the Common Output System (COS).  
 
 
2.2.1.3 A Reimbursement Claim's Remittance. 
 
The Common Output System (COS) handles the remittance, the Explanation of 
Benefits (EOB), and the writing of reimbursement claims information into the (Product 
Profitability Report) PPR. The PPR is a data warehouse of reimbursement claims 
information and is used to establish, in aggregate, the profitability of policy groups and 
programs.  
 
2.2.1.4 Other Trigon Systems and Services.   49
 
Professional Forum is a monthly provider newsletter designed to communicate useful 
information to physicians for managing their practice, as well as up-to-date medical 
issues. 
 
Healthy Returns is an optional service for health maintenance and screening of health 
life styles used mainly by members during maternity.  
 
The Trigon Web Site is an informational health care site and not associated with 
reimbursement claims adjudication.  
 
2.2.2 Trigon Sub Systems 
We now describe the individual components. We list them in the logical processing order 
used for Section 2.2.1, followed by a section for secondary systems. 
To locate a systems component rapidly, we provide here an alphabetical index for the 
various systems and their common abbreviation. 
 
 
•  2.2.2.13   AIMS  
•  2.2.2.5   Amisys  
•  2.2.2.16  Admission Summary Kiosk (ASK)  
•  2.2.2.15   Claim Analysis Report System (CARS and CURS)   
•  2.2.2.4   Comprehensive Health Insurance Processing System (CHIPS) 
•  2.2.2.3   Claims Management System (CMS) 
•  2.2.2.9   Common Output System (COS) 
•  2.2.2.11    Data Pharmacy  
•  2.2.2.12     Enrollment  
•  2.2.2.7    Federal Employee Program (FEP) 
•  2.2.2.18   FSS, now called FAS,  Financial audit 
•  2.2.2.14   Healthy Returns  Maternity advice 
•  2.2.2.8   Inter-Plan Teleprocessing System  (ITS)  
•  2.2.2.2   Open Network a front-end service supplied by MedUnite  
•  2.2.2.10  Payment System with electronic funds transfers and  paper checks  
•  2.2.2.19  Performance Reward Program (PEX)  
•  2.2.2.17  Pharmacy Data Mart  
•  2.2.2.1   Point of Care (POC) 
•  2.2.2.20   Product Profitability Report  (PPR) 
•  2.2.2.21   Professional Forum 
•  2.2.2.23   Trigon Web Site   
•  2.2.2.6    Trimed, the adjudication system  
•  2.2.2.22   Tutorial and other Training Programs  
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2.2.2.1 Point of Care (POC) 
 
Point of Care (POC) is a web-based application with the feature of: patient eligibility 
verification, verify patient's benefits (copay and deductibles), reimbursement claims 
status, 151 Forms, Referrals (create, update, view, inquiry) , eReports (weekly 
remittance, explanations of payment, HMO capitation), reimbursement claim error 
notification, and inpatient Admissions (pre-certification). 
 
A family member is identified with an ID number. Each member of the family is 
identified with the triple of name, relationship, and date of birth. 
 
Using this system an individual, usually an administrator at the provider's location, can 
query for member eligibility, obtain reimbursement claims history per member or per 
provider, request an adjustment (form 151) to an already existing reimbursement claim 
and view the results of that request, obtain a remittance statement, obtain reimbursement 
claim error notification letters, obtain benefit information, submit a referral request and 
obtain a referral identification number, and request a pre-certification or a pre-
authorization.  
 
POC also provides linkages to Open Network (see 2.2.2.2) for electronic reimbursement 
claims submission and to Professional Forum (see 2.2.2.21), a newsletter. 
 
2.2.2.2 Open Network provides for electronic reimbursement claims submission support 
by a front-end service supplied by MedUnite. Note that it is actually a proprietary, rather 
than a public network, also independent from the Internet.  In that sense Trigon fails one 
of [Singer:2000]'s criteria, see Section 5.3.6. 
 
2.2.2.3  Claims Management System(CMS) 
 
The Claims Management System(CMS) dispatches all received reimbursement claims. 
Included in the CMS claims processing are checks for input errors and missing data. The 
claims are also scrubbed for consistency. Acceptable reimbursement claims are now 
dispatched to one of several adjudication systems: the Comprehensive Health 
Insurance Processing System (CHIPS), the Federal Employee Program (FEP), the 
Inter-Plan Teleprocessing System (ITS), and Amisys. A reimbursement claim rejected 
for input errors generates a proof-of-loss statement, which is made available to the 
provider who submitted the claim.  
 
2.2.2.4 The Comprehensive Health Insurance Processing System (CHIPS) 
 
The Comprehensive Health Insurance Processing System (CHIPS) adjudicates 
reimbursement claims that fall within excepted health insurance policy guidelines. 
CHIPS works in tandem with TRIMED when a reimbursement claim requires medically   51
justified decision-making. CHIPS validates a member and a provider, prices a 
reimbursement claim based on policy guidelines, and verifies pre-authorization, pre-
certification, and referral information. Pre-authorization, pre-certification, and a referral 
are not a guaranty of future reimbursement claim adjudication. A reimbursement claim 
may be put into the "pend"(ing) status if additional medical information is required. This 
reimbursement claim is now sent to TRIMED for medical-based adjudication.  
 
2.2.2.5 Amisys. 
 
Amisys. HMO reimbursement claims are adjudicated by Amisys, a product purchased 
from an external vendor. Amisys and CHIPS perform similar functions in a similar 
fashion. Both CHIPS and Amisys work in tandem with TRIMED when a reimbursement 
claim requires additional medical information. Amisys validates a member, a provider, 
and a facility, prices an HMO reimbursement claim based on policy guidelines, and 
verifies pre-authorization, pre-certification, and referral information. Pre-authorization, 
pre-certification, and a referral are not a guarantee of future HMO reimbursement claim 
adjudication. An HMO reimbursement claim may be put into the "pend"(ing) status if 
additional medical information is required. This HMO reimbursement claim is now sent 
to TRIMED for medical assessment. 
 
HMO reimbursement claims enter the system using paper, fax, phone, or electronic 
submission.  Most of the HMO reimbursement claims are processed in a batch mode 
fashion. The HMO reimbursement claims are pre-processed and grouped into episodes. 
Paper, fax, and phone HMO reimbursement claims are processed by MACESS, another 
purchased product that also acts as a call center for HMO staff.  
 
All adjudicated HMO reimbursement claims are sent to the COS for remittance, EOB, 
and the writing of a PPR record.  
 
2.2.2.6 Trimed 
 
Trimed performs medical-based adjudication based on medical necessity. This includes 
the initial approval, identification for pre-authorization, pre-certification, and referrals. A 
reimbursement claim contains diagnosis and treatment information. Additional medical 
information that may be needed to adjudicate the reimbursement claim is obtained 
telephonically.  Trained medical employees staff Trimed. There is no automated denial. 
A MD eventually adjudicates all denials. Though most pre-authorizations, pre-
certification, and referrals initial approvals are done pre-treatment, there are provisions 
and a grace period for post-treatment approvals.  
 
2.2.2.7 Federal Employee Program (FEP) 
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The Federal Employee Program (FEP)  sends reimbursement claims for federal 
employees to an off-site  federal government system for adjudication. These are then 
returned back and enter COS for payment remittance.  
 
2.2.2.8 Inter-Plan Teleprocessing System (ITS) 
 
The Inter-Plan Teleprocessing System (ITS) processes  reimbursement claims 
occurring when a policyholder of one Blue-Cross system uses another state Blue-Cross 
system for treatment. ITS handles both cases: 1. the case when a Trigon member uses 
another Blue-Cross system and, 2.  the case when another Blue-Cross member uses a 
provider under the Trigon aegis. 
 
2.2.2.9 Common Output System (COS) 
 
The Common Output System (COS) handles the remittance, the Explanation of 
Benefits (EOB), and the writing of reimbursement claims information into the (Product 
Profitability Report) PPR. COS also updates the general ledger system and generates 
the Explanation of Benefits (EOB) statements.  
 
2.2.2.10 Payment Systems 
 
Payment Systems at Trigon include electronic funds transfers and issuing traditional 
paper checks.  
 
2.2.2.11 Data Pharmacy. 
 
Data Pharmacy. A third-party vendor, Medco, processes pharmaceutical reimbursement 
claims and in some cases laboratory reimbursement claims. A patient presents a 
prescription to the pharmacy. An electronic reimbursement claim is sent to Medco for 
adjudication and remittance information is returned, resulting in optional co-pay and the 
dispensing of the pharmaceutical or the completion of the laboratory procedure. The 
Medco system uses the National Council for Prescription Drug Programs (NCPDP) 
standard for reimbursement claims processing as well as drug utilization review dealing 
with potential drug interactions.  
 
This reimbursement claim adjudication is outside of the scope of Trigon's reimbursement 
claims processing and remittance systems. A pre-authorization identifier is obtained for 
some pharmaceutical reimbursement claims using the Point of Care system. A PPR 
record (see 2.2.2.20) is written for drug claims. 
 
2.2.2.12 Enrollment   53
 
Enrollment is a desktop application used to update membership information.   
 
2.2.2.13 AIMS 
 
AIMS is the call center system. Either a member or a provider can place a phone call to 
AIMS. Reimbursement claim status information can then be viewed and missing 
reimbursement claims information can be provided. However, a new reimbursement 
claim cannot be created in AIMS. A record of the conversation, both audio and data, is 
stored. The last several data records, called Units of Work, are retrieved and presented on 
the display when the call is routed to the workstation as well as other identifying 
information. Demographical information may be modified during the call. 
 
2.2.2.14 Healthy Returns 
 
Healthy Returns is a service provided by Health Management Corporation. This is an 
optional service for members. At the request of the primary care provider and the 
member, progress relating to preventive health activities are reviewed. This service is 
mainly used by members during maternity. No data flows back to Trigon. Some data is 
sent to HMC to stratify potential members who might be interested in the service.  
 
2.2.2.15 CARS and CURS 
 
CARS. The Claim Utilization Report System (CURS) mines the PPR archive of 
reimbursement claim data, in a retrospective fashion. It aggregates results into Episode 
Treatment Groups (ETG) using a product from Symmetry. About two years of data is 
maintained.  
 
The Claim Analysis Report System (CARS) generates a series of internal reports based 
on the CURS data summarizing profitability aggregated by providers, facilities, 
pharmaceuticals, or programs. Other statistics are provided including visits per thousand 
members, hospital inpatient days per thousands, procedures per thousand, and 
pharmaceutical usage per thousand members. The information from these reports 
influences future financial rates.  
 
2.2.2.16 Admission Summary Kiosk (ASK) 
 
The Admission Summary Kiosk (ASK) is a similar system to CARS. The ASK system 
mines data from  hospital reimbursement claims from the PPR archive. The 3M based 
group is used to establish Diagnostic Related Groups (DRG) (See Definition 3.4). A 
series of internal reports are generated, summarizing profitability aggregated by DRG. 
Other statistics are provided including Length of Stay (LOS). These statistics are then   54
compared with data provided by Milliman and Robertson. The information from these 
reports then influences future financial rates.  
 
2.2.2.17  Pharmacy Data Mart 
 
Trigon's Pharmacy Data Mart system post-processes the pharmaceutical reimbursement 
claims PPR records sent by the pharmacy system, Medco. A complex series of queries 
seek potential drug therapy problems relating to cost effectiveness of alternative 
pharmaceuticals, resulting in an informational letter to the primary physician on record. 
The Drug Pharmacy Mart does NOT suggest a drug treatment. If a drug is prescribed 
when a lower cost alternative exists, then it makes a suggestion based on cost and not 
treatment. In addition, financial information, in the aggregate, is mined. 
 
2.2.2.18  FSS  
 
FSS , now called FAS, is a financial audit system at the facility and provider level. This 
information is mined from the PPR in aggregate. 
 
2.2.2.19 Performance Reward Program. 
 
Performance Reward Program. Provider Profiling is a system based on Soluicent's 
Peer-a-Med product that ranks primary care physicians associated with either the HMO 
or the POS plans within their peer group. In a retro-perspective fashion, about a year of 
PPR reimbursement claim data is mined. Informational reports are generated 
summarizing direct costs, indirect costs, and average patient cost per episode adjusted for 
clinical risk. Other statistics include financial information for top diagnoses and top 
procedures. These reports are then mailed to the provider.  
 
Performance Extra Program (PEX) is a physician incentive program based half on quality 
indicators and half on financial indications. A score is calculated. A patient satisfaction 
survey contributes 15% to the score. If the patient is provided tobacco cessation 
information, another 5% is contributed to the score. If the CDC guidelines are followed 
indicating adherence to the antibiotic usage guidelines, another 15%is added to the score. 
If either mammograms or adolescence well visits are indicated, another 15% is 
contributed to the score. If the provider accepts new patients that are covered under a 
Trigon policy, another 20% is contributed to the score. If the provider uses Point-of-Care 
for submission of claims, another 15% is contributed to the score. The provider profiling 
contributes the remaining 15% to the score. The score will be used to generate an annual 
financial incentive. This system is described in [ProfessionalForum:2001]. 
 
2.2.2.20 Product Profitability Report (PPR) 
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Product Profitability Report (PPR) is a data warehouse of archived reimbursement 
claims information and is used to establish, in aggregate, the profitability of policy 
groups and programs. Its contents cannot fulfill the need of a Medical History for patients 
covered by the organizations served by Trigon.  See Sections 3.7 and 3.8 for such 
distinctions.  Data are kept for two years and then periodically removed.   In addition to 
its limited content, it also fails Allcare's witness [Singer:2000]'s  criterion of maintaining 
long-lived data, see Section 5.3. 
 
2.2.2.21 Professional Forum 
 
Professional Forum is a monthly provider newsletter designed to communicate useful 
information for managing their practice, as well as up-to-date medical issues, and thus 
does not infringe on the `105 patent.  
 
2.2.2.22 Tutorial 
 
Tutorial and other Training Programs are educational. 
 
2.2.2.23 Trigon Web Site 
 
The Trigon Web Site is an information only service. 
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2.3 Elements of Patent `105 Claim that Disallow Infringement.  
 
The following asserted `105 patent claims are not infringed for the reasons stated in this 
section. We use Trigon here for the totality of systems available at Trigon.  In the next 
section we address individual systems against which `105 claims have been asserted. To 
the extent requested, I expect to testify on the facts set forth in Defendants’ claim chart 
and the Defendants’ positions set forth in the Joint Claim Chart.  
 
When the reason for disallowing infringement in a dependent claim is due inheritance 
from its independent predecessor, we have listed the entry in parentheses and prefixed it 
as (From Claim n ... ). 
 
 
Claim 1. (d) No patient symptom data are available for processing. [See 2.1.2] Trigon 
does not process symptoms. [See 2.1.2] Trigon does not automatically prevent payment 
for medical reasons. [See 2.1.1] 
 
Claim 2. Trigon does not propose ancillary services. [See 2.1.7] Trigon does not provide 
ancillary services. [See 2.1.7] (From Claim1: Trigon does not process symptoms. [See 
2.1.2] Trigon does not automatically prevent payment for medical reasons. [See 2.1.1])  
 
Claim 4. (b) Trigon's databanks do not include predetermined items of medical history. 
[See 2.1.3] (e) Trigon does not process symptoms. [See 2.1.2] 
 
Claim 5. Trigon 's databanks do not include physical profiles. [See 2.1.3] (From Claim 4 
(b) Trigon’s databanks do not include predetermined items of medical history. [See 2.1.3] 
(e) Trigon does not process symptoms. [See 2.1.2])  
 
Claim 6. Trigon does not collect predetermined items of medical history. [See 2.1.3] 
(From Claim 4 (b) Trigon's databanks do not include predetermined items of medical 
history. [See 2.1.3] (e) TRIGON does not process symptoms. [See 2.1.2])  
 
Claim 7. (From Claim 4 (b) Trigon's databanks do not include predetermined items of 
medical history. [See 2.1.3] (e) Trigon does not process symptoms. [See 2.1.2])  
 
Claim 8.  (From Claim 4 (b) Trigon's databanks do not include predetermined items of 
medical history. [See 2.1.3] (e) Trigon does not process symptoms. [See 2.1.2].  
 
Claim 9. (From Claim 4 (b) Trigon's databanks do not include predetermined items of 
medical history. [See 2.1.3] (e) TRIGON does not process symptoms. [See 2.1.2])  
 
Claim 12. (From Claim 4 (b) Trigon's databanks do not include predetermined items of 
medical history. [See 2.1.3] (e) Trigon does not process symptoms. [See 2.1.2])  
 
Claim 16. (d) No patient symptom data are available for processing at Trigon. [See 2.1.2]   57
Trigon does not process symptoms. [See 2.1.2]  Trigon does not automatically prevent 
payment for medical reasons. [See 2.1.1] Trigon does not provide for second opinions. 
[See 2.1.5] 
 
Claim 17. Trigon does not propose ancillary services. [See 2.1.7] Trigon does not provide 
ancillary services. [See 2.1.7] (From Claim 16 (d) No patient symptom data are available 
for processing at Trigon. [See 2.1.2] Trigon does not process symptoms. [See 2.1.2]  
Trigon does not automatically prevent payment for medical reasons. [See 2.1.1] Trigon 
does not provide for second opinions. [See 2.1.5]) 
 
Claim 19. (b) Trigon does not store a medical history. [See 2.1.3] (e) Trigon does not 
process symptoms. [See 2.1.2] Trigon does not automatically prevent payment for 
medical reasons. [See 2.1.1] Trigon does not provide for second opinions. [See 2.1.5] 
 
Claim 20. Trigon does not store physical profiles. [See 2.1.3] (From Claim 19 (b) Trigon 
does not store a medical history. [See 2.1.3] (e) Trigon does not process symptoms. [See 
2.1.2] Trigon does not automatically prevent payment for medical reasons. [See 2.1.1] 
Trigon does not provide for second opinions. [See 2.1.5]) 
 
Claim 21. Trigon does not collect predetermined items of medical history. [See 2.1.3] (b) 
Trigon does not store a medical history. [See 2.1.3] (e) Trigon does not process 
symptoms. [See 2.1.2] Trigon does not automatically prevent payment for medical 
reasons. [See 2.1.1] Trigon does not provide for second opinions. [See 2.1.5] 
 
Claim 22. (From Claim 19 (b) Trigon does not store a medical history. [See 2.1.3] (e) 
Trigon does not process symptoms. [See 2.1.2] Trigon does not automatically prevent 
payment for medical reasons. [See 2.1.1] Trigon does not provide for second opinions. 
[See 2.1.5]) 
 
Claim 23. (From Claim 19 (b) Trigon does not store a medical history. [See 2.1.3] (e) 
Trigon does not process symptoms. [See 2.1.2] Trigon does not automatically prevent 
payment for medical reasons. [See 2.1.1] Trigon does not provide for second opinions. 
[See 2.1.5]) 
 
Claim 24. (From Claim 19 (b) Trigon does not store a medical history. [See 2.1.3] (e) 
Trigon does not process symptoms. [See 2.1.2] Trigon does not automatically prevent 
payment for medical reasons. [See 2.1.1] Trigon does not provide for second opinions. 
[See 2.1.5]) 
  
Claim 27. (From Claim 19 (b) Trigon does not store a medical history. [See 2.1.3] (e) 
Trigon does not process symptoms. [See 2.1.2] Trigon does not automatically prevent 
payment for medical reasons. [See 2.1.1] Trigon does not provide for second opinions. 
[See 2.1.5]) 
 
Claim 34. (a) Trigon does not collect patient symptoms. [See 2.1.2] (b) Trigon does not 
store a medical history. [See 2.1.3] (c) Trigon does not keep a list of predetermined   58
procedures requiring ancillary services. [See 2.1.7] (d) Trigon does not propose ancillary 
services. [See 2.1.7] Trigon does not provide ancillary services. [See 2.1.7]  
 
Claim 35. Trigon does not store physical profiles. [See 2.1.3] (From Claim 34 (a) Trigon 
does not collect patient symptoms. [See 2.1.2] (b) Trigon does not store a medical 
history. [See 2.1.3] (c) Trigon does not keep a list of predetermined procedures requiring 
ancillary services. [See 2.1.7] (d) Trigon does not propose ancillary services. [See 2.1.7] 
Trigon does not provide ancillary services. [See 2.1.7]) 
 
Claim 36. Trigon does not collect predetermined items of medical history. [See 2.1.3] 
(From Claim 34. (a) Trigon does not collect patient symptoms. [See 2.1.2] (b) Trigon 
does not store a medical history. [See 2.1.3] (c) Trigon does not keep a list of 
predetermined procedures requiring ancillary services. [See 2.1.7] (d) Trigon does not 
propose ancillary services. [See 2.1.7] Trigon does not provide ancillary services. [See 
2.1.7]) 
 
Claim 37. (From Claim 34. (a) Trigon does not collect patient symptoms. [See 2.1.2] (b) 
Trigon does not store a medical history. [See 2.1.3] (c) Trigon does not keep a list of 
predetermined procedures requiring ancillary services. [See 2.1.7] (d) Trigon does not 
propose ancillary services. [See 2.1.7] Trigon does not provide ancillary services. [See 
2.1.7]) 
 
Claim 38. (From Claim 34. (a) Trigon does not collect patient symptoms. [See 2.1.2] (b) 
Trigon does not store a medical history. [See 2.1.3] (c) Trigon does not keep a list of 
predetermined procedures requiring ancillary services. [See 2.1.7] (d) Trigon does not 
propose ancillary services. [See 2.1.7] Trigon does not provide ancillary services. [See 
2.1.7]) 
 
Claim 39. (From Claim 34. (a) Trigon does not collect patient symptoms. [See 2.1.2] (b) 
Trigon does not store a medical history. [See 2.1.3] (c) Trigon does not keep a list of 
predetermined procedures requiring ancillary services. [See 2.1.7] (d) Trigon does not 
propose ancillary services. [See 2.1.7] Trigon does not provide ancillary services. [See 
2.1.7]) 
 
Claim 43. (From Claim 34. (a) Trigon does not collect patient symptoms. [See 2.1.2] (b) 
Trigon does not store a medical history. [See 2.1.3] (c) Trigon does not keep a list of 
predetermined procedures requiring ancillary services. [See 2.1.7] (d) Trigon does not 
propose ancillary services. [See 2.1.7] Trigon does not provide ancillary services. [See 
2.1.7]) 
 
Claim 52. (c) Trigon does not collect patient symptoms. [See 2.1.2] Trigon does not 
process symptoms. [See 2.1.2] (d) Trigon does not automatically prevent payment for 
medical reasons. [See 2.1.1] 
  
Claim 53. Trigon does not propose ancillary services. [See 2.1.7] Trigon does not provide 
ancillary services. [See 2.1.7] (From Claim 52. (c) Trigon does not collect patient   59
symptoms. [See 2.1.2] Trigon does not process symptoms. [See 2.1.2] (d) Trigon does 
not automatically prevent payment for medical reasons. [See 2.1.1]) 
 
Claim 54. Trigon does not identify preventive health routines based on Symptoms. [See 
2.1.6] (From Claim 52. (c) Trigon does not collect patient symptoms. [See 2.1.2] Trigon 
does not process symptoms. [See 2.1.2] (d) Trigon does not automatically prevent 
payment for medical reasons. [See 2.1.1]) 
  
Claim 55. (b) Trigon does not store a medical history. [See 2.1.3] (d) Trigon does not 
collect patient symptoms. [See 2.1.2] Trigon does not process symptoms. [See 2.1.2] (e) 
Trigon does not automatically prevent payment for medical reasons. [See 2.1.1] 
 
Claim 56. The claim wording is incomplete. (From Claim 55. (b) Trigon does not store a 
medical history. [See 2.1.3] (d) Trigon does not collect patient symptoms. [See 2.1.2] 
Trigon does not process symptoms. [See 2.1.2] (e) Trigon does not automatically prevent 
payment for medical reasons. [See 2.1.1]) 
 
Claim 57. Trigon does not collect predetermined items of medical history. [See 2.1.3] 
(From Claim 55. (b) Trigon does not store a medical history. [See 2.1.3] (d) Trigon does 
not collect patient symptoms. [See 2.1.2] Trigon does not process symptoms. [See 2.1.2] 
(e) Trigon does not automatically prevent payment for medical reasons. [See 2.1.1]) 
 
Claim 58. (From Claim 55. (b) Trigon does not store a medical history. [See 2.1.3] (d) 
Trigon does not collect patient symptoms. [See 2.1.2] Trigon does not process symptoms. 
[See 2.1.2] (e) Trigon does not automatically prevent payment for medical reasons. [See 
2.1.1]) 
 
Claim 59. (From Claim 55. (b) Trigon does not store a medical history. [See 2.1.3] (d) 
Trigon does not collect patient symptoms. [See 2.1.2] Trigon does not process symptoms. 
[See 2.1.2] (e) Trigon does not automatically prevent payment for medical reasons. [See 
2.1.1]) 
 
Claim 60. (From Claim 55. (b) Trigon does not store a medical history. [See 2.1.3] (d) 
Trigon does not collect patient symptoms. [See 2.1.2] Trigon does not process symptoms. 
[See 2.1.2] (e) Trigon does not automatically prevent payment for medical reasons. [See 
2.1.1]) 
 
Claim 63. (From Claim 57. Trigon does not collect predetermined items of medical 
history. (From Claim 55. (b) Trigon does not store a medical history. [See 2.1.3] (d) 
Trigon does not collect patient symptoms. [See 2.1.2] Trigon does not process symptoms. 
[See 2.1.2] (e) Trigon does not automatically prevent payment for medical reasons. [See 
2.1.1]) 
   
Claim 67. (c) Trigon does not collect patient symptoms. [See 2.1.2] (e) Trigon does not 
process symptoms. [See 2.1.2] (f) Trigon does not provide for second opinions. [See 
2.1.5]   60
 
Claim 68. (d) Trigon does not process symptoms automatically. [See 2.1.2] Trigon does 
not propose ancillary services. [See 2.1.7] Trigon does not provide ancillary services. 
[See 2.1.7] (From Claim 67. (c) Trigon does not collect patient symptoms. [See 2.1.2] (e) 
Trigon does not process symptoms. [See 2.1.2] (f) Trigon does not provide for second 
opinions. [See 2.1.5]) 
  
Claim 69. Trigon does not propose preventive care based on Symptoms. [See 2.1.6] 
(From Claim 67. (c) Trigon does not collect patient symptoms. [See 2.1.2] (e) Trigon 
does not process symptoms. [See 2.1.2] (f) Trigon does not provide for second opinions. 
[See 2.1.5]) 
 
Claim 70. (c) Trigon does not keep a medical history. [See 2.1.3] (c) Trigon does not 
provide for second opinions. [See 2.1.5] (d) Trigon does not collect patient symptoms. 
[See 2.1.2] (f) Trigon does not attempt to identify treatment modes based on a medical 
history nor on symptoms. [See 2.1.4]  (g) Trigon does not provide for second opinions. 
[See 2.1.5] 
 
Claim 71. Trigon does not collect physical profiles. [See 2.1.3] (From Claim 70. (c) 
Trigon does not keep a medical history. [See 2.1.3] (c) Trigon does not provide for 
second opinions. [See 2.1.5] (d) Trigon does not collect patient symptoms. [See 2.1.2] (f) 
Trigon does not attempt to identify treatment modes based on a medical history nor on 
symptoms. [See 2.1.4]  (g) Trigon does not provide for second opinions. [See 2.1.5]) 
 
Claim 72. Trigon systems cannot access predetermined items of medical history. [See 
2.1.3] (From Claim 70. (c) Trigon does not keep a medical history. [See 2.1.3] (c) Trigon 
does not provide for second opinions. [See 2.1.5] (d) Trigon does not collect patient 
symptoms. [See 2.1.2] (f) Trigon does not attempt to identify treatment modes based on a 
medical history nor on symptoms. [See 2.1.4]  (g) Trigon does not provide for second 
opinions. [See 2.1.5]) 
 
Claim 73. (From Claim 70. (c) Trigon does not keep a medical history. [See 2.1.3] (c) 
Trigon does not provide for second opinions. [See 2.1.5] (d) Trigon does not collect 
patient symptoms. [See 2.1.2] (f) Trigon does not attempt to identify treatment modes 
based on a medical history nor on symptoms. [See 2.1.4]  (g) Trigon does not provide for 
second opinions. [See 2.1.5]) 
 
Claim 74. (From Claim 70. (c) Trigon does not keep a medical history. [See 2.1.3] (c) 
Trigon does not provide for second opinions. [See 2.1.5] (d) Trigon does not collect 
patient symptoms. [See 2.1.2] (f) Trigon does not attempt to identify treatment modes 
based on a medical history nor on symptoms. [See 2.1.4]  (g) Trigon does not provide for 
second opinions. [See 2.1.5]) 
 
Claim 75. (From Claim 70. (c) Trigon does not keep a medical history. [See 2.1.3] (c) 
Trigon does not provide for second opinions. [See 2.1.5] (d) Trigon does not collect 
patient symptoms. [See 2.1.2] (f) Trigon does not attempt to identify treatment modes   61
based on a medical history nor on symptoms. [See 2.1.4]  (g) Trigon does not provide for 
second opinions. [See 2.1.5]) 
 
Claim 78. (From Claim 72. Trigon systems cannot access predetermined items of medical 
history. [See 2.1.3] (From Claim 70. (c) Trigon does not keep a medical history. [See 
2.1.3] (c) Trigon does not provide for second opinions. [See 2.1.5] (d) Trigon does not 
collect patient symptoms. [See 2.1.2] (f) Trigon does not attempt to identify treatment 
modes based on a medical history nor on symptoms. [See 2.1.4]  (g) Trigon does not 
provide for second opinions. [See 2.1.5])) 
 
Claim 80. We consider the term illness here ill defined. [See 2.1.8] (From Claim 70. (c) 
Trigon does not keep a medical history. [See 2.1.3] (c) Trigon does not provide for 
second opinions. [See 2.1.5] (d) Trigon does not collect patient symptoms. [See 2.1.2] (f) 
Trigon does not attempt to identify treatment modes based on a medical history nor on 
symptoms. [See 2.1.4]  (g) Trigon does not provide for second opinions. [See 2.1.5]) 
  
Claim 85. (c) Trigon does not keep predetermined items of medical history. [See 2.1.3] 
(d) Trigon does not process medical histories. [See 2.1.3] Trigon does not identify 
proposed modes of treatment. [See 2.1.5] Trigon does not propose ancillary services. [See 
2.1.7] Trigon does not provide ancillary services. [See 2.1.7] 
 
Claim 86. Trigon does not collect physical profiles. [See 2.1.3] (From Claim 85. (c) 
Trigon does not keep predetermined items of medical history. [See 2.1.3] (d) Trigon does 
not process medical histories. [See 2.1.3] Trigon does not identify proposed modes of 
treatment. [See 2.1.5] Trigon does not propose ancillary services. [See 2.1.7] Trigon does 
not provide ancillary services. [See 2.1.7]) 
 
Claim 87. Trigon does not collect predetermined items of medical history. [See 2.1.3] 
(From Claim 85. (c) Trigon does not keep predetermined items of medical history. [See 
2.1.3] (d) Trigon does not process medical histories. [See 2.1.3] Trigon does not identify 
proposed modes of treatment. [See 2.1.5] Trigon does not propose ancillary services. [See 
2.1.7] Trigon does not provide ancillary services. [See 2.1.7]) 
 
Claim 88. (From Claim 87. Trigon does not collect predetermined items of medical 
history. [See 2.1.3] (From Claim 85. (c) Trigon does not keep predetermined items of 
medical history. [See 2.1.3] (d) Trigon does not process medical histories. [See 2.1.3] 
Trigon does not identify proposed modes of treatment. [See 2.1.5] Trigon does not 
propose ancillary services. [See 2.1.7] Trigon does not provide ancillary services. [See 
2.1.7]) 
 
Claim 89. (From Claim 88. (From Claim 87. Trigon does not collect predetermined items 
of medical history. [See 2.1.3] (From Claim 85. (c) Trigon does not keep predetermined 
items of medical history. [See 2.1.3] (d) Trigon does not process medical histories. [See 
2.1.3] Trigon does not identify proposed modes of treatment. [See 2.1.5] Trigon does not 
propose ancillary services. [See 2.1.7] Trigon does not provide ancillary services. [See 
2.1.7])   62
 
Claim 91. Trigon does not tentatively identify preventive health routines based on 
Symptoms. [See 2.1.6] (From Claim 85. (c) Trigon does not keep predetermined items of 
medical history. [See 2.1.3] (d) Trigon does not process medical histories. [See 2.1.3] 
Trigon does not identify proposed modes of treatment. [See 2.1.5] Trigon does not 
propose ancillary services. [See 2.1.7] Trigon does not provide ancillary services. [See 
2.1.7]) 
 
Claim 93. (From Claim 87. Trigon does not collect predetermined items of medical 
history. [See 2.1.3] (From Claim 85. (c) Trigon does not keep predetermined items of 
medical history. [See 2.1.3] (d) Trigon does not process medical histories. [See 2.1.3] 
Trigon does not identify proposed modes of treatment. [See 2.1.5] Trigon does not 
propose ancillary services. [See 2.1.7] Trigon does not provide ancillary services. [See 
2.1.7]) 
 
Claim 94. We consider the term illness ill defined. [See 2.1.8] Trigon has not entered 
identification of symptoms for diagnosis of illnesses. [See 2.1.8] (From Claim 85. (c) 
Trigon does not keep predetermined items of medical history. [See 2.1.3] (d) Trigon does 
not process medical histories. [See 2.1.3] Trigon does not identify proposed modes of 
treatment. [See 2.1.5] Trigon does not propose ancillary services. [See 2.1.7] Trigon does 
not provide ancillary services. [See 2.1.7]) 
 
Claim 95. We consider the term illness ill defined. [See 2.1.8] Trigon has not entered 
identification of symptoms for treatment of illnesses. [See 2.1.8] (From Claim 85. (c) 
Trigon does not keep predetermined items of medical history. [See 2.1.3] (d) Trigon does 
not process medical histories. [See 2.1.3] Trigon does not identify proposed modes of 
treatment. [See 2.1.5] Trigon does not propose ancillary services. [See 2.1.7] Trigon does 
not provide ancillary services. [See 2.1.7]) 
 
Claim 102. (b) Trigon does not collect a personal health profile data for each of a 
predetermined plurality of persons. [See 2.1.3] (d) Trigon does not provide for second 
opinions. [See 2.1.5] (e) Trigon does not propose medical treatments. [See 2.1.5] 
 
In summary, all of the asserted `105 claims, when properly interpreted contain limitations 
that are not identically contained in Trigon’s systems or performed by Trigon’s 
operations.  In addition, the Trigon systems and operations are not the equivalent of what 
is set forth in any of the asserted claims as they do not perform substantially the functions 
in substantially the same way to obtain substantially the same results.  In the following 
Section 2.4 we will expand the non-infringement observations by showing how none of 
the subsystems involved in Trigon's operations infringe on the claims that the plaintiffs 
assert against them.   
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2.4 Accused Component Systems 
 
The following asserted `105 patent claims are not infringed by the accused Trigon 
systems for the reasons stated in this section. In the following section a numbered claim 
indicates a direct accusation while a numbered claim in parenthesis indicates an 
accusation by reference. They are listed in the order presented by the plaintiff.  Specifics 
of the systems are provided in Section 2.2. 
 
2.4.1 Trigon Web Site 
 
The Trigon Web Site is an information site and does not infringe on Claims 1, 1b, (4c), 
52, 52b, 54, (55c), (69), (85d), (91), (102a), (102b), (102c), 102d, and (102f) as directly 
or indirectly accused.  
 
Not in the scope of the `105 patent.  
 
2.4.2 Trimed 
 
Trimed does not infringe on Claims 1, 1b, 1d, 2, 4b, (4c), (4e), (5), (6), (16d), (17), 
(19b), (19e), (20), (21), (34a), (34b), (34c), (34d), (35), (36), (37), (38), (39) , (52), (52d), 
(53), (55b), (55e), (56) , (56), (67f), (68), (70b), (70g), (71), (72), (85c) , (85d), (85e), 
(86), (87) , (102a) , (102b) , (102c), (102d), (102e), and (102g) as directly or indirectly 
accused. 
 
Trimed does not automatically prevent payment for medical reasons. [See 2.1.1] 
No patient symptom data are available for processing. [See 2.1.2]  
Trimed does not process symptoms. [See 2.1.2]  
Trimed does not collect patient symptoms. [See 2.1.2] 
Trimed does not process symptoms automatically. [See 2.1.2] 
Trimed databanks do not include predetermined items of medical history. [See 2.1.3] 
Trimed systems cannot access predetermined items of medical history. [See 2.1.3] 
Trimed does not collect predetermined items of medical history. [See 2.1.3] 
Trimed does not keep predetermined items of medical history. [See 2.1.3] 
Trimed 's databanks do not include physical profiles. [See 2.1.3] 
Trimed does not store a medical history. [See 2.1.3] 
Trimed does not store physical profiles. [See 2.1.3] 
Trimed does not collect physical profiles. [See 2.1.3] 
Trimed does not keep a medical history. [See 2.1.3] 
Trimed does not process medical histories. [See 2.1.3]  
Trimed does not collect a personal health profile data for each of a predetermined 
plurality of persons. [See 2.1.3] 
Trimed does not attempt to identify treatment modes based on a medical history nor on 
symptoms. [See 2.1.4] 
Trimed does not provide for second opinions. [See 2.1.5]   64
Trimed does not identify proposed modes of treatment. [See 2.1.5] 
Trimed does not propose medical treatments. [See 2.1.5] 
Trimed does not propose ancillary services. [See 2.1.7] 
Trimed does not keep a list of predetermined procedures requiring ancillary services. 
[See 2.1.7]  
Trimed does not provide ancillary services. [See 2.1.7] 
 
2.4.3 Enterprise Network 
 
The Enterprise Network is an unidentifiable accused system. 
 
2.4.4 Open Network 
 
The Open Network does not infringe on Claims 1, 1c, 1d, (4d), (4e), (16c), (16d), (19d), 
(19e), (52), 52a, (52d), (55e), (67d), (70e), and (102g) as directly or indirectly accused. 
 
Open Network does not automatically prevent payment for medical reasons. [See 2.1.1] 
No patient symptom data are available for processing. [See 2.1.2]  
Open Network does not process symptoms. [See 2.1.2]  
Open Network does not collect patient symptoms. [See 2.1.2] 
Open Network's databanks do not include predetermined items of medical history. [See 
2.1.3] 
Open Network does not store a medical history. [See 2.1.3] 
Open Network does not keep a medical history. [See 2.1.3] 
Open Network does not collect a personal health profile data for each of a predetermined 
plurality of persons. [See 2.1.3] 
Open Network does not attempt to identify treatment modes based on a medical history 
nor on symptoms. [See 2.1.4]  
Open Network does not provide for second opinions. [See 2.1.5] 
Open Network does not propose medical treatments. [See 2.1.5] 
 
2.4.5 Point of Care 
 
Point of Care does not infringe on Claims 1, 1a, 1b, 1c, 1d, 2, 4a, 4b,  (4c), (4d), (4e), 
(5), (6), 7, 8, 9, (12), (16a), 16b, (16c), (16d), (17), (19a), (19b), 19c, (19d), (19e), (20), 
(21), 22, 23, 24, (27), (34a), (34b), (34c), (34d), (35), (36), (37), (38), (39), (43), 52, 52a, 
52b, 52c, (52d), (53), 55a, (55b), (55c), (55d), (55e), (56), 58, 59, 60, (63), (67a), (67b), 
67c, 67e, (67f), (68), (70a), (70b), (70c), (70d), (70e), 70f,, (70g), (71), (72), 73, 74, 75, 
(78), 80, (85a), (85b), (85c), (85d), (85e), (86), (87), 88, 89, (93), 95, (102a), 102b, 
(102c), (102d), 102e, 102f, and (102g) as directly or indirectly accused. 
 
Point of Care does not automatically prevent payment for medical reasons. [See 2.1.1] 
No patient symptom data are available for processing. [See 2.1.2] 
Point of Care does not process symptoms. [See 2.1.2] 
Point of Care does not collect patient symptoms. [See 2.1.2] 
Point of Care does not process symptoms automatically. [See 2.1.2]   65
Point of Care has not entered identification of symptoms for treatment of illnesses. [See 
2.1.8] 
Point of Care's databanks do not include predetermined items of medical history. [See 
2.1.3] 
Point of Care 's databanks do not include physical profiles. [See 2.1.3] 
Point of Care does not collect predetermined items of medical history. [See 2.1.3] 
Point of Care systems cannot access predetermined items of medical history. [See 2.1.3] 
Point of Care does not keep predetermined items of medical history. [See 2.1.3] 
Point of Care does not collect a personal health profile data for each of a predetermined 
plurality of persons. [See 2.1.3] 
Point of Care does not store a medical history. [See 2.1.3] 
Point of Care does not store physical profiles. [See 2.1.3] 
Point of Care does not keep a medical history. [See 2.1.3] 
Point of Care does not process medical histories. [See 2.1.3] 
Point of Care does not attempt to identify treatment modes based on a medical history nor 
on symptoms. [See 2.1.4]  
Point of Care does not provide for second opinions. [See 2.1.5] 
Point of Care does not identify proposed modes of treatment. [See 2.1.5] 
Point of Care does not propose medical treatments. [See 2.1.5] 
Point of Care does not propose ancillary services. [See 2.1.7]  
Point of Care does not provide ancillary services. [See 2.1.7] 
Point of Care does not keep a list of predetermined procedures requiring ancillary 
services. [See 2.1.7] 
We consider the term illness here ill defined. [See 2.1.8] 
 
2.4.6 Performance Reward Program 
 
Performance Reward Program does not infringe on Claims 1a, (4a) , (6) , (12) , (16a) , 
(19a) , (21) , (27) , (34a) , (36) , (43) , (52) , (56) , (63) , (67a) , (70a) , (72) , (78) , (85a) , 
(85b) , (87) , and (93) as directly or indirectly accused. 
 
Performance Reward Program does not automatically prevent payment for medical 
reasons. [See 2.1.1] 
No patient symptom data are available for processing. [See 2.1.2]  
Performance Reward Program does not process symptoms. [See 2.1.2]  
No patient symptom data are available for processing at Performance Reward Program. 
[See 2.1.2] 
Performance Reward Program does not collect patient symptoms. [See 2.1.2] 
Performance Reward Program's databanks do not include predetermined items of medical 
history. [See 2.1.3] 
Performance Reward Program does not collect predetermined items of medical history. 
[See 2.1.3]  
Performance Reward Program does not store a medical history. [See 2.1.3] 
Performance Reward Program does not keep a medical history. [See 2.1.3] 
Performance Reward Program does not process medical histories. [See 2.1.3]   66
Performance Reward Program systems cannot access predetermined items of medical 
history. [See 2.1.3] 
Performance Reward Program does not keep predetermined items of medical history. 
[See 2.1.3] 
Performance Reward Program does not attempt to identify treatment modes based on a 
medical history nor on symptoms. [See 2.1.4] 
Performance Reward Program does not provide for second opinions. [See 2.1.5] 
Performance Reward Program does not identify proposed modes of treatment. [See 2.1.5] 
Performance Reward Program does not keep a list of predetermined procedures requiring 
ancillary services. [See 2.1.7] 
Performance Reward Program does not propose ancillary services. [See 2.1.7]  
Performance Reward Program does not provide ancillary services. [See 2.1.7] 
 
2.4.7 Tutorial 
 
Tutorial and other training programs are educational services and do not infringe on 
Claims 1a, (4a), (6), (12) , (16a) , (19a) , (21) , (27) , (34a) , (36) , (43) , (52) , (56) , (63) , 
(67a) , (70a) , (72) , (78) , (85a) , (85b) , (87) , and (93) as directly or indirectly accused.  
 
Not in the scope of the `105 patent.  
 
2.4.8 Professional Forum 
 
Professional Forum is an informational newsletter and does not infringe on Claims 1a, 
1b, (4a), (4c) , (6) , (12) , (16a) , (19a) , (21) , (27) , (34a) , (36) , (43) , (52) , 52b, (55c) , 
(56) , (63) , (67a) , (67b) , (70a) , (70c) , (72) , (78) , (85a) , (85b) , (85d) , (87) , (93) , 
(102c) , (102d) , and (102f) as directly or indirectly accused.  
 
Not in the scope of the `105 patent.  
 
2.4.9 Provider Office Computers used in Point of Care 
 
Provider Office Computers used in Point of Care do not infringe on Claims 1a, (4a), 
(6), (12), (16a), (19a), (21), (27), (34a), (36), (43), (52), (56), (63), (67a), (70a), (72), 
(78), (85a), (85b), (87), and (93) as directly or indirectly accused. 
 
Provider Office Computers used in Point of Care do not automatically prevent payment 
for medical reasons. [See 2.1.1] 
No patient symptom data are available for processing. [See 2.1.2]  
Provider Office Computers used in Point of Care do not process symptoms. [See 2.1.2]  
No patient symptom data are available for processing at Provider Office Computers used 
in Point of Care. [See 2.1.2] 
Provider Office Computers used in Point of Care do not collect patient symptoms. [See 
2.1.2] 
Provider Office Computers used in Point of Care's databanks do not include 
predetermined items of medical history. [See 2.1.3]   67
Provider Office Computers used in Point of Care do not collect predetermined items of 
medical history. [See 2.1.3]  
Provider Office Computers used in Point of Care do not store a medical history. [See 
2.1.3] 
Provider Office Computers used in Point of Care do not keep a medical history. [See 
2.1.3] 
Provider Office Computers used in Point of Care do not process medical histories. [See 
2.1.3] 
Provider Office Computers used in Point of Care systems cannot access predetermined 
items of medical history. [See 2.1.3] 
Provider Office Computers used in Point of Care do not keep predetermined items of 
medical history. [See 2.1.3] 
Provider Office Computers used in Point of Care do not attempt to identify treatment 
modes based on a medical history nor on symptoms. [See 2.1.4] 
Provider Office Computers used in Point of Care do not provide for second opinions. 
[See 2.1.5] 
Provider Office Computers used in Point of Care do not identify proposed modes of 
treatment. [See 2.1.5] 
Provider Office Computers used in Point of Care do not keep a list of predetermined 
procedures requiring ancillary services. [See 2.1.7] 
Provider Office Computers used in Point of Care do not propose ancillary services. [See 
2.1.7]  
Provider Office Computers used in Point of Care do not provide ancillary services. [See 
2.1.7] 
 
2.4.10 Amisys 
 
Amisys does not infringe on Claims 1b, 1c, 1d, 4b, (4c) , (4d) , (4e) , (5) , (6) , (16c) , 
(16d) , (19b) , (19d) , (19e) , (20) , (21) , (34a) , (34b) , (35) , (36) , (52) , (52d) , (55b) , 
(55e) , (56) , (56) , (67d) , (67f) , (70b) , (70e) , (70g) , (71) , (72) , (85c) , (85d) , (86) , 
(87) , (102a) , (102b) , (102c) , (102d) , (102e) , and (102g) as directly or indirectly 
accused. 
 
Amisys does not automatically prevent payment for medical reasons. [See 2.1.1] 
No patient symptom data are available for processing. [See 2.1.2]  
Amisys does not process symptoms. [See 2.1.2]  
No patient symptom data are available for processing at Amisys. [See 2.1.2] 
Amisys does not collect patient symptoms. [See 2.1.2]  
Amisys does not store a medical history. [See 2.1.3] 
Amisys does not store physical profiles. [See 2.1.3]  
Amisys does not collect predetermined items of medical history. [See 2.1.3] 
Amisys does not keep a medical history. [See 2.1.3] 
Amisys does not collect physical profiles. [See 2.1.3] 
Amisys systems cannot access predetermined items of medical history. [See 2.1.3] 
Amisys does not keep predetermined items of medical history. [See 2.1.3] 
Amisys does not process medical histories. [See 2.1.3]   68
Amisys does not collect predetermined items of medical history. [See 2.1.3] 
Amisys does not collect a personal health profile data for each of a predetermined 
plurality of persons. [See 2.1.3] 
Amisys's databanks do not include predetermined items of medical history. [See 2.1.3] 
Amisys 's databanks do not include physical profiles. [See 2.1.3]  
Amisys does not attempt to identify treatment modes based on a medical history nor on 
symptoms. [See 2.1.4] 
Amisys does not provide for second opinions. [See 2.1.5] 
Amisys does not identify proposed modes of treatment. [See 2.1.5]  
Amisys does not propose medical treatments. [See 2.1.5] 
Amisys does not keep a list of predetermined procedures requiring ancillary services. 
[See 2.1.7] 
Amisys does not propose ancillary services. [See 2.1.7] 
Amisys does not provide ancillary services. [See 2.1.7] 
 
2.4.11 CMS 
 
CMS does not infringe on Claims 1b, 1c, 1d, (4c), (4d), (4e) , (16c) , (16d) , (19d) , (19e) 
, (52) , (52d) , (55e) , (67d) , (67f) , (70e) , (70g) , (85d) , (102c) , (102d) , and (102g) as 
directly or indirectly accused. 
 
CMS does not automatically prevent payment for medical reasons. [See 2.1.1] 
No patient symptom data are available for processing. [See 2.1.2]  
No patient symptom data are available for processing at CMS. [See 2.1.2]  
CMS does not process symptoms. [See 2.1.2]  
CMS does not collect patient symptoms. [See 2.1.2] 
CMS's databanks do not include predetermined items of medical history. [See 2.1.3] 
CMS does not store a medical history. [See 2.1.3]  
CMS does not keep a medical history. [See 2.1.3] 
CMS does not keep predetermined items of medical history. [See 2.1.3] 
CMS does not process medical histories. [See 2.1.3]  
CMS does not collect a personal health profile data for each of a predetermined plurality 
of persons. [See 2.1.3] 
CMS does not attempt to identify treatment modes based on a medical history nor on 
symptoms. [See 2.1.4] 
CMS does not provide for second opinions. [See 2.1.5] 
CMS does not identify proposed modes of treatment. [See 2.1.5] 
CMS does not propose medical treatments. [See 2.1.5] 
CMS does not propose ancillary services. [See 2.1.7]  
CMS does not provide ancillary services. [See 2.1.7] 
 
2.4.12 CHIPS 
 
CHIPS does not infringe on Claims 1b, 1c, 1d, 4b, (4c), (4d), (4e), (5), (6), (16c), (16d), 
(19b), (19d), (19e), (20), (21), (34a), (34b), (35), (36), (52), (52d), (55b), (55e), (56),   69
(56), (67d), (67f), (70b), (70e), (70g), (71), (72), (85c), (85d), (86), (87), (102a), (102b), 
(102c), (102d), (102e), and (102g) as directly or indirectly accused. 
 
CHIPS does not automatically prevent payment for medical reasons. [See 2.1.1] 
No patient symptom data are available for processing. [See 2.1.2]  
No patient symptom data are available for processing at CHIPS. [See 2.1.2] 
CHIPS does not process symptoms. [See 2.1.2]  
CHIPS does not collect patient symptoms. [See 2.1.2]  
CHIPS does not store a medical history. [See 2.1.3] 
CHIPS does not store physical profiles. [See 2.1.3]  
CHIPS does not collect predetermined items of medical history. [See 2.1.3] 
CHIPS does not keep a medical history. [See 2.1.3] 
CHIPS does not collect physical profiles. [See 2.1.3] 
CHIPS systems cannot access predetermined items of medical history. [See 2.1.3] 
CHIPS does not keep predetermined items of medical history. [See 2.1.3] 
CHIPS does not process medical histories. [See 2.1.3] 
CHIPS does not collect predetermined items of medical history. [See 2.1.3] 
CHIPS does not collect a personal health profile data for each of a predetermined 
plurality of persons. [See 2.1.3] 
CHIPS's databanks do not include predetermined items of medical history. [See 2.1.3] 
CHIPS 's databanks do not include physical profiles. [See 2.1.3]  
CHIPS does not attempt to identify treatment modes based on a medical history nor on 
symptoms. [See 2.1.4] 
CHIPS does not provide for second opinions. [See 2.1.5] 
CHIPS does not identify proposed modes of treatment. [See 2.1.5]  
CHIPS does not propose medical treatments. [See 2.1.5] 
CHIPS does not keep a list of predetermined procedures requiring ancillary services. [See 
2.1.7] 
CHIPS does not propose ancillary services. [See 2.1.7] 
CHIPS does not provide ancillary services. [See 2.1.7] 
 
2.4.13 PPR 
 
PPR does not infringe on Claims 1b, 4b, (4c), (5), (6), (19b), (20), (21), (34a), (34b), 
(35), (36), (52), 54, (55b), (56), (69), (70b), (71), (72), (85c), (85d), (86), (87), (91), 
(102a), (102b), (102c), (102d), (102e), and (102f) as directly or indirectly accused. 
 
PPR does not automatically prevent payment for medical reasons. [See 2.1.1] 
No patient symptom data are available for processing. [See 2.1.2]  
PPR does not process symptoms. [See 2.1.2]  
PPR does not collect patient symptoms. [See 2.1.2] 
PPR's databanks do not include predetermined items of medical history. [See 2.1.3] 
PPR 's databanks do not include physical profiles. [See 2.1.3]  
PPR does not collect predetermined items of medical history. [See 2.1.3]  
PPR does not store a medical history. [See 2.1.3] 
PPR does not store physical profiles. [See 2.1.3]    70
PPR does not keep a medical history. [See 2.1.3] 
PPR does not collect physical profiles. [See 2.1.3]  
PPR systems cannot access predetermined items of medical history. [See 2.1.3]  
PPR does not keep predetermined items of medical history. [See 2.1.3] 
PPR does not process medical histories. [See 2.1.3]  
PPR does not collect a personal health profile data for each of a predetermined plurality 
of persons. [See 2.1.3] 
PPR does not attempt to identify treatment modes based on a medical history nor on 
symptoms. [See 2.1.4] 
PPR does not provide for second opinions. [See 2.1.5] 
PPR does not identify preventive health routines based on Symptoms. [See 2.1.6] 
PPR does not propose preventive care based on Symptoms. [See 2.1.6] 
PPR does not identify proposed modes of treatment. [See 2.1.5] 
PPR does not tentatively identify preventive health routines based on Symptoms. [See 
2.1.6] 
PPR does not propose medical treatments. [See 2.1.5] 
PPR does not keep a list of predetermined procedures requiring ancillary services. [See 
2.1.7] 
PPR does not propose ancillary services. [See 2.1.7]  
PPR does not provide ancillary services. [See 2.1.7] 
 
2.4.14 Unnamed Databases 
 
Unnamed Databases are vague, but we will interpret it liberally by considering all 
claims that have a databank component.  Trigon databases do not infringe on Claims 1b, 
4b, (4c) , (5) , (6), 7, 8, 9, (19b) , (20) , (21) , (34a) , (34b) , (35) , (36) , (52) , (55b) , 
(55c) , (56) , (56) , (70b) , (71) , (72) , (85c) , (85d) , (86) , (87) , (102a) , (102b) , (102c) , 
(102d) , and (102e) as directly or indirectly accused.   
 
UNKNOWN DATABASE does not automatically prevent payment for medical reasons. 
[See 2.1.1] 
No patient symptom data are available for processing. [See 2.1.2]  
UNKNOWN DATABASE does not process symptoms. [See 2.1.2]  
UNKNOWN DATABASE does not collect patient symptoms. [See 2.1.2] 
UNKNOWN DATABASE's databanks do not include predetermined items of medical 
history. [See 2.1.3] 
UNKNOWN DATABASE 's databanks do not include physical profiles. [See 2.1.3]  
UNKNOWN DATABASE does not collect predetermined items of medical history. [See 
2.1.3]  
UNKNOWN DATABASE does not store a medical history. [See 2.1.3] 
UNKNOWN DATABASE does not store physical profiles. [See 2.1.3]  
UNKNOWN DATABASE does not keep a medical history. [See 2.1.3] 
UNKNOWN DATABASE does not collect physical profiles. [See 2.1.3]  
UNKNOWN DATABASE systems cannot access predetermined items of medical 
history. [See 2.1.3]    71
UNKNOWN DATABASE does not keep predetermined items of medical history. [See 
2.1.3] 
UNKNOWN DATABASE does not process medical histories. [See 2.1.3]  
UNKNOWN DATABASE does not collect a personal health profile data for each of a 
predetermined plurality of persons. [See 2.1.3] 
UNKNOWN DATABASE does not attempt to identify treatment modes based on a 
medical history nor on symptoms. [See 2.1.4] 
UNKNOWN DATABASE does not provide for second opinions. [See 2.1.5] 
UNKNOWN DATABASE does not identify preventive health routines based on 
Symptoms. [See 2.1.6] 
UNKNOWN DATABASE does not propose preventive care based on Symptoms. [See 
2.1.6] 
UNKNOWN DATABASE does not identify proposed modes of treatment. [See 2.1.5] 
UNKNOWN DATABASE does not tentatively identify preventive health routines based 
on Symptoms. [See 2.1.6] 
UNKNOWN DATABASE does not propose medical treatments. [See 2.1.5] 
UNKNOWN DATABASE does not keep a list of predetermined procedures requiring 
ancillary services. [See 2.1.7] 
UNKNOWN DATABASE does not propose ancillary services. [See 2.1.7]  
UNKNOWN DATABASE does not provide ancillary services. [See 2.1.7] 
 
2.4.15 Payment System 
 
Payment System is vague. We interpret liberally as all the Payment systems operated by 
Trigon. They do not infringe on Claims 1c, (4d), (16c), (19d), (52), (67d), and (70e) as 
directly or indirectly accused. 
 
PAYMENT SYSTEM does not automatically prevent payment for medical reasons. [See 
2.1.1]  
No patient symptom data are available for processing. [See 2.1.2]  
No patient symptom data are available for processing at PAYMENT SYSTEM. [See 
2.1.2]  
PAYMENT SYSTEM does not process symptoms. [See 2.1.2]  
PAYMENT SYSTEM does not collect patient symptoms. [See 2.1.2] 
PAYMENT SYSTEM's databanks do not include predetermined items of medical 
history. [See 2.1.3] 
PAYMENT SYSTEM does not store a medical history. [See 2.1.3] 
PAYMENT SYSTEM does not keep a medical history. [See 2.1.3] 
PAYMENT SYSTEM does not attempt to identify treatment modes based on a medical 
history nor on symptoms. [See 2.1.4] 
PAYMENT SYSTEM does not provide for second opinions. [See 2.1.5] 
2.4.16 COS 
 
COS does not infringe on Claims 1c, (4d), (16c), (19d), (52), (67d), and (70e) as directly 
or indirectly accused. 
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COS does not automatically prevent payment for medical reasons. [See 2.1.1]  
No patient symptom data are available for processing. [See 2.1.2]  
No patient symptom data are available for processing at COS. [See 2.1.2]  
COS does not process symptoms. [See 2.1.2]  
COS does not collect patient symptoms. [See 2.1.2] 
COS's databanks do not include predetermined items of medical history. [See 2.1.3] 
COS does not store a medical history. [See 2.1.3] 
COS does not keep a medical history. [See 2.1.3] 
COS does not attempt to identify treatment modes based on a medical history nor on 
symptoms. [See 2.1.4] 
COS does not provide for second opinions. [See 2.1.5] 
 
2.4.17 FSS 
 
FSS does not infringe on Claims 1c, (4d), (16c), (19d), (52), (67d) , and (70e) as directly 
or indirectly accused. 
 
FSS does not automatically prevent payment for medical reasons. [See 2.1.1]  
No patient symptom data are available for processing. [See 2.1.2]  
No patient symptom data are available for processing at FSS. [See 2.1.2]  
FSS does not process symptoms. [See 2.1.2]  
FSS does not collect patient symptoms. [See 2.1.2] 
FSS's databanks do not include predetermined items of medical history. [See 2.1.3] 
FSS does not store a medical history. [See 2.1.3] 
FSS does not keep a medical history. [See 2.1.3] 
FSS does not attempt to identify treatment modes based on a medical history nor on 
symptoms. [See 2.1.4] 
FSS does not provide for second opinions. [See 2.1.5] 
 
2.4.18 payerpath.com 
 
payerpath.com is not a Trigon system.  
 
Not in the scope of this report.  
 
2.4.19 Systems at the Medical College of Virginia 
 
Systems at the Medical College of Virginia are not Trigon systems.  
 
Not in the scope of this report. 
 
2.4.20 Bon Secours Health Systems 
 
Bon Secours Health Systems are not Trigon systems.  
 
Not in the scope of this report.   73
 
2.4.21 Columbia/HCA 
 
Columbia/HCA is not a Trigon system.  
 
Not in the scope of this report. 
 
2.4.22 Provider-based Practice Management Systems 
 
Provider-based Practice Management Systems are not Trigon systems.  
 
Not in the scope of this report. 
 
2.4.23 CARS 
 
CARS does not infringe on Claims 4b, (5), (6), (19b), (20), (21), (34a), (34b), (35), (36), 
(52), (55b), (56), (70b), (71), (72), (85c), (86), (87), (102a), (102b), and (102e) as directly 
or indirectly accused. 
 
CARS does not automatically prevent payment for medical reasons. [See 2.1.1]  
CARS does not process symptoms. [See 2.1.2] 
CARS does not collect patient symptoms. [See 2.1.2] 
CARS's databanks do not include predetermined items of medical history. [See 2.1.3]  
CARS 's databanks do not include physical profiles. [See 2.1.3]  
CARS does not collect predetermined items of medical history. [See 2.1.3] 
CARS does not keep predetermined items of medical history. [See 2.1.3] 
CARS does not store a medical history. [See 2.1.3] 
CARS does not process medical histories. [See 2.1.3] 
CARS does not store physical profiles. [See 2.1.3] 
CARS does not collect physical profiles. [See 2.1.3] 
CARS does not keep a medical history. [See 2.1.3] 
CARS systems cannot access predetermined items of medical history. [See 2.1.3] 
CARS does not collect a personal health profile data for each of a predetermined plurality 
of persons. [See 2.1.3] 
CARS does not attempt to identify treatment modes based on a medical history nor on 
symptoms. [See 2.1.4] 
CARS does not provide for second opinions. [See 2.1.5] 
CARS does not identify proposed modes of treatment. [See 2.1.5] 
CARS does not propose medical treatments. [See 2.1.5] 
CARS does not keep a list of predetermined procedures requiring ancillary services. [See 
2.1.7] 
CARS does not propose ancillary services. [See 2.1.7]  
CARS does not provide ancillary services. [See 2.1.7]  
2.4.24 ASK 
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ASK does not infringe on Claims 4b, (5), (6), (19b), (20), (21), (34a), (34b), (35), (36), 
(52), (55b), (56), (70b), (71), (72), (85c), (86), (87), (102a), (102b), and (102e) as directly 
or indirectly accused. 
 
ASK does not automatically prevent payment for medical reasons. [See 2.1.1]  
ASK does not process symptoms. [See 2.1.2] 
ASK does not collect patient symptoms. [See 2.1.2] 
ASK's databanks do not include predetermined items of medical history. [See 2.1.3]  
ASK 's databanks do not include physical profiles. [See 2.1.3]  
ASK does not collect predetermined items of medical history. [See 2.1.3] 
ASK does not keep predetermined items of medical history. [See 2.1.3] 
ASK does not store a medical history. [See 2.1.3] 
ASK does not process medical histories. [See 2.1.3] 
ASK does not store physical profiles. [See 2.1.3] 
ASK does not collect physical profiles. [See 2.1.3] 
ASK does not keep a medical history. [See 2.1.3] 
ASK systems cannot access predetermined items of medical history. [See 2.1.3] 
ASK does not collect a personal health profile data for each of a predetermined plurality 
of persons. [See 2.1.3] 
ASK does not attempt to identify treatment modes based on a medical history nor on 
symptoms. [See 2.1.4] 
ASK does not provide for second opinions. [See 2.1.5] 
ASK does not identify proposed modes of treatment. [See 2.1.5] 
ASK does not propose medical treatments. [See 2.1.5] 
ASK does not keep a list of predetermined procedures requiring ancillary services. [See 
2.1.7] 
ASK does not propose ancillary services. [See 2.1.7]  
ASK does not provide ancillary services. [See 2.1.7]  
 
2.4.25 Data Pharmacy 
 
Data Pharmacy does not infringe on Claims 4b, (5), (6), (19b), (20), (21), (34a), (34b), 
(35), (36), (52), (55b), (56), (56), (70b), (71), (72), (85c), (86), (87), (102a), (102b), and 
(102e) as directly or indirectly accused. 
 
DATA PHARMACY does not automatically prevent payment for medical reasons. [See 
2.1.1]  
DATA PHARMACY does not process symptoms. [See 2.1.2] 
DATA PHARMACY does not collect patient symptoms. [See 2.1.2] 
DATA PHARMACY's databanks do not include predetermined items of medical history. 
[See 2.1.3]  
DATA PHARMACY 's databanks do not include physical profiles. [See 2.1.3]  
DATA PHARMACY does not collect predetermined items of medical history. [See 
2.1.3] 
DATA PHARMACY does not keep predetermined items of medical history. [See 2.1.3] 
DATA PHARMACY does not store a medical history. [See 2.1.3]   75
DATA PHARMACY does not process medical histories. [See 2.1.3] 
DATA PHARMACY does not store physical profiles. [See 2.1.3] 
DATA PHARMACY does not collect physical profiles. [See 2.1.3] 
DATA PHARMACY does not keep a medical history. [See 2.1.3] 
DATA PHARMACY systems cannot access predetermined items of medical history. 
[See 2.1.3] 
DATA PHARMACY does not collect a personal health profile data for each of a 
predetermined plurality of persons. [See 2.1.3] 
DATA PHARMACY does not attempt to identify treatment modes based on a medical 
history nor on symptoms. [See 2.1.4] 
DATA PHARMACY does not provide for second opinions. [See 2.1.5] 
DATA PHARMACY does not identify proposed modes of treatment. [See 2.1.5] 
DATA PHARMACY does not propose medical treatments. [See 2.1.5] 
DATA PHARMACY does not keep a list of predetermined procedures requiring 
ancillary services. [See 2.1.7] 
DATA PHARMACY does not propose ancillary services. [See 2.1.7]  
DATA PHARMACY does not provide ancillary services. [See 2.1.7]  
 
2.4.26 Provider-based Electronic Medical Records 
 
Provider-based Electronic Medical Records are not Trigon systems.  
 
Not in the scope of this report. 
 
2.4.27 AIMS 
 
AIMS does not infringe on Claims 7, 8, and 9 as directly or indirectly accused. 
 
AIMS's databanks do not include predetermined items of medical history. [See 2.1.3] 
AIMS does not process symptoms. [See 2.1.2] 
.  
2.4.28 BEX 
 
BEX is an unknown system.  
Not in the scope of this report. 
 
2.4.29 Enrollment 
 
Enrollment does not infringe on Claims 7, 8, and 9 as directly or indirectly accused. 
 
Enrollment's databanks do not include predetermined items of medical history. [See 
2.1.3]   76
Enrollment does not process symptoms. [See 2.1.2] 
 
2.4.30 Healthy Returns 
 
Healthy Returns does not infringe on Claims 54 and (91) as directly or indirectly 
accused. 
 
Healthy Returns does not identify preventive health routines based on Symptoms. [See 
2.1.6]  
Healthy Returns does not collect patient symptoms. [See 2.1.2]  
Healthy Returns does not process symptoms. [See 2.1.2]  
Healthy Returns does not automatically prevent payment for medical reasons. [See 2.1.1] 
Healthy Returns does not tentatively identify preventive health routines based on 
Symptoms. [See 2.1.6]  
Healthy Returns does not keep predetermined items of medical history. [See 2.1.3] 
Healthy Returns does not process medical histories. [See 2.1.3]  
Healthy Returns does not identify proposed modes of treatment. [See 2.1.5]  
Healthy Returns does not propose ancillary services. [See 2.1.7]  
Healthy Returns does not provide ancillary services. [See 2.1.7] 
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2.5 Other Non Infringement Issues 
 
2.5.1 Workflow 
 
The Trigon system, comprising employees and computer systems, combines automated 
work with human intervention, decision making, and interaction in a traditional 
distributed data processing workflow architecture. The claims of the `105 patent represent 
a fully automated system with no intervening human interactions. Thus, the activities of 
the Defendants do not fall within the scope of the asserted claims.  
 
2.5.2 Comprehensive Health Care Management System  
 
The Trigon systems collectively form a reimbursement claims processing system and 
thus are only one component of a comprehensive health care management system as 
specified in the `105 patent.  
 
2.5.3 Data Input Terminal 
 
The Point of Care system uses a web-interface based on a modern computer-based 
desktop for data input at the provider's site. The provider computer used to accomplish 
the data input is not equivalent (not the same mechanism) as the point-of-sale terminal as 
described in the `105 patent.  
 
2.5.4 Authentication 
 
The Trigon system identifies a member but does not authenticate the member with any 
secret password or other technique.  
 
2.5.5 Adjudication 
 
The Trigon adjudication process is a judgment system and not a simple automated 
decision system. In adjudication systems a judgement is made based on the currently 
known information. This judgment can be later reviewed and overturned, changed, or left 
whole, as new information becomes available. This judgment can be appealed to a higher 
authority. The claimant and not the adjudication initiate the claim process.  
 
The `105 patent claims describe a simple decision process of payment blocking. This is 
not equivalent to the more complex process of adjudication.  
 
2.5.6 Multiple Payment Sources 
 
The `105 patent describes a system where payment is blocked for a proposed treatment 
pending other actions. This approach assumes centralized control, consonant with the 
author of the `105 patent’s intention to have a single, integrated system. The Trigon   78
system operates in an environment where there are multiple payer sources. The two are 
not equivalent.    79
3.  Definitions 
We list here terms that have led to disagreements in the `105 claims chart constructions 
by plaintiff and defendant as well as terms that have been disputed in interpretation of the 
patent and the ensuing reports. 
 
The definitions are introduced in a logical order and not in alphabetical order. For the 
readers' convenience we provide an alphabetical index. The index also lists some terms 
that are secondary elements in a primary definition, as `Illness' and `Disease' within 
`Diagnosis'.  Definitions for some medical terms used in the report are provided in 
Appendix C. 
 
  3.16   Algorithmic systems  
  3.11   Ancillary Services 
  3.9   Case Manager 
  3.7   Chart Access 
  3.13   Comprehensive Health Care  
  3.12   Comprehensive Health Care System  
  3.10   Cost-effectiveness review  
  3.3   Diagnosis  
  3.3   Disease 
  3.4   DRG codes 
  3.18   Doc-in-a-box 
  3.11   Drug Cost-effectiveness Review 
  3.17   Expert System  
  3.21   Factor analysis  
  3.26           Health Risk Assessment (HRA) 
  3.3    Illness  
  3.22   Integrated Systems 
  3.14   Medical Director 
  3.7   Medical History 
  3.7   Patient Chart. 
  3.11   Pharmacy 
  3.7   Physical Profiles. 
  3.7   Physician's Chart. 
  3.25   Point-of-Sale Terminal 
  3.8   Reimbursement Claims History 
  3.26 RHA 
  3.19   Rule-based systems 
  3.6   Second Opinions  
  3.2   Sign 
  3.15   Smart System 
  3.1   Symptoms 
  3.20   Table  
  3.24   Terminal 
  3.5   Treatments   80
  3.9   Utilization Review (UR) 
  3.23   Work Flow System 
 
3.1 Symptoms 
 
Symptoms are evidence of an abnormal state of one's health. Symptoms, if the patient 
deems them serious, are reported to a health care provider for a follow-up investigation. 
When patients describe symptoms, the physician to help arrive at a diagnosis (see 
Definition 3.3) will use them. Symptoms are rarely written down, although they may be 
noted in a problem statement for physicians that follow Larry Weed's methodology 
[BjornC:1970]. Occasionally symptoms are collected as free text. Physical observations, 
measurements, and laboratory tests provide further signs (see Definition 3.2) of normal or 
abnormal health. Perusing the patient's Medical History (see Definition 3.7) rounds out 
the material required to arrive at a diagnosis. 
 
The definition of Symptom in the American Heritage Dictionary sense 2. [Heritage:2000] 
is "A sign or an indication of disorder or disease, especially when experienced by an 
individual as a change from normal function, sensation, or appearance."  
 
The definition of Symptom in Stedman's Medical Dictionary [Stedman:2000] is "Any 
morbid phenomenon or departure from the normal in structure, function, or sensation, 
experienced by the patient and indicative of disease."  
 
These definitions are consistent with our use of the term. These terms are not likely to 
have changed since 1990. 
 
There are coding schemes available for symptoms: CMIT [Gordon:1971] and 
[RCGP:1974].  A symptom-oriented entry form, oriented towards physician use  
[SFT:2002] shows approximately 4000 candidate symptoms. Selecting the proper term 
for the variety of symptoms presented by a patient requires medical insight. Coding of 
symptoms can be useful for utilization review (see Definition 3.97.) since it allows 
matching patient's complaints with diagnoses and treatment. An earlier patent cited in 
‘105 patent [Sinay  4290114 Sep., 1981] (see Section 5.17) developed its own coding 
scheme for symptoms presented in emergency care.  Coding of symptoms is rarely 
performed in U.S. medical practice since the costs outweigh the benefits. Claims are not 
reimbursed on the mere basis of symptoms by TRIGON, the Federal government, nor by 
any insurance carrier we are aware of.  We show examples of symptoms, taken from 
[Holland:2002], in Appendix B.  A few diseases are pathognomonic, in that a single 
symptom determines the disease, for instance Koplik’s spots (on the buccal mucosa 
opposite the 1st and 2nd upper molars) are pathognomonic of measles (see Appendix C 
for its definition). Medical knowledge is still required in such case, since few patients 
will report that symptom, but rather complain of fatigue and rashes. 
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3.2 Sign  
A Sign is an observation made by a health care worker or obtained from a clinical test to 
help determine a diagnosis. As such, signs complement the patient's reported symptoms.   
 
The definition of Sign in The American Heritage Dictionary [Heritage:2000] is (8) “A 
body manifestation that serves to indicate the presence of malfunction of disease.”  
 
The definition of Sign in Stedman's Medical Dictionary [Stedman:2000] is “Any 
abnormality indicative of disease, discoverable on examination of the patient; an 
objective indication of disease, in contrast to a symptom, which is a subjective indication 
of disease.”  
 
These definitions are consistent with our use of the term. This term is not likely to have 
changed since 1990. 
 
3.3 A Diagnosis 
 
A Diagnosis is a specification of a disease, i.e., an abnormality that causes abnormal 
signs and symptoms. Most diagnoses relate to multiple symptoms. Not all symptoms 
occur for given diagnoses. People with multiple diagnoses often show patterns of 
symptoms that differ from the sum of the patterns for each distinct diagnosis. The 
International Classification of Diseases (ICD-9) coding, used by the defendant and cited 
by the plaintiff has currently over 12,000 entries in its disease category. 
 
The definition of Diagnosis in The American Heritage Dictionary [Heritage:2000] is "[a] 
The act or process of identifying or determining the nature and cause of a disease or 
injury through evaluation of patient history, examination, and review of laboratory data 
and [b] The opinion derived from such an evaluation."  
 
The definition of Diagnosis in Stedman's Medical Dictionary [Stedman:2000] is "The 
determination of the nature of a disease, injury, or congenital defect." 
 
These definitions are consistent with our use of the term. These terms are not likely to 
have changed since 1990.   
 
Having an illness indicates a state of poor health.  Being ill can be due to having one or 
multiple diseases, and for that reason is not a term used frequently in medicine.  
 
The definition of Illness in The American Heritage Dictionary [Heritage:2000] is "1a. 
Poor health resulting from disease of body or mind; sickness. 1b. A disease. ". 
 
Illness is not in Stedman [Stedman:2000]. 
 
The ‘105 patent generally uses the term ‘illness’ where medical specialists would use the 
term `disease'.  The term disease is only used 3 times. When used in the `105 patent it is   82
unclear if a single disease, susceptible to a particular treatment, is intended, or if the 
holistic state of not being well is intended.  We found no meaningful difference in the 
usage of the term, and hold them to be equivalent here. 
 
3.4 DRG codes. 
 
DRG codes. For governmental billing purposes (Medicare, etc.) the 12,000 ICD-9-CM 
codes have been grouped into 23 major diagnostic categories representing almost 500 
individual Diagnostic-related Group (DRG) codes. DRG codes do not contain sufficient 
information to prescribe treatment.  They do provide an indication of the range of effort 
required for treating a disease in an inpatient setting, and appropriate billing ranges. 
Because of their imprecision, they are used less than in the past but are still prevalent in 
many inpatient hospital environments.  
 
3.5 Treatments 
 
Treatments are the processes used to restore to a normal state. Their selection depend 
on the primary diagnosis, on other aspects of the patients health state, including 
concurrent diagnoses, and the utility that patient and doctor agree to a treatment when 
multiple treatments are possible, say medication versus surgery.  The CPT coding used 
by the defendant and cited by the plaintiff has currently over 8,000 entries. 
 
The definition of Treatment in The American Heritage Dictionary [Heritage:2000] is 
"(2a) an Administration or application of remedies to a patient or for a disease or injury; 
medicinal or surgical management; therapy. " 
 
The definition of Treatment in Stedman's Medical Dictionary [Stedman:2000] is "A 
Medical or surgical management of a patient".  
 
These definitions are consistent with our use of the term `Treatment'. The meaning of this 
term is not likely to have changed since 1990. 
 
3.6 Second Opinions 
 
Second Opinions are used when the patient or his/her surrogate wants to be assured 
that a treatment selected by a physician is indeed appropriate. Second opinions are valued 
when  
i)  a treatment has a high risk, as some surgeries,  
ii)  a treatment imposes much discomfort, say chemotherapy, or  
iii)  a treatment has a high cost.   
Differences about treatment are often due to different value systems. For instance, a 
physician may seek a more promising treatment, but the patient has an aversion to risk or   83
pain. Sometimes patients have heard about costly or unusual treatments that the physician 
has rejected as having had little or no additional benefit over commonly accepted 
alternatives. 
 
Some insurance plans will reimburse for second opinions in certain cases.  Second 
opinions should be provided by an independent physician, not by medical directors at 
insurance companies.    
 
The Blue Shield of California Handbook advises patients that "Second Opinions are 
helpful if you have any doubt that the proposed Surgery is the best option for your 
problem. Consider getting an opinion from a different type of doctor who treats similar 
Problems" [Kemper:1995]. More detail is provided in the exhibits in [Singer:1990] from 
The Managed Health Care Handbook,  a guide for Health Maintenance Organizations 
(HMOs), page 381:  [Mullahy:1996]  
 
Also used to determine a diagnosis, a second opinion exam is often performed to 
help clarify a complex medical outlook or to prepare alternatives to the current or 
proposed treatment. In group medical plans, a second opinion exam is sometimes 
required prior to certain surgical procedures that the carrier or the latest utilization 
review statistics show to have a high usage rate (such as hysterectomies, hip 
replacements, cardiac bypass, magnetic resonance imaging scans, disc surgery, 
etc.). Such exams are also called for when there is a conflict between potential 
treatment plans, when a questionable treatment is in place, or when the existing 
treatment plan is not achieving the expected outcome. The case manager who 
arranged for the second opinion exam is usually in attendance, and the physician 
conducting the exam often will become a treating physician. 
 
To get greater benefit from independent medical exam and second opinion exams, 
a case manager should thoroughly understand the purpose of any exam ordered 
and be specific about what the physician’s report should address. The examining 
physician should be given as much information as possible (operative reports, 
diagnostic test reports, X-rays, computed tomography [CT] scans, etc.) and be 
given enough time to review all the data prior to the actual exam. After reviewing 
the physician’s report to confirm that it is responsive to the initial request for 
information, the case manager should speak to the physician about unanswered 
issues. 
 
We see here that getting second opinions requires clinical expertise and records, and 
involves the patient, multiple physicians, and, if the setting is an HMO, a case manager 
able to monitor the patients' progress. 
 
3.7 The Medical History  
 
The Medical Record, in private practice often referred to as the Patient Chart, is the 
collection of all past medical events, treated as an inpatient or as an outpatient in any   84
setting or location, insured or not, for an individual. This chart is also referred to as the 
Physician’s Chart, emphasizing its location. It is an important information source for 
establishing diagnoses and selecting a beneficial treatment.  It should include problems 
and symptoms presented by the patient, tests made and signs obtained, diagnoses, 
treatments ordered, prognoses made and results achieved (see [Weed:1981], 
[Weed:1985], and [Shortliffe:1990]).Since the medical record includes historical data, it 
is sometimes called the medical history.  We follow Holland's [Holland: 2002] example 
and quote [Noble:2001]:  
 
Perhaps the most central part of any medical database involves the collection of 
information regarding previous medical diagnoses, their treatment and response to 
treatment, current and previous medications and allergies, history of 
immunizations and childhood illnesses, and prior surgical history including 
response to anesthesia. This is generally accomplished through patient interview, 
through review of immediately available medical records, and by formally 
requesting medical records from previous providers or hospitals at which the 
patient was treated. The information obtained should be recorded on a problem 
list, which is generally organized into active and inactive problems, and 
prominently located in the patient's office chart. 
 
Singer [Singer:1990, p.27] also stresses the importance of comprehensive contents in his 
definition of Medical History. He does not include Symptoms however.    
 
A physical profile is an optional but useful abstraction of the current state of health of a 
patient and complements the medical record. The ARAMIS system, used in Immunology 
clinics, focuses on a time-oriented sequence of Physical Profiles [Wiederhold:1975]. 
Each snapshot includes specific diagnoses of current problems, subjective observations, 
signs from clinical tests results, and treatments prescribed, for a total of about 330 values. 
Some `105 patent claims require Physical profiles, but the accused system, Trigon, 
collects only diagnoses and treatment data submitted for reimbursement. 
 
The `105 patent places chart access (`105 in Fig.5) in the physician's office, presumably 
in the `Physician file' (44 in Figures 1 and 3). Because of confidentiality concerns the 
patient's medical history is best kept within the physician's computers, but the `105 is 
inconsistent about its location (see Section 1.4), often confusing it with the collection of 
elements reported for claims reimbursement (see Definition 3.8).   
 
An ideal, comprehensive medical record is hard to achieve since the information is 
created at many points in the healthcare system.  It has not been achieved in any systems 
prior to the patent, nor has it been achieved now.  Singer criticizes potential prior art, 
brought forward by earlier defendant's, for not having long-term laboratory results 
available as part of such a history (see Section 5.3).   The `105 patent makes no 
contribution towards achieving a comprehensive medical history. Instead it confuses the 
experts (see Section 1.4).   
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3.8 The Reimbursement Claims History 
 
The Reimbursement Claims History is the collection of billing events that an 
insurance carrier can collect. Depending on the comprehensiveness of the coverage, more 
or fewer events will be collected. The data collected is limited to the reimbursement 
claims justification. The problems that a patient presents, the response to treatments, 
allergies, details of hospitalizations, including medications and routine treatments given 
there, over-the-counter medications, and social and financial history elements are not 
available. There are also legal limitations on the time that reimbursement claims records 
may be kept, typically 7 years. Childhood events and immunizations are not available for 
adults. Reimbursement claims paid by other insurance carriers are also not available. In 
order to get a broader view of reimbursement claims histories, some companies provide 
integration over multiple insurance carriers [VantageMed:2002]. The Medical Insurance 
bureau aggregates information for the industry, but limits its classifications to 230 items, 
including non-medical observations [MIB:2002]. While an insurance reimbursement 
claim history is a subset of a medical history, it cannot replace the medical history for 
making treatment decisions. It is important for insurance companies to spot cases of 
individual, provider, and group over utilization as well as outright fraud.  Actuaries to 
determine health plan rates to be set for future contracts will also use it. 
 
3.9 Utilization Review 
 
We will use in our report the definition of Utilization Review in [Shortliffe:1990]: "In a 
hospital, inspection of patients' medical records to identify cases of inappropriate care, 
including excessive or insufficient use of resources."  Utilization reviews are carried out 
by quality review boards, focusing on cases that are reported to them, or selected as being 
inadequate or excessive.  Utilization review has become important in the last 20 years, as 
more health care is being delivered on a capitated basis, to assure that adequate care is 
being delivered where there is no incremental financial incentive to provide such care. 
 
From Allcare's claims chart: "The evaluation of medical necessity, and efficiency or 
quality of health care services, either prospectively, concurrently, or retrospectively." 
That definition matches [Cummings:2002, p.85-86] 
 
From Trigon's claims chart: "cost effectiveness." Because of the gap in definitions we 
will define another term that matches Trigon's definition of Utilization Review, a 
definition which stems from its business, being an insurance carrier and not a quality 
review board. 
 
As Holland acknowledged in his deposition [Holland:2002D], the term utilization review 
has different interpretations depending on which organizational unit is involved..  
 
 
Q. And did that smart claims payment system perform utilization review?   86
A. It performed a form of utilization review. To a claims manager, what it did, i.e. 
claim edits that were attempting to look for inappropriate care, inappropriate 
claims, redundant claims, that is a form of utilization review in a claims 
environment. But a medical manager, i.e., a physician, a medical director or a 
nurse working in the medical management department of health care, of a 
healthcare, health plan, would not consider that utilization review, so you have to 
understand that terms were used interchangeably and some were embraced by 
different departments. 
[Holland:2002D, p. 101 l. 21-22, p. 102 l. 1-22]. 
 
Singer [Singer:2000, p. 61], being a specialist in this area, points out the proper 
distinction between utilization review and pre-authorization of treatments. 
 
3.10 Cost-effectiveness review 
 
We define Cost-effectiveness review to be a process that, typically a priori, reviews 
expected expenditures for treatment and determines if the medical condition warrants the 
treatment expenditure. Cost-effectiveness review may disallow reimbursement for costly 
alternatives or deny treatment reimbursement altogether. The patient or the provider may 
appeal such decisions or decide to proceed with the treatment without insurance 
coverage. Note that cost-effectiveness review, carried out by insurance carriers, can 
easily be in direct conflict with utilization review (see Definition 3.9)  
  
The cost-effectiveness review process, is referred to in the Allcare documents also as 
Utilization Review, in the sense of review of treatments ordered for medical effectiveness 
at the given cost.  As such, it is a health-care reimbursement-oriented subset of 
Utilization review, focusing only on denial of treatments and not considering changes or 
augmentation of treatments. 
 
Cost-effectiveness review is related to cost-benefit review.  In performing cost-benefit 
reviews, the assumption is that all factors can be reduced to monetary terms, i.e., dollar 
amounts. In health care delivery, patient welfare is a concern that cannot be reduced to 
monetary values, and medical knowledge is needed. 
 
3.11 Drug Cost-effectiveness Review 
 
Drug Cost-effectiveness Review is a subset of Cost effectiveness review (q.v.). 
Medical practice allows the substitution of equivalents of prescribed medications by a 
pharmacy, unless the physician has indicated that no substitution is permissible. 
Performing this function is generally subcontracted to specialized organizations that 
interact with the pharmacies frequented by the patients. In the patent no explicit mention 
has been made of pharmacy services, but the term ancillary services is used frequently.  
Experts opining for the plaintiff have included pharmacy services within ancillary 
services. That is not our definition of the term, but we won't quibble. Well known   87
ancillary services are laboratories, providing quantitative signs (q.v.) to help in diagnoses, 
X-ray and other scanning modalities, Physical Therapy, Physical Rehabilitation, 
Radiation treatment, and an ever-broadening range of medical technologies.  
 
In the case of prescribed medications, cost-effectiveness review may direct generic 
substitution for prescribed compounds. Medication review is performed outside of the 
Trigon systems at Medco, following published guidelines. Trigon systems do allow 
retrospective analyses of medication expenses for patient groups. 
  
3.12 Comprehensive Health Care System  
 
A comprehensive information system should include all the information processing 
components needed in a discipline. We use the common meaning of "including much, of 
large content or scope" [OED:2002] for the term comprehensive, and when we apply it to 
health care systems there is no doubt that the vision in `105 specifications is indeed of a 
`Comprehensive Health Care System', in fact so much so that is quite beyond our -- and 
that includes our government's -- ability to implement it all.  We can refer to such a 
system as a Health-care Vision.   
 
Because of the breadth of that vision, the use of the term `Comprehensive Health Care 
System' leads to disagreement here. It is used in more than one sense in the `105 patent. 
Because of this we find that the patent does not establish an adequate basis to give notice 
of the metes and bounds of the term.  Furthermore, the patent holder uses the term 
`Comprehensive' to apply to his vision of health care [Cummings:2002]. We will define 
that term as well in Section 3.13.. 
 
The preambles of asserted claims 1,4, 16, 19, 34, as well as claims 31,32,33 of the `105 
patent all recite a comprehensive health care system, although the actual body of the ‘105 
claims recite a very small subset of the system described in the specification. For 
instance, claim 1 is limited to entry of a patient identifier and the patient's symptoms, 
having the means of payment known, providing suggestions on treatment, and indicating 
those treatments for which payment is to be prevented.  Such a system is merely a 
Health-care Payment Control System Based on Symptoms (with automated treatment 
proposals).  
 
Note that the systems provided by Trigon are a Health-care Payment System Based on 
Diagnoses. They differ from the claimed Health-care Payment System Based on 
Symptoms at least in the input they require. But, because of that difference, they differ 
drastically in methods and technology - and must differ, since the claimed systems cannot 
be built with today's technology, due to the discontinuity elaborated in Section 1.1. 
 
3.13 Comprehensive Health Care  
   88
A social organization to provide Comprehensive Health Care is a vision of many leaders 
in health care and refers to the gamut of health services, including preventive care, 
curative care, and rehabilitation [Kostrzewski:1976]. The author of the patent has focused 
throughout his career on preventive care, leading to wellness. The curative aspects deal 
with illnesses (see Definition in Section 3.3) and include emergency and long term care. 
For our aged we must also include palliative care. In the sense that health care should 
deal with all aspects of our body and our psyche, comprehensive care is also referred to 
as holistic care. This spectrum of care is delivered by a wide array of services for the 
well, during maternity, for ambulatory outpatients, for hospital inpatients, and for the 
aged. Comprehensive health care must also be delivered affordably and consistently to all 
economic strata by a wide variety of health care providers and institutions 
[Kellogg:1999]. This goal cannot be achieved merely by having a Comprehensive Health 
Care System in the sense of definition 3.12, but requires societal commitments beyond 
what seems to be affordable. 
 
Unfortunately, the term "Comprehensive Health Care" is also an attractive advertising 
term, and as such used by many organizations in the field, all different, often modest, to 
describe their offerings. 
 
3.14 A Medical Director 
 
A Medical Director is a certified M.D. employed by an insurance carrier or provides 
service to an insurance carrier, such as Trigon, to establish the medical necessity of 
treatments. Such services are required when the decision to disallow reimbursement, 
either prior to the treatment or subsequently in a reimbursement claim cannot be based on 
administrative rules, as not being a member of the health plan or not being covered by the 
plan for specific diagnoses or services, say, psychiatric care.   In addition to 
reimbursement claims data (diagnostic code, requested treatment, a brief optional note), 
the medical director can access the local reimbursement claims history for the patient. If 
more medical information is needed the Medical Director contacts the patient's physician 
office by telephone to discuss the case with the health care provider. 
 
3.15 Smart System 
 
Smart System is not a well-defined term in Computer Science. Informally, a smart 
system is a computer system that is able to make decisions or suggest actions using 
reasoning that are not immediately obvious to the beholder. Such a definition of course 
depends on the competence of the beholder. The complement to such smart systems are 
algorithmic systems (see Definition 3.16), systems whose behavior can be predicted. 
 
In the 2000 deposition an attempt was made to arrive at a definition through the 
following interchange [Cummings I: 2000,  pp. 161  l. 23-25, 162  l. 1-14]  
 
Q: `So the system of Claim 1 is a smart system, correct?'    89
A: `It's part of the utilization. Right'.  
Q: `Is the answer yes?' 
A: `yes',  
Q: `What is a smart system?'  
A: A smart system is capable of managed artificial intelligence or rules based'.  
Q: `What is artificial intelligence?' 
A: `Pattern analysis'.  
Q: `Okay. What is Pattern analysis?'  
A: `The ability to keep a system learning as you add more data'.   
 
While we would not consider Pattern Analysis an Artificial Intelligence system, we do 
agree that a system that keeps learning as more data is added does fall into that category.   
 
Kaliski, in his deposition [Kaliski:2002D, p. 38], argues that even a system employing 
simple business rules is smart:  
 
Likewise, CHIPS and AMISYS are rules-based applications for determining 
whether to pay, deny or pend incoming reimbursement claims based upon a 
review of the content of the [reimbursement] claims themselves. (Felts deposition, 
pp. 15-19, discussing the business rules used therein).  
 
The reimbursement claims contain the patient's health care plan membership 
identification, their diagnoses, and proposed or performed treatments.  The business rules 
will deny payment to non-members, for non-insured diagnoses, and for certain treatments 
- absolutely or based on the diagnosis. If the situation is not covered by the simple 
algorithmic rules, as when a patient has multiple diagnoses, it is forwarded to the Trimed 
component  (see Section 2.2.2.6) for manual processing. Is a system that handles the 
filtering and only simple cases smart?  To a scientist, and I expect that this would include 
Prof. Kaliski and most educated observers, such a system falls into the algorithmic 
category, since the results of the computation are quite predictable.  Prof. Kaliski’s 
definition is flawed as applied to the technology of the ‘105 patent because, according to 
his definition, all computerized systems are smart systems.  Such a definition fails to give 
any meaning to “smart” and as such is not a meaningful definition. 
 
The Trigon systems are certainly less smart than a system envisaged by the `105 patent 
applicant, which:  
 
In accordance with the "Smart system" characteristics of the invention, Physician 
File 44 preferably will include an identification of the most commonly 
encountered diseases and other ailments, together with symptoms usually 
associated therewith. Accordingly, if symptoms are entered into the system 
terminal (e.g., one of terminals 11a-11c), and an identification of the 
corresponding illness is requested from the Processing System 10, the physician's 
file is interrogated, and the system prepares a list of the most likely medical 
condition corresponding to such symptoms, together with the generally approved 
and/or recommended treatment protocols.    90
 
As discussed in Section 1.1, we do not know now how to build such a smart system 
today. Any beholder would indeed consider a system smart that could recommend 
treatment from symptoms without further tests providing signs (see Definition 3.2) , 
without the patient's medical history (See Definition 3.7). While the `105 patent's 
specification only generates a list to reduce the physician's work to selecting choices, the 
patent `105 claims fail to provide for the needed physician interaction.  
 
Unfortunately, the `105 patent does not and cannot teach us how to build such a smart 
system. 
 
3.16 Algorithmic Systems 
 
Algorithmic systems use predetermined procedures to arrive at a result. As such, 
their results are perfectly predictable.  Most usage of computers is for algorithmic 
systems, and systems that approve payment must be, because if a question arises an 
explanation is required. We quote an entry from the [OED:2002]:  
 
Algorithm 3. Med. A step-by-step procedure for reaching a clinical decision or 
diagnosis often set out in the form of a flow chart, in which the answer to each 
question determines the next question to be asked.  
 
           Algorithmic systems have been developed that aid a physician in refining a 
           diagnosis: 
Flow-charts, diagnostic keys and algorithms in the diagnosis of dysphasia. 
[Lusted:1970]  
 
Flowcharts, a pictorial presentation of algorithms, are also available in self-help books 
that provide guidance to people that wish to decide what to do in case of illness, e.g., 
[VickeryF:1989]. These books also stress when their algorithmic procedures fail and a 
doctor should be consulted. 
 
3.17 An Expert System 
 
An Expert System is an interactive computer program that helps users with problems 
that would otherwise require the assistance of human experts; a program that presents the 
computer as an expert on a particular topic. Expert systems capture knowledge in rules 
that can be communicated to others as advice or solutions.  
 
"The programs often simulate the reasoning process used by experts in certain 
well-defined fields." [Websters:1994].  
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The capabilities of such expert systems are limited to `well-defined topics', and not 
capable of the breadth envisioned in the `105 specifications [Buchanan:1985]. The term 
is only used once in the `105 specification (see Section 1.6). 
 
Expert systems are one topic in the field of Artificial Intelligence [AIM:1977]. Other 
topics in this field include speech recognition, image recognition, inference, abduction, 
deduction, and machine learning, i.e., in general computational methods that require a 
layer of explicit and manipulable knowledge about tasks that are to be performed 
[Davis:1982]. In the context of the `105 patent, such knowledge might include a model of 
human metabolisms, connecting the etiology of diseases to possible external 
manifestations. Unfortunately we are just in the beginning of understanding metabolic 
interactions. The `105 patent does not contribute to our knowledge, nor teaches us how to 
acquire such knowledge. 
 
3.18 Doc-in-a-Box 
 
Doc-in-a-box is an informal term that denotes an Expert system (q.v.) that performs 
some of the functions that one expects a clinician to be able to perform [Holland:2002D, 
p. 151 l. 11]. In practice the tasks performed automatically are small subsets of a 
clinician's capability, for instance selecting and ranking relevant treatments for a known 
diagnosis. The most common technology used is Rule-based Systems (q.v.), but some 
Doc-in-the-box program have used computational, i.e., algorithmic (q.v.) approaches, as 
in [Bleich:1969].  
 
3.19 Rule-Based Systems 
 
Rule-based systems are a technology for expert systems (q.v.) where the 
experience of experts, in our case typically physicians, is encoded in If-a-then-b rules.  
The 'a' term can combine multiple factors, as data or the results 'b' of prior rules.  In 
Section 4 we cite some such systems, for instance Mycin [Shortliffe:1976].  When the 
number of rules grows large, say more than 50, the result becomes hard to predict, even 
for the author of the software. Such systems indeed become `smart systems' by our 
definition. To cope with the unpredictability, smart systems, such as Mycin have been 
equipped with ancillary programs that provide an explanation service [Davis:1982]. 
  
Unfortunately, medicine is to complex to allow us to build rule systems that could bridge 
the gap from general symptoms to treatment. For instance: 
 
"MYCIN was one of the first systems dealing with this issue, although the system 
was actually restricted to the clinical areas of sepsis and meningitis" (see Section 
4.6.4) [LucasBSH:2000].  
 
 Rule-based systems have not grown beyond a few hundred non-grounded rules. 
Grounded rules are just a way of entering data into rule-based systems. The complexity   92
of interactions among hundreds of rules is such that adding subsequent rules and testing 
their effect becomes an impossible task. Rule-based systems, or production systems using 
an earlier convention, are described in [Barr:1989].  
 
The definition given in [Barr:1989] is operational: 
A rule-based system is a system that  
a.  reasons with domain-specific knowledge that is symbolic as well as numerical 
b.  uses domain-specific methods that are heuristic (plausible) as well as followings 
procedures that are algorithmic (certain) 
c.  performs well in its problem area 
d.  explains or makes understandable both what it knows and the reasons for its 
answers 
e.  retains flexibility. 
 
The systems used at Trigon do not carry out:  
a.) reasoning in the sense of [Barr:1989],  
b.) do not use heuristics, and 
c.) do not explain what they know.  
 
3.20 A Table 
 
A Table, as used in Computer Science, is “an arrangement of numbers, words, or items 
of any kind, in a definite and compact form, so as to exhibit some set of facts or relations 
in a distinct and comprehensive way, for convenience of study, reference, or calculation. 
Now chiefly applied to an arrangement in columns and lines occupying a single page or 
sheet, as the multiplication table, tables of weights and measures, a table of logarithms, 
astronomical tables, insurance tables, time-tables, etc. But a table is sometimes merely: 
‘An orderly arrangement of particulars, a list.’”   [OED:2002]. 
The orderliness characteristic of a table inhibits its use in supporting medical decision-
making.  The symptoms presented by a patient are not orderly, are incomplete, and 
overlap. The regularity of a table is also inefficient in situations that are as complex as 
health care tasks. Even the treatments that are candidates, once a diagnosis has been made 
vary in applicability, in number, in length, and in availability. Tables will be found in 
simple situations, say where a treatment is associated with a price, member identification 
is listed with the plan, or where a physician code can provide the provider's name and 
address.  Tables are not considered instances of `smart systems'.     
 
3.21 Factor Analysis 
  
Factor analysis is a well-known statistical technique that analyzes effects due to 
multiple causes. While simpler analyses focus on one factor at a time, keeping all other 
factors constant. If there are more than 10 factors, the single factor approach soon 
becomes unwieldy. In health care, there are typically many factors.  Factor analysis   93
processes observations from past experiments using models describing causes and effects 
in order to produce multiple factors that can be used to predict effects in future situations 
that are describable by the same factors [Snedecor:1967]. Factor analysis has been widely 
used in agriculture, where there is a single outcome, namely the yield of corn in a 
controlled plot of land.  Once the best combination of factors, as planting time, fertilizer, 
and irrigation is known, the results can be used in future plantings. In the examples cited 
by Cummings in his depositions, a Health Risk Assessment (HRA), there may be as 
many as 20 candidate factors and one outcome, perhaps the patients' blood pressure.  
Such a study will require many hundreds of cases. Since ‘wellness’, rather than 
management of disease has been the primary interest of the patent holder, he uses his 
experience with Health Risk Assessments (HRA) as a model for disease management in a 
Comprehensive Health Care System.  Giving advice on managing wellness does not 
involve making diagnosis, and does not require the medical certification required for 
diagnosing and treating diseases.  Only a modest number of factors are involved, 
focusing on diet, smoking, drinking, exercise, and sometimes workplace related risks.  
 
If the effects are not linear combinations of the causing factors, as is often the case in 
health where large amounts of, say a drug, have disproportional large effects because of 
inability of the human metabolism to excrete excess products, many more observations 
are required.  If factors interact, as say smoking and exercise, still more data is required 
in order to extract the interaction effects.  Note that 20 factors could have 380 simple 
interactions. An HRA study typically cannot afford to look at the actual desired effect, 
namely patient survival, and may use a surrogate as low blood pressure. Since significant 
healthcare effects are often delayed, studies into actual disease outcomes have to collect 
data over long periods of time.  The premier HRA study is the Framingham study to 
elucidate factors leading to heart disease [Framingham:2001].  Here over 5000 patients 
have been followed about 50 years and over additional 5000 patients representing 
offspring of the original patients have been followed for 30 years.  Only a few global 
studies of this type exist, partially because of cost, partially because other diseases have 
lower incidences, so that we cannot collect large enough populations for trustworthy 
analyses. 
 
A great deal of uncertainty remains in health care outcomes, even in simple studies, due 
to an inability to consider all factors. For instance, only a few genetic factors can be 
obtained today, while we estimate that there are about 35,000 genes controlling many of 
our functions, with yet an unknown number of promoters and inhibitors.  In the absence 
of factors, many more patients must be randomly selected for health care studies in order 
to even out the effect of such natural variances.  
 
In summary, the effect of the limits of purely statistical analysis to drive health care 
prediction, and the amount of data required to analyze the relationships of several 
thousand interacting symptoms to hundreds of treatments, exceeds by far the population 
of the world. Medical science and education provides an understanding of the processes 
and the mechanisms, so that human intelligence and experience can largely overcome the 
inadequacies of global, formal statistical techniques.   
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Factor analysis remains a useful tool to analyze disease models that are well understood. 
The remaining uncertainty can be tolerated when the actions to be taken are not life 
threatening -- as in reducing Health Risks or if they are simply advice to a physician. 
Factor analysis falls far short of providing the information that a general smart system, as 
hypothesized in the Cummings deposition [Cummings II:2000 p.206 p. 207 p. 208 l.  4-
7], would need.  
 
In [Cummings:2002] the magnitude of the problem becomes clear. Performing a factor 
analysis for a marketing study with 345 factors and 144 variables was a major task, 
performing a factor analysis for 12,000 diagnoses and 7,000 symptoms dealing with 
millions of patients over decades is a task many more orders of magnitude of complexity. 
The limits of available programs in that period was f factors and y variables 
[BMD:1979]. 
<<work this out>> 
 
3.22 Integrated Systems. 
 
We define an Integrated system as one where each participating component can share 
data electronically with other components, continuously or at an adequate schedule. This 
definition is generous and allows multiple sites, multiple networks, multiple 
communication standards, multiple vendors, multiple owners, multiple types of 
computers, multiple operating systems, and multiple computer languages to be used. 
Limiting the extent of multiplicity will reduce confusion and costs, but does not affect the 
principle.  Removing all the multiples, i.e., placing it all on one computer is the ultimate 
integration, but only feasible when the totality is modest.  
 
In practice, the scope of integration for computer systems varies greatly and has changed 
over time. My research in the 70’s and early 80’s dealt with integration of data from 
many sources into one coherent database, leading to tightly coupled systems.  As 
communication improved the need to tightly integrate systems lessened, and most 
systems became loosely integrated, often managed and owned by distinct entities. Such 
systems can be much larger and support the vision of the `105 patent. Since it integrates 
needs of patients, healthcare providers, insurance companies, employers, and financial 
institutions, it is of necessity loosely coupled.   Not mentioned, but crucial, is the role of 
the federal government, both as a supplier of reimbursements (Medicare), funding 
(Grants to hospitals and health care researchers), operator of hospitals (the Veterans 
Administration and Department of Defense) and consumer (see the FEP module in 
TRIGON, for instance, described in Section 2.2.2.7). 
 
Formal definitions do not help much in this field, in part because the concept keeps 
changing with the progress in computing and communication. For instance: 
 
•  "Integrate: The process of putting various components together to form a 
harmonious computer system." [Webster:1988. 1994] Harmonious is not 
defined.   95
•  "Integration: The combining of diverse elements of hardware and software 
often acquired from different vendors, into a unified system. 
[Webster:1994], but later editions give up and fail to define this or related 
terms [Websters:2000]. 
 
3.23 Work Flow System 
 
A processing system that combines automated processing with manual human 
interventions.  
 
The partial automation of a process, during which information or jobs are passed from 
one human to another for action, according to a set of procedural rules. 
 
3.24 Terminal 
 
The definition of Terminal in the American Heritage Dictionary sense 5. [Heritage:2000] 
is "A device, often equipped with a keyboard and a video display, through which data or 
information can be entered or displayed." 
 
A smart terminal would include significant computational capabilities while a dumb 
terminal would have very limited computational capabilities.  
 
3.25 Point-of-Sale Terminal 
 
The definition of Point-of-Sale in the American Heritage Dictionary  [Heritage:2000] is 
"A business or place where a product or service can be purchased." 
 
A Point-of-Sale (POS) terminal may include bar-code readers, credit card swipe 
capability, a phone interface, cash register functionality, and specialized keys mapped to 
specialized functions.  
 
3.26 Health Risk Assessment (HRA) 
 
The Rippe Health Assessment (RHA), called the Health Risk System by Cummings, is 
based on a philosophy involving five pillars for comprehensive health evaluation. Every 
RHA client receives comprehensive evaluations in each of these five important areas: 
(Based on Dr. Ripple book "Lifestyle Medicine" published in September 1999). 
 
•  Comprehensive Medical History, Physical Examination, and Laboratory Work: Every 
client of the Rippe Health Assessment receives a comprehensive health history as 
well as a physical examination performed using protocols developed by Dr. Rippe. In   96
addition, complete laboratory work, including a variety of sub-specialty tests and 
procedures using state-of-the-art medical technologies and equipment are available. 
•  Optimal Nutrition: Optimal nutrition is a key to good health. The Rippe Health 
Assessment nutrition team provides a comprehensive in-depth nutritional evaluation 
to all RHA clients along with recommendations for change. 
•  Physical Activity/Exercise: An active lifestyle is a healthy lifestyle. Dr. Rippe is a co-
author of the guidelines developed by the Centers for disease Control and the 
American College of Sports Medicine on physical activity for adults. An RHA 
Exercise Physiologist provides an in-depth assessment of physical activity and 
exercise followed by a personalized program tailored to the individual's needs, 
interests and current fitness level. 
•  Personal Vitality: Vitality is much more than just physical well being and freedom 
from disease; it is also spiritual, emotional and social health. The RHA vitality staff 
provides in-depth analysis and counseling to provide every RHA client with 
guidelines to achieve optimal vitality. 
•  Pharmacy Evaluation: Often, interactions between medications, supplements, 
vitamins and minerals represent an area of great confusion for individuals. The 
RHA/PharmaCare pharmacy staff provides a comprehensive pharmacy assessment to 
address these important concerns. 
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4.  Pre-1990 State of the Art in Health Care System 
 
We start with a general introduction. We then examine the limitations and asserted claims 
using Allcare's claim construction chart in Section 4.2. 
We then list on Section 4.3 general references that provided overviews of prior art. 
In Section 4.4 we list specific health care systems that must be considered prior art by the 
broader interpretation of the patent. In Section 4.5 we describe some relevant health care 
reimbursement systems, since these are congruent with the objectives of the `105  patent 
claim and the services provided by the accused.  In Section 4.6 we list and briefly 
describe some specific technologies that are cited in the patent or by experts as 
representing prior art. Through out Sections 4.3 to Sections 4.6, several key systems are 
compared to the asserted claims. This section concludes with a summary.  
 
Brief descriptions of the patents actually cited as prior art that were cited in the patent 
application are provided in Sections 5.10 to 5.17. 
4.1 The Failure to Present Relevant Prior Art. 
We start by presenting certain inconsistent testimony offered by Allcare’s witnesses, the 
applicant (Cummings), and Charles Singer, a consultant to Allcare.  Singer assumed that 
for the patent to be valid it required full automation, since the health care processes 
described in the patent had been ongoing with manual paper-processing for ages, and 
since the middle 1960’s with increasing levels of automation. 
 
We now cite the testimonies that have led us to this conclusion, first Cummings, then 
Conner, and finally Singer: 
 
Q: (Patent office) "just did searches of patents, did not do searches of what vendor 
systems there were or what other hospitals were doing, what insurance companies 
were doing, did they?   
A. My background and assumption on that was Bill (Conner) was with the 
managed care side.  
Q. So you were relying on Bill Conner for the expertise to determine whether or 
not this was novel; is that correct?  
A: I was relying upon Bill and the way he worked with the patent attorneys with 
John and Andy to do that and when Bill asked for a search to be done, I assumed 
it was a literature search, because a couple of searches were done. So I assumed it 
included the literature as well. But Bill's knowledge of the HMO systems and so 
forth was far – he had been in the business, so his knowledge of that and the 
technology people he had and, you know, the fact that he had brought in a guy 
from, you know, the Tandy organization and his relationship with that and 
American Airlines and those folks, that's really where I saw the contribution and 
the expertise that I relied on.  [Cummings VI 2000, p.130. l. 2-24] 
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A. Yes. I basically put this under John's leadership, worked with him on it.  He 
had the power of attorney.  He worked with me for that disclosure.  And when 
you looked at this particular document, to me it was a subset of what we were 
already doing and what we had already declared was out there. And we didn't -- 
we were not saying medical payments was a part of the process that was key.  It 
was the managing of the care, and managing the care was really the key. 
Q. So you're saying it was out of your hands, you gave it over to Bill Conner? 
A. I gave it to Bill as my responsibility, so I viewed my responsibility as to get it 
into Bill's hands. When I saw Bill had referenced going over BankOne material, I 
assumed that Andy had seen that and the question to me is basically, you know, 
has -- have I gotten it into Bill's hands, and have I done my responsibility?  And 
that was my responsibility to do that. 
Q. You feel like you fulfilled your responsibility to Bill Conner? 
A. I feel like I fulfilled my responsibility to the process of putting the patent 
application in place. 
 Q. But you didn't follow through and make sure that the patent examiner had the 
BankOne disclosure? 
 A. The logic that I had relative to the BankOne disclosure was, we've seen these 
disclosures and here is where BankOne was not a substantive difference from this 
particular disclosure. 
Q. So you're saying that you didn't think it was material and didn't need to be 
provided to the patent office? 
 A. Well, I'm basically saying I thought the information had gotten to John, and 
John had made a judgment relative to the information as he reviewed all the 
relevant material. 
Q. Do you think sitting here now that it should have been provided to the patent 
office? 
A. I don't, basically because I don't see it as having substantive difference other 
than just a payment system.  It's a generic credit card transaction system turned 
towards the payers.  You're just sliding in different people instead of retailers or 
others.  It's not a system that in itself really is anything more than a payment 
system. 
Q. Even though the system includes a point of sale terminal at a provider office, a 
connection to insurance company, connection to an employer, a connection to a 
patient's checking account or credit card, connection to drug companies, et cetera? 
 A. That's all payment.  I mean, the definition of the system is that it's a payment 
system. [Cummings:2002, p. 124  l. 19-25, p. 125 l. 1-25, p,126  l. 1-12] 
 
Charles Singer was retained by Allcare in 1990 to investigate the position of the `105 
patent with respect to the state of the health care industry. 
 
"A: I don't remember any report in writing. He verbally said that he  
looked in all of the places that he felt, at the beginning of our relationship. such 
prior art might exist, if it did, and was  satisfied that it didn't"  [Conner II:2000, p. 
35] 
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His earlier publication documents his knowledge of the health care industry. [The Singer 
reports]. We can assume that he was familiar with many, if not all of the systems cited in 
Section 4 of this report.  For preparing his reports, he would also be comfortable in 
performing literature reviews which document these and other entries in this chapter.  
 
The report Singer prepared for Allcare states:  
 
that, by law, an issued patent is presumed valid" [Singer:2000, p.6].  
For the description of the patent Singer relies on the preferred embodiment: 
p 140 "to be honest with you, I looked at the claims  probably spent – those 
charts, and probably spent 5 to 10 minutes on them, and then decided that I would 
prefer the language of the patent directly. I found the charts sometimes a bit 
confusing, harder to read, than just reading it directly. [Singer:2000, p.140 l. 3-9]  
 
quoting,  
 
the `105 patent specifically states that `The preferred embodiment of the present 
invention includes integrated connection and interaction of the patient, healthcare 
provider, bank and other financial institution, utilization review, case manager ... 
[Singer:2000, p.11] 
 
Inadequate automation causes, for instance, Singer to dismiss the Optimed system: 
 
In the OPTIMED system described and documented by Mr. Weelman, it is clear 
that the input terminal is housed at the utilization review organization or the 
insurance company. Furthermore the described communication link between the 
physician's office and the UR staff is not a computerized data link, but rather the 
then traditional (and inefficient) phone call that the `105 patent means to eliminate 
[Singer:2000, p.11]. 
 
Singer also values the term `comprehensive' used in the `105 patent as having to include 
all functions cited, even tough the claims are much narrower. For instance, he fails the 
HELP system of the LDS hospitals for not having a long-term patient record: 
 
.. a comprehensive system as described in the `105 patent is dependent on a 
comprehensive longitudinal patient history, with information being retained for 
significantly longer periods of time, if not over the patient's lifetime. 
[Singer:2000, p. 9] 
 
The `105 claims have no such requirement, and in fact seem only to collect symptom and 
treatment codes.  Neither does the accused system maintain such desirable longitudinal 
records. 
  
We see that the applicant and the person who investigated prior art for that patent hold 
opposing views of what the patent means. 
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If we were to allow the construction advocated by the patent holder and Allcare, and 
allow, for instance, that  
 
•  a comprehensive system does not have to be all inclusive  
•  any computation can be a smart system 
•  that the required terminal hardware can be placed wherever needed, even if not 
specified 
•  the process can include a mixture of automated and manual steps,  
 
then, systems as described below in Section 4.3 and 4.5, with their accompanying support 
environment will invalidate the `105 patent in whole or in parts.  
 
The plaintiff cannot have it both ways: 
1.  reject prior art as not providing comprehensive and integrated full 
automation as stated in the `105 vision 
2.  seek license fees and/or damages from current systems that do not 
provide comprehensive and integrated  full automation. 
 
A particularly pernicious example is that any system that does not provide both inpatient 
and outpatient services is not regarded as being prior art, since the `105 patent specifies 
its integration.  But the plaintiff is willing to extract license fees from systems that have 
disjoint processing of such data.  In practice, the information system demands of inpatient 
(intense, rapid response, high cost) differ greatly from outpatient operations (voluminous, 
long term, modest costs). Every health care manager would prefer the integration, but 
technical difficulties have prevented it in most places, including at Celebration Hospital, 
the model institution associated with Disney's technology demonstrations where 
Cummings is a council member, executive vice-president, and fund-raiser. 
 
"...  And those ranges from our historic involvement with the hospital at the new 
Disney City called Celebration where we brought that on-line through the 
visioning.  [Cummings:2002, p. 12. l. 16-18] 
A. So we advance through either capital campaigns or through particular annual 
giving campaigns or special events the opportunity to get people a chance to 
invest their philanthropic dollars in building health care in Orlando.  
Q. So it's fund-raising and then distribution of funds for the purpose?   
Q. You said that you also sit on the president's council for Adventist Hospitals?  
A. Yes. [ibid, p13. l.11 -- p14 l.1] 
... I  believe you testified that you're the executive vice president for Florida 
Adventist?      
A. Right, for the Florida Division of the Adventist Health System. [ibid p.14, l. 
16-l20 
We were talking about the level of integration of the systems at the Florida 
Hospital.  I believe that you testified that they were not integrated to the extent 
that you would like to see them integrated.  
A. Yes.      101
Q. Is that correct?  Is there any reason why they're not as integrated as you would 
like?    
A. Sure. The health care industry in general is not integrated.  It's behind.  Florida 
Hospital is probably on the leading 25 percent of that integration, but the health 
care industry by and large has a tremendous I.S. -- underlying I.S. issue.  We just 
don't have the ability to integrate all the data, unlike many other industries. It's 
been a universal criticism and cry of the presidents of the institutes of medicine to 
others saying we've got to change the I.S. system.  We've got to have an 
investment in I.S., something like Hill Burton was to invest in infrastructure into 
the bricks and mortar. [ibid. p. 67, l. 1-17] 
 
Everywhere vision differs from practice, even at leading institutions.  
     
We now proceed with the specifics.   102
4.2 Claim Construction with their Limitations 
 
Using Allcare's claims construction chart, the asserted claims of the `105 patent are 
construed by first building limitations, which are then assembled into claims. The 
constructed limitations and asserted claims of the `105 patent (CCL) are then compared 
to the features of the systems included in this section.  
 
4.2.1 Claim Limitations. 
 
•  [CCL-Preamble] The preamble is not a limitation.  
•  [CCL-Input Means] A physician office terminal. 
•  [CCL-Patient ID] Information identifying one of two or more persons identified in 
advance. 
•  [CCL-DB-Treatments-UR] Database of elected procedures identified for utilization 
review [The evaluation of medical necessity, and efficiency or quality of health care 
services, either prospectively, concurrently or retrospectively. Examples of criteria for 
utilization review cited within the patent include “any of a variety of factors for 
review such as Cost, Treatment Results, Referral Matters, Other Opinions, and the 
like.”]. 
•  [CCL-Payment Means] 1. Medical payment system or 2.  Computer system which 
performs an adjudication procedure and electronic payment or 3. Computer system 
programmed to perform automated funds transfer. 
•  [CCL-Symptoms] Information relating to or representing a sign or an indication of 
disorder or disease, especially when experienced by an individual as a change from 
normal function, sensation, or appearance. 
•  [CCL-Proposed Treatments] 1. Smart System that proposes mode of treatment or 2. 
Computer system that accesses patterns of treatment protocols to determine whether 
the treatment is appropriate or 3. Computer system that permits the user to enter a 
proposed mode of treatment. 
•  [CCL-Indicia] 1. A conventional printer capable of printing out reports in hard copy 
form or 2. A monitor screen for displaying visual display or review of data. 
•  [CCL-Prevent Payment] 1. Any of the payment means [a. Medical payment system 
or b. Computer system which performs an adjudication procedure and electronic 
payment or c. Computer system programmed to perform automated funds transfer.] 
including a computer system where claims fail to indicate approval of the 
action[utilization review]. or 2.  A smart system for approving procedures. or 3. 
Computer system having the features of at least one identified structure within [CCL-
Proposed Treatment], and at least one identified structure within [CCL-Indicia], that 
prevents payment until and unless the claim includes data indicating the action 
[utilization review] resulted in approval or authorization. 
•  [CCL- Indicia-Treatments Ancillary Service] Indicia of treatments provided by 
pharmacist, dentist, optometrist, audiologist, laboratories, medical specialists and 
others either using a printer or monitor screen. 
•  [CCL-Provide Ancillary Service] 1. An automated system, medical director or other 
suitable person indicates that payment will be made for a particular ancillary service   103
as an approved treatment protocol or part of an approved treatment protocol. 2. A 
provider electronically communicates a request for an ancillary service (such as a 
referral to a medical specialist) using the computer system. 3. Smart system for 
approving ancillary service treatments.  
•  [CCL-DB Medical History] Data base of Medical History [Predetermined items of 
medical history are any specific items which a database is established to collect where 
the items are items relating to patient data and heath history, items such as those 
found on patient medical charts and historical records, items that would be found on a 
patient summary report, items showing prior visits, treatments and tests, radiology 
and laboratory records and the like, caregiver comments and notes. May include items 
on a patient’s chart and historical record.  May also include a “medical chart 
summary report” and items typically displayed as part of “drug profiles”]. 
•  [CCL-DB Physical Profile] Medical History includes physical profile[Attributes of 
the body, including things that would result from a physical examination of the 
patient such as the patient’s height, weight, age, sex, and habits affecting the body 
(e.g., smoker, drinker)]  
•  [CCL-Data Input Terminal] A physician office terminal used to enter items of 
medical history. 
•  [CCL-Responsive Data Input Terminal] A physician office terminal that is 
responsive to inputs. 
•  [CCL-Verify Authenticity] Checking to make sure an individual who is a 
prospective patient has a genuine member identification number, which function can 
be accomplished 1. Manually through a computer terminal that is part of the system, 
or 2. Through the use of various types of data cards. 
•  [CCL-Eligibility] Verifying a member’s authorization to participate in the system. 
•  [CCL-Manual Keyboard] Manual entry of information may be made by depressing 
keys on a keyboard. 
•  [CCL-DB-Treatments-2
nd-Opinion] Database of that indicate an opportunity or 
requirement to obtain a clinical evaluation by a provider other than the one originally 
making a recommendation for a proposed health care service to assess the medical 
necessity and/or appropriateness of the initial proposed health care service. 
•  [CCL-Data Processor] At least one computer processor, e.g., personal computer, 
mainframe, central processing system, microprocessor or the like. 
•  [CCL-Data Bank Memory] A repository of data; any substantial collection of data 
that can be stored and retrieved. 
•  [CCL-Identify Preventive Health Routines] Accessing recommendations for 
pertinent changes in lifestyle, such as changes in diet, elimination of smoking, 
reducing the consumption of alcohol, reducing weight, participation in an exercise 
program, reduction of blood pressure and the like. 
•  [CCL-DB-Patient Data] A database of unspecified patient data. 
•  [CCL-DB-Terminal-Patient-Data] An unspecified terminal to enter patient data.  
•  [CCL-Payer DataPayer Data] Data designating the identity of the payer: 
information indicating the insurance company, HMO, managed care organization, 
self-funded plan or other party who is responsible for paying for all incurred covered 
medical services and related benefits in accordance with the terms of a contract   104
between that entity and the patient (or a family member of the patient) and/or their 
employer. 
•  [CCL-Data Representing Treatment] Data representing treatment for each of a 
predetermined plurality of illnesses: Such data can be a name, code or abbreviation 
that stands for, denotes or symbolizes generally accepted treatments for any two or 
more illnesses.  The Current Procedural Terminology (i.e., CPT) and International 
Code of Disease (ICD), Volume III codes are examples of widely accepted sets of 
such symbols. Data may be entered 1. A physician or a member of his or her staff 
enters the proposed treatment, such as through entering a CPT code, such provider 
wishes to propose in order to address each illness he or she has diagnosed the patient 
as having. or 2. A programmer or system administrator, in configuring and/or 
establishing the system, enters a list of treatments or treatment codes for any number 
of reasons relating to the operation and/or use of the system. 
•  [CCL-DB-Personal Health Profile Data]  Information about a patient that is useful 
in evaluating a patient’s health and including but not limited to information relating to 
the physical profile of a patient. 
 
4.2.2 Asserted Claims with their Limitations  
 
Claim 1: Claim Construction Limitations [CCL-Preamble], [CCL-Input Means], [CCL-
Patient ID], [CCL-DB-Treatments-UR], [CCL-Payment Means], [CCL-Symptoms], 
[CCL-Proposed Treatments], [CCL-Indicia], and [CCL-Prevent Payment]. 
 
Claim 2: All of the limitation of Claim 1 and Claim Construction Limitations [CCL- 
INDICIA-Treatments Ancillary Service], and [CCL-Provide Ancillary Service]. 
 
Claim 4: Claim Construction Limitations [CCL-Preamble], [CCL-Input Means], [CCL-
Patient ID], [CCL-DB-Treatments-UR], [CCL-Payment Means], [CCL-Symptoms], 
[CCL-Proposed Treatments], [CCL-Indicia], [CCL-Prevent Payment], and [CCL-DB 
Medical History]. 
Claim 5: All of the limitations of Claim 4 and [CCL-DB Physical Profile]. 
Claim 6: All of the limitations of Claim 4 and [CCL-Data Input Terminal]. 
Claim 7: All of the limitations of Claim 4 and [CCL-Responsive Data Input Terminal]. 
Claim 8: All of the limitations of Claim 7 and [CCL-Verify Authenticity]. 
Claim 9: All of the limitations of Claim 8 and [CCL-Eligibility]. 
Claim 12: All of the limitations of Claim 4 and [CCL-Manual Keyboard]. 
Claim 16: Claim Construction Limitations [CCL-Preamble], [CCL-Input Means], [CCL-
Patient ID], [CCL-DB-Treatments-2
nd-Opinion], [CCL-Payment Means], [CCL-
Symptoms], [CCL-Proposed Treatments], [CCL-Indicia], and [CCL-Prevent Payment].   105
Claim 17: All of the limitations of Claim 16 and Claim Construction Limitations [CCL- 
INDICIA-Treatments Ancillary Service], [CCL-Provide Ancillary Service]. 
Claim 19: Claim Construction Limitations [CCL-Preamble], [CCL-Input Means], [CCL-
Patient ID], [CCL-DB-Treatments-2
nd-Opinions], [CCL-Payment Means], [CCL-
Symptoms], [CCL-Proposed Treatments], [CCL-Indicia], [CCL-Prevent Payment], and 
[CCL-DB Medical History]. 
Claim 20: All of the limitations of Claim 19 and [CCL-DB Physical Profile]. 
Claim 21: All of the limitations of Claim 19 and [CCL-Data Input Terminal]. 
Claim 22: All of the limitations of Claim 19 and [CCL-Responsive Data Input Terminal]. 
Claim 23: All of the limitations of Claim 22 and [CCL-Verify Authenticity]. 
Claim 24: All of the limitations of Claim 23 and [CCL-Eligibility]. 
Claim 27: All of the limitations of Claim 19 and [CCL-Manual Keyboard]. 
Claim 34: Claim Construction Limitations [CCL-Preamble], [CCL-Input Means], [CCL-
Patient ID], [CCL- INDICIA-Treatments Ancillary Service], [CCL-Provide Ancillary 
Service], [CCL-Symptoms], [CCL-Proposed Treatments], [CCL-Indicia], and [CCL-DB 
Medical History]. 
Claim 35: All of the limitations of Claim 34 and [CCL-DB Physical Profile]. 
Claim 36: All of the limitations of Claim 34 and [CCL-Data Input Terminal]. 
Claim 37: All of the limitations of Claim 34 and [CCL-Responsive Data Input Terminal]. 
Claim 38: All of the limitations of Claim 34 and [CCL-Verify Authenticity]. 
Claim 39: All of the limitations of Claim 34 and [CCL-Eligibility]. 
Claim 43: All of the limitations of Claim 37 and [CCL-Manual Keyboard]. 
Claim 52: Claim Construction Limitations [CCL-Preamble], [CCL-Input Means], [CCL-
Data Processor], [CCL-Data Bank Memory],  [CCL-Patient ID], [CCL- DB-Treatments-
UR], [CCL-Payment Means], [CCL-Symptoms], [CCL-Proposed Treatments], [CCL-
Indicia], and [CCL-Prevent Payment] 
Claim 53: All of the limitations of Claim 52 and [CCL- INDICIA-Treatments Ancillary 
Service], and [CCL-Provide Ancillary Service] 
Claim 54: All of the limitations of Claim 52 and [CCL-Identify Preventive Health 
Routines]   106
Claim 55: Claim Construction Limitations [CCL-Preamble], [CCL-Input Means], [CCL-
Data Processor], [CCL-Data Bank Memory], [CCL-Patient ID], [CCL- DB-Treatments-
UR], [CCL-Payment Means], [CCL-Symptoms], [CCL-Proposed Treatments], [CCL-
Indicia], [CCL-Prevent Payment], and [CCL-Medical History]. 
Claim 56: All of the limitations of Claim 55 and [CCL-DB Physical Profile]. 
Claim 57: All of the limitations of Claim 55 and [CCL-Data Input Terminal]. 
Claim 58: All of the limitations of Claim 55 and [CCL-DB-Patient Data]. 
Claim 59: All of the limitations of Claim 58 and [CCL- Verify Authenticity]. 
Claim 60: All of the limitations of Claim 59 and [CCL-Eligibility]. 
Claim 63: All of the limitations of Claim 57 and [CCL-Manual Keyboard]. 
Claim 67: Claim Construction Limitations  [CCL-Preamble],  [CCL-Terminal-Patient-
Data], [CCL-Patient ID], [CCL-Payment Means], [CCL-Symptoms], [CCL-Proposed 
Treatments], [CCL-Indicia], [CCL-Prevent Payment], and [CCL-DB-2
nd-Opinion]. 
Claim 68: All of the limitations of Claim 67 and [CCL- INDICIA-Treatments Ancillary 
Service], and [CCL-Provide Ancillary Service]. 
Claim 69: All of the limitations of Claim 67 and [CCL-Identify Preventive Health 
Routines]. 
Claim 70: Claim Construction Limitations [CCL-Preamble], [CCL-Input Means], [CCL-
Data Processor], [CCL-Data Bank Memory], [CCL-Patient ID], [CCL-Payment Means], 
[CCL-Symptoms], [CCL-Proposed Treatments], [CCL-Indicia], [CCL-Prevent Payment], 
[CCL-DB-Medical History], and [CCL-DB-2
nd-Opinion]. 
Claim 71: All of the limitations of Claim 70 and [CCL-DB Physical Profile] 
Claim 72: All of the limitations of Claim 70 and [CCL-Data Input Terminal]. 
Claim 73: All of the limitations of Claim 70 and [CCL-Payer Data]. 
Claim 74: All of the limitations of Claim 73 and [CCL- Verify Authenticity]. 
Claim 75: All of the limitations of Claim 74 and [CCL-Eligibility]. 
Claim 78: All of the limitations of Claim 72 and [CCL-Manual Keyboard]. 
Claim 80: All of the limitations of Claim 70 and [CCL-Data Representing Treatment]. 
Claim 85: Claim Construction Limitations [CCL-Preamble], [CCL-Patient ID], [CCL-
Proposed Treatments], [CCL-Indicia], [CCL-DB-Medical History], [CCL- INDICIA-
Treatments Ancillary Service], and [CCL-Provide Ancillary Service].   107
Claim 86: All of the limitations of Claim 85 and [CCL-DB Physical Profile]. 
Claim 87: All of the limitations of Claim 85 and [CCL-Data Input Terminal]. 
Claim 88: All of the limitations of Claim 86 and [CCL- Verify Authenticity]. 
Claim 89: All of the limitations of Claim 88 and [CCL-Eligibility]. 
Claim 91: All of the limitations of Claim 85 and [CCL-Identify Preventive Health 
Routines]. 
Claim 93: All of the limitations of Claim 87 and [CCL-Manual Keyboard]. 
Claim 95: All of the limitations of Claim 85 and [CCL-Data Representing Treatment]. 
Claim 102: Claim Construction Limitations [CCL-Preamble], [CCL-Input Means], 
[CCL-Data Bank Memory], [CCL-Patient ID], [CCL-Payment Means], [CCL-Proposed 
Treatments], [CCL-Indicia], [CCL-DB-Medical History], [CCL- DB-Treatments-UR], 
[CCL-Symptoms], [CCL-Prevent Payment], [CCL-DB-2
nd-Opinion], [CCL-DB-Personal 
Health Profile Data], and [CCL-Data Representing Treatment]. 
4.3 General References Summarizing Prior Art. 
By 1990 Medical Informatics was a well-established field. In 1977 three societies 
covering overlapping aspects of the field merged into the American Medical Informatics 
Association (AMIA). AMIA sponsors annual meetings, titled Annual Symposium on 
Computer Applications in Medical Care (SCAMC). Those meetings often had keynotes 
promoting visions congruent with those of Cummings, but also hundreds of papers by 
researchers, physicians, and engineers trying to address the many details needed to bring, 
through use of computers and information systems, greater effectiveness to health care. 
Several thousand participants attended the meetings each year. 
 
As Cummings surmised, much research in the area is sponsored by the National Institutes 
of Health (NIH), and its dissemination arm, The National Library of Medicine (NLM).  
 
"I felt there had to be, you know, other plug-and-play types of things.  
Q: what do you mean by plug-and-play?  
A: Where people – you have existing databases from, like the national institutes 
of health or someplace like that where you can take that module for treatment of a 
particular kind of disease and you can use it."  [Cummings III:2000, p.314  l. 9-
15] 
 
Research relevant to financing and reimbursement of health care is also sponsored by 
other governmental agencies, as the Health Care Financing Agency (HICFA) and its 
successors -- cited by Cummings, the National Center for Health Services Research 
(NCHSR) and its successors as well as by a number of private foundations.  The upshot is 
that it would have been very easy for an expert (as Mr.Singer) to gather an adequate 
collection of prior art in 1990, if that had been the goal.   108
 
4.3.1 The Next Three Generations of Healthcare Information Systems  
 
4.3.1.1 Overview 
 
[Halverson:1984] describes three generations of Healthcare Information Systems  (HIS). 
His article presages the vision expressed in the specification section of the `105 patent.  
 
The first generation combines an enhanced financial, reimbursement, marketing, and 
departmental budgeting system. This generation included standard insurance, patient 
billing algorithms, and data processing functions. In addition, this generation analyze 
with accuracy the costs of providing patient care by diagnosis within departments for 
both inpatient and outpatient activities, taking into account disease progression and 
severity, as well as the DRG classification (see Definition 3.4). 
 
The second generation, built upon the first, is an extension to the current patient care and 
medical record database. This generation included the capture of patient care events, test 
results, and historical data on the interaction between physician-nurse-patient trilogy. 
This generation had communication between the financial and medical databases. 
Information captured included patient medication, reactions, patient diet, changes in diet, 
laboratory results, vital signs, surgical procedures, and disease severity, diagnosis, and 
medical treatment history of the patient. We are still trying to achieve this vision today. 
This generation was "from patient womb to tomb" and represented the Integrated 
Hospital Information System. The prospective payment systems has the ability to track 
not only the budgetary performance of departments and the costs by diagnosis of 
individual patient, but will analyze health care protocols to determine standards and 
norms by diagnosis. This generation could negotiate accurate reimbursement levels by 
diagnosis and disease progression. 
 
The third generation of health information system will necessarily build on the first two-
the integration of financial and patient management systems. This generation includes 
clinical decision support systems or medical expert systems, computer aids to diagnosis 
and for medical treatment, and treatment protocols. This generation is built on the 
technology of artificial intelligence system. 
 
The authors are Mr. Halverson who is a managing partner of the Atlanta consulting firm 
of Management Associates.  Mr. Halverson is a former employee of IBM; Pete, Marwick, 
Mitchel & Co.; and Technicon Data Systems. Steven A. Huesing (Steve) has been 
involved in Healthcare Information systems for over twenty years. 
 
We now compare the asserted limitations with the Three Generations HIS vision. If one 
accepts the Allcare claims construction of the limitations where the preamble is not a 
limitation (i.e., the system need not be comprehensive), the system does not have to be 
completely automated, and that many of the `smart system` functions are performed 
manually with human intervention, then I can express the following opinions.    109
 
4.3.1.2 Invalidity and Anticipation of asserted claims 
I hold the opinions that  
the Three Generations HIS  includes the limitation of [CCL-Input Means] by 
construction. 
 
the Three Generations HIS  includes the limitation of [CCL-Patient ID] by 
construction. 
 
the Three Generations HIS  includes the limitation of [CCL-DB-Treatments-UR] by 
construction. 
 
the Three Generations HIS  includes the limitation of [CCL-Payment Means] sense 3 
by construction. 
 
the Three Generations HIS  includes the limitation of [CCL-Symptoms] by 
construction. 
 
the Three Generations HIS  includes the limitation of [CCL-Proposed Treatments] 
sense 3 by construction. 
 
the Three Generations HIS  includes the limitation of [CCL-Indicia] sense 2 by 
construction. 
 
it is obvious that Three Generations HIS  could be extended to include [CCL-Prevent 
Payment] sense 1 by one of ordinary skill in the art by simple technology extensions. 
 
the Three Generations HIS  includes the limitation of [CCL-Provide Ancillary 
Service] sense 2 by construction. 
 
the Three Generations HIS  includes the limitation of [CCL- Indicia-Treatments 
Ancillary Service] by construction. 
 
the Three Generations HIS  includes the limitation of [CCL-DB Medical History] by 
construction. 
 
the Three Generations HIS  includes the limitation of [CCL-DB Physical Profile] by 
construction. 
 
the Three Generations HIS  includes the limitation of [CCL-Data Input Terminal] by 
construction. 
 
the Three Generations HIS  includes the limitation of [CCL-Responsive Data Input 
Terminal] by construction. 
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the Three Generations HIS  includes the limitation of [CCL-Verify Authenticity] 
sense 1 by construction. 
 
the Three Generations HIS  includes the limitation of [CCL-Eligibility] by 
construction. 
 
the Three Generations HIS  includes the limitation of [CCL-Manual Keyboard] by 
construction. 
 
it is obvious that Three Generations HIS  could be extended to include [CCL-DB-
Treatments-2
nd-Opinion] by one of ordinary skill in the art by known technology 
extensions. 
 
the Three Generations HIS  includes the limitation of [CCL-Data Processor] by 
construction. 
 
the Three Generations HIS  includes the limitation of [CCL-Data Bank Memory] by 
construction. 
 
it is obvious that Three Generations HIS  could be extended to include [CCL-Identify 
Preventive Health Routines] by one of ordinary skill in the art by simple technology 
extensions. 
 
the Three Generations HIS  includes the limitation of [CCL-DB-Patient Data] by 
construction. 
 
the Three Generations HIS  includes the limitation of [CCL-DB-Terminal-Patient-
Data] by construction. 
 
the Three Generations HIS  includes the limitation of [CCL-Payer Data] by 
construction. 
 
the Three Generations HIS  includes the limitation of [CCL-Data Representing 
Treatment] sense 1 by construction. 
 
the Three Generations HIS  includes the limitation of [CCL-DB-Personal Health 
Profile Data] by construction. 
 
Recall that we are assuming that the Allcare claims construction of the limitations where 
the preamble is not a limitation (i.e., the system need not be comprehensive), the system 
does not have to be completely automated, and that many of the `smart system` functions 
are performed manually with human intervention, then I can expresss the following 
opinion:.  
 
It is my opinion that the asserted claims [1, 2, 4, 5, 6, 7, 8, 9, 12, 16, 17, 19, 20, 21, 22, 
23, 24, 27, 34, 35, 36, 37, 38, 39, 43, 52, 53, 54, 55, 56, 57, 58, 59, 60, 63, 67, 68, 69, 70,   111
71, 72, 73, 74, 75, 78, 80, 85, 86, 87, 88, 89, 91, 93, 95, 102] of the `105 patent are 
invalidated by the Three Generations HIS  because the limitations are either included or 
obvious by one of ordinary skill in the art, if one uses the Allcare claims construction.  
 
It is my opinion that the asserted claims of the `105 patent are anticipated by the Three 
Generations HIS  if one uses the Allcare claims construction because all asserted claims 
are invalidated.  
 
4.3.2 AAMRS  
 
4.3.2.1 Overview 
 
In a 1975 Analysis of Automated Ambulatory Medical Record Systems (AAMRS) is 
presented covering existing systems at many health care organizations that were serving 
outpatients [Wiederhold:1975]. A guide was created and then used to interview 17 health 
care institutions in detail. The results are summarized in the report. The study presaged 
the features expected in future healthcare systems, with an emphasis on outpatient 
requirements, but included the desured linkages to inpatient information. 
 
The study includes an Interview Guide for technical and operational evaluation of health 
care institutes concentrated on the ambulatory automated record systems, which lists the 
function that might exist in such systems. Areas covered (with respect to the `105 patent) 
on the topic of computer systems and hardware included: 
 keyboard, terminals, data entry, data storage, and the integration of functions.  
Financial areas included:  
billing, financial history of patient, monthly billing statement, third party bills 
(reimbursement claims), insurance carriers, financial management (billing, 
reimbursement claims processing, and cost analysis), ability to pay (bank name, 
credit check, and employer), budget management (fiscal decision makers), 
financial classification, and allocation of costs.  
Ancillary services were discussed. Areas to be investigated regarding medical patient 
chart included: 
identification of patient, complete patient record, flow sheet for the patient, 
worksheet for the patient, patient diagnosis, symptoms, patient medical history, 
physical exam info including height, weight, and sex, treatment and physician 
progress notes.  
In the areas of wellness topics included: 
health risk factors such as smoking, alcohol, accidents, and nutritional diet.  
Scheduling of procedures is covered as well as follow-up services, triage, and referrals. 
Patient benefit analysis indicated : 
more time per patient, patient cost savings (reduced charge per service, reduced 
deductible, reduced subscription rates, fewer diagnostic tests and ancillary 
services, reduced waiting time, elimination of unnecessary visits due to referral 
process)    112
while management benefits centered around automation. The report described systems 
that were a combination of diagnosis, symptoms, treatment, and financial. Both quality of 
care reviews and utilization reviews were covered. No actual system investigated fulfilled 
all the expectations that the AAMRS report documented. However. that report expressed 
a vision that is congruent with the vision expressed in the `105 patent.  
 
We note that even in 1975 the concept of a totally integrated and comprehensive health 
care management system was well established. Creating actual systems based on that 
vision is an ongoing process. The report also generated several papers and formed the 
basis for chapters in books, for instance [Blum:1986].  The report also provided input to 
[Wiederhold:1981] where examples of 4 health care computing systems are given, 
covering the breadth of information applications in health care: CCPDS (Public Health, 
Seattle), ECOG and RTOG (Cancer Trials, Harvard Medical School), TOD and ARAMIS 
(disease management, Stanford), COSTAR and HCHS (an HMO, the Harvard 
Community Health Plan), and POMCS (a hospital system, supported by IBM, in Coral 
Gables, Florida). 
 
We will now compare the asserted limitations with an expected AAMRS . If one assumes 
the Allcare claims construction of the limitations where the preamble is not a limitation 
(i.e., the system need not be comprehensive), the system does not have to be completely 
automated, and that many of the `smart system` functions are performed manually with 
human intervention, then I can express the following opinions.  
 
4.3.2.2 Invalidity and Anticipation of asserted claims 
It is my opinion that 
an AAMRS  includes the limitations of [CCL-Input Means] by construction. 
 
an AAMR  includes the limitations of [CCL-Patient ID] by construction. 
 
an AAMRS  includes the limitations of [CCL-DB-Treatments-UR] by construction. 
 
an AAMRS  includes the limitations of [CCL-Payment Means] sense 3 by construction. 
 
an AAMRS  includes the limitations of [CCL-Symptoms] by construction. 
 
an AAMRS  includes the limitations of [CCL-Proposed Treatments] sense 3 by 
construction. 
 
an AAMRS  includes the limitations of [CCL-Indicia] sense 2 by construction. 
 
it is obvious that Three Generations HIS  could be extended to include [CCL-Prevent 
Payment] sense 1 by one of ordinary skill in the art by simple technology extensions. 
 
an AAMRS  includes the limitations of [CCL-Provide Ancillary Service] sense 2 by 
construction.   113
 
an AAMRS  includes the limitations of [CCL- Indicia-Treatments Ancillary Service] 
by construction. 
 
an AAMRS  includes the limitations of [CCL-DB Medical History] by construction. 
 
an AAMRS  includes the limitations of [CCL-DB Physical Profile] by construction. 
 
an AAMRS  includes the limitations of [CCL-Data Input Terminal] by construction. 
 
an AAMRS  includes the limitations of [CCL-Responsive Data Input Terminal] by 
construction. 
 
an AAMRS  includes the limitations of [CCL-Verify Authenticity] sense 1 by 
construction. 
 
an AAMRS  includes the limitations of [CCL-Eligibility] by construction. 
 
an AAMRS  includes the limitation of [CCL-Manual Keyboard] by construction. 
 
it is obvious that AAMRS  could be extended to include [CCL-DB-Treatments-Second 
Opinion] by one of ordinary skill in the art by known technology extensions. 
 
an AAMRS  includes the limitations of [CCL-Data Processor] by construction. 
 
an AAMRS  includes the limitations of [CCL-Data Bank Memory] by construction. 
 
an AAMRS  includes the limitations of [CCL-Identify Preventive Health Routines] by 
construction. 
 
an AAMRS  includes the limitations of [CCL-DB-Patient Data] by construction. 
 
an AAMRS  includes the limitations of [CCL-DB-Terminal-Patient-Data] by 
construction. 
 
an AAMRS  includes the limitations of [CCL-Payer Data] by construction. 
 
an AAMRS  includes the limitations of [CCL-Data Representing Treatment] sense 1 
by construction. 
 
an AAMRS system includes the limitations of [CCL-DB-Personal Health Profile Data] 
by construction. 
 
Recall that we are assuming that the Allcare claims construction of the limitations where 
the preamble is not a limitation (i.e., the system need not be comprehensive), the system 
does not have to be completely automated, and that many of the `smart system` functions   114
are performed manually with human intervention, then the following opinions can be 
expressed.  
 
I hold the opinion that the asserted claims [1, 2, 4, 5, 6, 7, 8, 9, 12, 16, 17, 19, 20, 21, 22, 
23, 24, 27, 34, 35, 36, 37, 38, 39, 43, 52, 53, 54, 55, 56, 57, 58, 59, 60, 63, 67, 68, 69, 70, 
71, 72, 73, 74, 75, 78, 80, 85, 86, 87, 88, 89, 91, 93, 95, 102] of the `105 patent are 
invalidated by a system as presaged as an AAMRS because the limitations are either 
included or obvious by one of ordinary skill in the art, if one uses the Allcare claims 
construction.  
 
I hold the opinion that the asserted claims of the `105 patent are anticipated by asystem as 
presaged as an  AAMRS if one uses the Allcare claims construction because all asserted 
claims are invalidated.  
 
 
4.3.3 Automated Hospital Information Systems  
 
4.3.3.1 Overview 
 
A study sponsored by The National Center for Health Services Research of the US. Dept 
of HHS and largely performed at the Center for Health Services research of The 
University of Southern California, under the leadership of Dr. Dorcas Hardy generated  a 
1981 workbook and guide for hospital administrators [Brian:1981]. The workbook 
covered suppliers of automated hospital information systems as well as a survey of 
several information systems at various hospitals. The workbook describes a list of more 
than 175 healthcare information applications. 
 
In the AHIS work book you will find several charts. One chart, System Supplier vs. 
Applications, pages B-1 to B-11, contains a table of about two dozen suppliers of health 
care systems and which applications of the over 175 applications they provide. Another 
chart, Hospital vs. Applications, pages B-14 to B-21, contains a table of 29 hospitals and 
the applications actually installed, based on the same list of over 175 applications. 
 
The matrices are intended to serve as points of reference for hospital decision-
makers to use in the process of developing system specifications and selecting an 
AHIS. The Hospital/Applications Matrix may be used to identify what types of 
applications are being employed by various sizes of hospitals. The System 
Supplier/Application matrix may be used to match against your hospital's desired 
application profile to determine the likelihood that the configuration desired will 
be available from one or more potential suppliers [AHIS:1981, p. B2]. 
 
Technical elements of the descriptions include a listing of the applications offered 
and their mode of operation, the type of user interface equipment used, data 
retention characteristics and development support requirements. These elements 
are designed to be employed by personnel with the technical experience and   115
expertise to determine the relevance of these characteristics to the individual 
hospital's desires and requirements [AHIS:1981, p. C1]. 
 
That various combinations of these features will be available in actual systems is made 
clear in the literature. 
 
By 1981 not only was the concept of a totally integrated and comprehensive health care 
management system well established, the hospitals were moving towards a complete 
operational system. Which of the more than 175 candidate applications were present at a 
particular hospital was governed by available resources, urgency of need, and system 
dependencies, filtered through cost-effectiveness analyses and not by any great 
intellectual insight.   
 
Section A of the manual describes 180 individual functions that a commercially available 
AHIS may perform. These functions are divided into 31 areas.  
 
1.  Administrative Services: Application functions includes: Budget Preparation – 
Other, Equipment Budget Preparation, Hospital Manuals and Procedures, Laundry 
Management, Message Communication, Salary Budget Control, Salary Budget 
Preparation, Space Use Planning and Control, Supplies Budget Preparation, System 
Security and Access Control, Telephone Lists for Patients, and Word Processing. 
2.  Admission: Application functions includes: Admission/Discharge/Transfer 
Notification, Address graph Plate Generation by Patient, Bed Assignment and Status, 
Label Generation by Patient, Newborn Registration with Mother’s Data, Patient Date 
Base Historical Record Updating/Retrieval, Patient Identification Number 
Assignment, Patient Name Retrieval, Patient Number Retrieval, and Registration 
Reports and Form Printing. 
3.  Cardiology: Application functions includes: CCU Arrhythmia Monitoring System, 
EKG Historical Baseline by Patient, and EKG Interpretation. 
4.  Data Processing: Application functions includes: Central Hardware Utilization 
Measurement, Communications Utilization Measurement, Data Processing Cost 
Reporting, Data Volume Library Management, Diskette Utilization Measurement, 
Keypunch Production Reporting, Magnetic Tape Utilization Measurement, Project 
Control, Project Time and Effort Reporting, Remote Hardware Utilization 
Measurement, and Software Efficiency Measurement. 
5.  Dietary: Application functions includes: Dietary Master List, Menu Forecasting, 
Patient Menus, and Special Diet List. 
6.  Emergency: Application functions includes: Emergency Registration/Data Base 
Linkage, Emergency Room Statistics, Emergency Service Rosters, Patient 
Allergy/Drug Incompatibility, Risk Patient Tracking, and Trauma Registry. 
7.  Energy/Environmental Management: Application functions includes: Automated 
Elevator/Cart/Conveyor Control, Energy Use Controls, Physical Access Controls, and 
Temperature Controls. 
8.  Epidemiology: Application functions includes: Antibiotic Use Reporting, Detection 
of Bacterial Infection, Infection Notices, and Laboratory Culture Screening.   116
9.  Financial Management: Application functions includes: Accounts Payable, Bad 
Debt Accounting, Budget/Actual Expense Reports, Capital Equipment Accounting, 
Capital Equipment Depreciation, Cash Accounts, Coordination of Insurance Benefits, 
Cost Allocation by Cost Center, Credit and Collections, Demand Billing, Financial 
Analysis of Occupancy and Revenue by Department, General Ledger Interface, 
Inpatient Accounting, Inpatient Billing, Insurance Billing, Medicare Billing, 
Outpatient Accounting, Outpatient Billing, Professional Billing, and Professional Fee: 
Revenue and Cash Reporting. 
10. Housekeeping: Application functions includes: Housekeeping Schedule Reminders, 
Housekeeping Staff Scheduling, and Retrieve/Update Housekeeping Bed Records. 
11. Intensive Care: Application functions includes: Intensive Care Patient Monitoring. 
12. Internal Medicine: Application functions includes: Patient Medication Profile 
Retrieve/Update, Patient Plan of Care/Length of Stay, and Update Problem/Diagnosis 
for Patient. 
13. Laboratory: Application functions includes: Analog Signal Acquisition, Blood Bank 
Management, Blood Donor File Management, Cadaver Organ and Tissue Retrieval, 
Clinical Lab Result Quality Control, Clinical Lab Specimen Control (log), Clinical 
Lab Workload Reporting, Digital Work Station Input, Histopathology Reporting, 
Laboratory Compacted Cumulative Historical Report by Patient, Laboratory Current 
Cumulative Report by Patient, Laboratory Historical Results Baseline by Patient or 
Characteristics of a Group, Laboratory Utilization Statistics, Other Work Schedules, 
Pathology/Cytology Comparative Result File Retrieval, Pathology/Cytology 
Reporting, Results Reporting, Schedule Clinical Lab Tests, Specimen Pick-Up 
Schedule, and Worksheets. 
14. Materials Management: Application functions includes: Drug Distribution 
Monitoring, Non-Sterile Supplies Inventory, Office Supplies Inventory, Pharmacy 
Central Inventory, Purchasing Storeroom Inventory, and Sterile Supplies Inventory. 
15. Mechanical/Electronic Maintenance: Application functions includes: Equipment 
Maintenance Schedules and Maintenance Staff Schedules. 
16. Medical Records: Application functions includes: Discharge Abstract Preparation, 
Discharge Analysis and Reports, Discharge Summary Control, Disease Index 
Preparation, Medical Chart Reports, Medical Record Management, Medical Record 
Number Assignment, Operations Index Preparation, Patient Data Base Management, 
Patient Medical History Data Collection, Patient Record Data Collection, and Update 
Patient Data Base. 
17. Medical Staff: Application functions includes: Access to Medical Research and 
Bibliography Searches, Medical Staff Activities Reporting, Medical Staff Privileges, 
Medical Staff Rosters, Patient Diagnosis/Order Profile Retrieve/Update, Physician 
BNDD Numbers (pharmacy), Physicians’ Index, Physician Meeting Schedule 
Management, Physician/Inpatients Linkage for Reporting, Physician/Outpatients 
Linkage for Reporting and Scheduling, Private Clinic & Group Practice Included in 
Hospital Data Base, and Telephone Lists for Physicians. 
18. Nursing: Application functions includes: Assign/Update Nursing Care Plan, Charge 
Compilation, Inpatient Census and Census Reporting, Nurses’ Notes and Vital Signs 
Update Chart, Nurse Staffing Management, Nursing Schedule Automatic Reminders,   117
Nursing Staff Rosters, Order Format Tailoring to Type of Order, Order Transmission, 
and Pharmacy Floor Stocks Inventory. 
19. OB/GYN: Application functions includes: Perinatal Risk Assessment. 
20. Oncology: Application functions includes: Radiation Therapy Management and 
Tumor Registry. 
21. Outpatients: Application functions includes: Ambulatory Therapy Scheduling, 
Outpatient Assignment and Status, Outpatient Scheduling, and Outpatient Visit 
Recording. 
22. Personnel/Payroll: Application functions includes: Checks and Registers, Hours and 
Wage Reports, Interactive Training, Labor Cost Distribution, Labor Time Collection, 
Personnel History, Personnel Surveys and Questionnaires, and Wage and Salary 
Studies. 
23. Pharmacy: Application functions includes: Cumulative Inpatient Drug Profile, 
Drug/Drug Incompatibility, Drug/Lab Incompatibility, Formulary (Pharmacy), 
Generic Name Cross Reference (Pharmacy), Narcotic Usage/Control, Patient 
Medication History, Pharmacy Manufacturing Reports, Prescription Issue/Label 
(Pharmacy), and Solutions (Pharmacy). 
24. Poison Control: Application functions includes: Computerized Poison Identification 
and Poison Control and Antidotes. 
25. Psychiatry: Application functions includes: Automated MMPI Interpretation. 
26. Radiology: Application functions includes: X-Ray Jacket Control. 
27. Respiratory Therapy: Application functions includes: Pulmonary Function Studies.  
28. Social Work: Application functions includes: Discharge Care Plan. 
29. Surgery: Application functions includes: Anesthesiology Monitoring, Operating 
Room/Recovery Room Log, Operating Room/Recovery Room Management, and 
Surgery Scheduling. 
30. Utilization Review: Application functions includes: Utilization Review. 
31. Volunteers: Application functions includes: Volunteer Services. 
 
4.3.3.2 Invalidity and Anticipation of asserted claims 
I hold the opinion that a system compliant with    
an AHIS  includes the limitations of [CCL-Input Means] by construction. 
 
an AHIS  includes the limitations of [CCL-Patient ID] by construction. 
 
an AHIS  includes the limitations of [CCL-DB-Treatments-UR] by construction. 
 
an AHIS  includes the limitations of [CCL-Payment Means] sense 3 by construction. 
 
an AHIS  includes the limitations of [CCL-Symptoms] by construction. 
 
an AHIS  includes the limitations of [CCL-Proposed Treatments] sense 3 by 
construction. 
 
an AHIS  includes the limitations of [CCL-Indicia] sense 2 by construction.   118
 
it is obvious that AHIS  could be extended to include [CCL-Prevent Payment] sense 1 
by one of ordinary skill in the art by simple technology extensions. 
 
an AHIS  includes the limitations of [CCL-Provide Ancillary Service] sense 2 by 
construction. 
 
an AHIS  includes the limitations of [CCL- Indicia-Treatments Ancillary Service] by 
construction. 
 
an AHIS  includes the limitations of [CCL-DB Medical History] by construction. 
 
an AHIS  includes the limitations of [CCL-DB Physical Profile] by construction. 
 
an AHIS  includes the limitations of [CCL-Data Input Terminal] by construction. 
 
an AHIS  includes the limitations of [CCL-Responsive Data Input Terminal] by 
construction. 
 
an AHIS  includes the limitations of [CCL-Verify Authenticity] sense 1 by 
construction. 
 
an AHIS  includes the limitations of [CCL-Eligibility] by construction. 
 
an AHIS  includes the limitation of [CCL-Manual Keyboard] by construction. 
 
it is obvious an AHIS  could be extended to include [CCL-DB-Treatments-Second-
Opinion] by one of ordinary skill in the art by known technology extensions. 
 
an AHIS  includes the limitations of [CCL-Data Processor] by construction. 
 
an AHIS  includes the limitations of [CCL-Data Bank Memory] by construction. 
 
an AHIS  includes the limitations of [CCL-Identify Preventive Health Routines] by 
construction. 
 
an AHIS  includes the limitations of [CCL-DB-Patient Data] by construction. 
 
an AHIS  includes the limitations of [CCL-DB-Terminal-Patient-Data] by 
construction. 
 
an AHIS  includes the limitations of [CCL-Payer Data] by construction. 
 
an AHIS  includes the limitations of [CCL-Data Representing Treatment] sense 1 by 
construction. 
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an AHIS  includes the limitations of [CCL-DB-Personal Health Profile Data] by 
construction. 
 
Recall that we are assuming that the Allcare claims construction of the limitations where 
the preamble is not a limitation (i.e., the system need not be comprehensive), the system 
does not have to be completely automated, and that many of the `smart system` functions 
are performed manually with human intervention, then the following opinions can be 
expressed.  
 
I hold the opinion that the asserted claims [1, 2, 4, 5, 6, 7, 8, 9, 12, 16, 17, 19, 20, 21, 22, 
23, 24, 27, 34, 35, 36, 37, 38, 39, 43, 52, 53, 54, 55, 56, 57, 58, 59, 60, 63, 67, 68, 69, 70, 
71, 72, 73, 74, 75, 78, 80, 85, 86, 87, 88, 89, 91, 93, 95, 102] of the `105 patent are 
invalidated by an AHIS compliant system because the limitations are either included or 
obvious by one of ordinary skill in the art, if one uses the Allcare claims construction.  
 
I hold the opinion that the asserted claims of the `105 patent are anticipated by an AHIS 
compliant system if one uses the Allcare claims construction because all asserted claims 
are invalidated.  
 
 
4.3.4 Hospital Information Systems 1985  
 
[HIS:1985] is a 1985 published book on the state of the art of hospital information 
systems. This book covers the application topics of financial, nursing, information 
systems, laboratory systems, pharmacy systems, and medical records as they apply to 
community hospitals. Information about many hospitals and suppliers of applications was 
provided.  
 
4.3.5 Hospital Information Systems 1988  
 
[Wiederhold:1988] is a 1988 encyclopedic  review of Hospital Information Systems 
(HIS) technology. The HIS as described in the paper consists of over 150 functions with 
the sharing of information between both administrative and clinical systems while using 
integrated data, knowledge, and information in a synergistic approach. The HIS as 
described in the paper may use terminals, teletypes, telephones, machine-readable forms, 
shared large-scale computers, light pens, video display terminals (VDTs), bar codes, 
databases, and distributed systems. The HIS describes a robust clinical medical record 
supporting diagnosis, treatment, prognosis, nursing care plans, clinical decisions, order 
entry, and other ancillary services. Many financial sources including individuals, health 
insurance, Medicare and Medicaid, military, grants, investments, local government, and 
philanthropic. In the article are examples of utilization review, including financial, 
treatment, length of stay (LOS), treatment options reflecting different prognosis, medical 
audit, and inventory. Medical record concepts are described.   120
4.4 Health Care Support Systems that Provide Prior Art 
 
In this section we briefly review reports and description of Computer-based Health Care 
Data processing Systems or Health-care Management Systems.  The systems we list are 
practical composed systems.  There have been many systems that preceded the `105 
patent application which performed the tasks, often in concert with other systems and 
some manual operation, similar to the Trigon system that the owners and experts 
representing the '105 patent assert to be infringing on their patent..  We have shown in 
Sections 1 and 2, that such infringement claims represent an unwarranted broadening of 
the patent.  Any such broadening raises the issue of prior art that was not brought forward 
by the applicants, as described in the Section 4.1 above.  Neither was a search for such 
prior systems performed by the patent examiner.  We do not know enough about the 
operation of the patent office in those days to guess why prior systems with similar 
functionality were overlooked.   In the view of  the Allcare's expert who carried out the 
prior art search  the `105 patent specified full automation within a single automated 
system.   
 
Since the `105 patent claims to be comprehensive we can only include a small sample.   
We restrict ourselves to systems involving computer-based automation. Were we to 
accept the claims that the `105 patent covers fully manual data-processing as well, then 
there is no way that comprehensiveness can be achieved. We'd have to go back to the 
[Flexner:1910] report, which provided the basis for medical record keeping as it is 
practiced today in the United States. See also [Shortliffe:1990, pp. 185-187] for a brief 
historical summary.  
 
We note that comparisons of extant systems, with  
•  problems due to complex institutional settings,  
•  difficult financing,  
•  imperfect hardware,  
•  lack of trained people, and  
•  flaky technology.  
with a vision where  
•  the institution is supportive and all-encompassing,  
•  money is not a constraint,  
•  hardware is perfect,  
•  smart, certified people with deep medical and computing insights are 
available, and reliable technology is available that can even perform tasks that 
are beyond the state of the art   
are bound to prefer the vision. Note, for instance, that even the Veterans Administration 
system of the Defense Department could not obtain sufficient resources to implement 
their plans. 
 
4.4.1 Help  
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The HELP system had its origins in the LDS Hospital Cardiovascular Laboratory in 
1954 [Gardner:2000], under the leadership of Dr. Homer Warner. The program took in 
clinical findings, laboratory results, symptoms,  and conditional probabilities as input and 
produced a list of probable diseases that could account for the clinical findings. In 
addition, the system could generate a more complete differential diagnosis. It operates in 
the context of a larger health care system, and derivatives were commercially marketed 
by Control Data Corporation. 
 
4.4.2  Massachusetts General Hospital 
 
Massachusetts General Hospital (MGH) has been one of the primary sites for 
health care innovation, including collection of structured medical records, use of records 
for health care analysis, support for HMO services, as the COSTAR system, and 
development of infrastructure software such as MUMPS [Wiederhold:1981], the MGH 
Utility Multi-Programming System.  The prime site was the Harvard Community 
Health Plan, and outpatient focused HMO, with a variety of linkages to the hospitals that 
were used when the health plan members required inpatient services. The aggregate of 
the systems forms a comprehensive system, although not as tightly integrated as 
Cummings' vision demands. 
 
Its energetic director, Octo Barnett, has advocated the development of effective health 
care information systems in an incremental and modular fashion, to avoid the failures 
associated with attempts to build large, comprehensive health care systems.  The modular 
approach implements first the services that bring the greatest immediate benefits, and 
then develops further services on top of that infrastructure [Barnett:1967]. The wisdom of 
that approach has been borne out in practice. There are many health care systems in 
operation that provide benefits to their owners, they are mostly composed of modules, as 
the Trigon systems, and there are no successful systems that were designed to be 
comprehensive, as envisioned in the `105 patent.  
 
4.4.3 Brigham and Woman's Hospital in Boston  
 
Brigham and Woman's Hospital in Boston installed systems for inpatient care 
using support from Meditech (see Section 4.6.1) , adapting the outpatient-oriented 
systems developed at the Harvard Health Plan. Development was gradual and is 
continuing, as outlined by the  [Bleich:2000] report.  Other hospitals, as Beth-Israel, also 
in Boston eventually joined the effort.  The Meditech systems have been interfaced with a 
variety of functions, so that both hospital routine operations and the substantial research 
interest of its faculty and students are supported. Many papers describe aspects of the 
innovations at these hospitals. [www.brighamandwomens.org] 
 
4.4.4 The Veteran's Administration  
 
The Veteran's Administration (VA) is a long time user of automation for both its 
inpatient and outpatient facilities. The VA provides comprehensive services to veterans 
and their families.  Wellness, as control of alcoholism etc.,  is a concern to the VA, since   122
many veterans suffer from the effects of stress induced by their experiences, greatly 
increasing the cost of veterans' healthcare. Its health information system, the 
Decentralized Hospital Computer Program (DHCP) was initiated in 1982, and had its 
core program in operation, including outpatient and inpatient modules by 1987. It relies 
greatly on effective electronic communication, since veterans are eligible to visit any of 
the many VA facilities., and do so. A total of 51 service modules were envisaged and 
planned for. At the core of its system is a Comprehensive Medical record, congruent with 
the vision presented by Cummings in the `105 patent. Its billing structure is specific to 
the Defense Department, but validation of eligibility is an important and complex aspect 
and a full accounting of services supplied to its patients is maintained. A module for 
billing of ineligible fees was in development in 1987.  The software used is again 
MUMPS-based, supported by several vendors.[VA:1990], Being a government operation, 
its functions are very well documented and in the public domain. The cost of developing 
and operating such a comprehensive system were worrisome to the government, and a 
1987 GAO study recommend a slowing down of the development of additional modules 
[GOA:87].  Note that the problem was not one of lack of vision,  concepts, or 
technological and medical understanding of the methods needed to build the system, but 
one of financing and marshalling enough management and technological resources within 
the Department of Defense.  
 
4.4.5 TDS, formerly Technicon  
 
TDS, formerly Technicon Medical Information System, is a hospital focused 
system that innovated the integrated flow from order entry at the bedside to billing. Its 
development was initiated by Lockheed Corporation, and installed starting September 
1971 at El Camino Hospital in Mountain View, California. An evaluation of its 
effectiveness was sponsored by the National Center for Health Services Research 
[Batelle:1973]  and widely disseminated.   
The Clinical Center at NIH was served by a TDS installation when the `105 patent was 
conceived, and has had regular tours to show its inpatient and outpatient operations. Due 
to its research focus it does not do routine billing. 
 
4.4.6 The Kaiser Permanente Health Plan  
 
The Kaiser Permanente Health Plan is an HMO that has been a long-term 
innovator in automated processing. The vision of Dr. Morris Collen, the long-term leader 
of its information system, stressed support for wellness through its Health-testing and 
guidance programs, as well as inpatient and outpatient care support.  Since the Kaiser 
operation is a medical partnership actual agreement has been hard to achieve so that 
different sites may offer automation for inpatient, or outpatient, or both services, or none. 
As a leader in the HMO field, its concept have been widely studied and analyzed   
 
4.4.7 Promis  
 
Promis, developed by Dr. Larry Weed the University of Vermont introduced the 
Problem-Oriented Medical Information System built in the early 1970s. Physicians at the   123
hospital used computer terminals to order tests and drugs, record medical history, 
physical exam data, and progress notes. Promis implemented Weeds vision of the 
problem-oriented medical record in which all diagnostic and therapeutic actions are tied 
to an underlying patient problem. Promis at summarized in [Shortliffe:1990], see also 
[Weed:1981] and [Weed:1985]. The technology was also adapted into nearby private 
outpatient clinics [BjornC:1970]. 
 
4.4.8 Regenstrief  
 
The Regenstrief Clinic provides outpatient services  within the Indiana University 
Medical Center.  Dr. Clem McDonald and his colleagues introduced the RMRS 
(Regenstrief Medical Record System) in the 1974 time frame. By 1988, it maintained 
substantial medical histories for at least 250,000 patients with over 25 million separate 
patient observations.  The Regenstrief Clinic and its computer system is part of a large 
academically-based health care system that also handles appointment scheduling and 
charge capture. Mathods developed for communicating data from extrernal clinical 
laboratories in the 1980's have become the accepted standard for health care institutions. 
The system includes support for quality-assurance, flow sheet summary, problem lists, 
prescriptions, order tests, physician progress notes, and encoding of information. 
Specialized subsystems provided services that carry out some of the functions indicated 
as being smart in Allcare reports: diabetes management, weight control, and the like, 
although none map symptoms to treatments.  Numerous papers describing the system and 
analyzing cost-benefit tradeoffs of their health care system modules have appeared in the 
literature; the system is summarized in [Shortliffe:1990]  
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4.5 Health Care Reimbursement Systems 
Reimbursement-oriented systems have not been as well described in the formal literature 
since they attract less formal attention. But, because of their importance to the survival of 
the health care system, they have actually received more support than patient care 
systems. We reserve the right to augment this section as information becomes accessible. 
 
4.5.1 Bank One  
Bank One N/A. a financial institution, designed and developed a Medical Payment 
System (MPS) and started marketing it in 1989.  It was placed into operation in 
Wisconsin in 1992-1993. The system is described in a brochure and in the deposition of 
Gerald Kurtyka, Vice president at the bank in charge of MPS  [Kurtyka:2000]. This 
system was divulged to Mr. Cummings  [Kurtyka:2000, pp.6-7] at an AHA meeting in 
Phoenix, AZ, in May 1990. 
Mr. Cummings was very excited and stated "I've been working on exactly the 
same thing!".   
Follow-up contacts included meetings with Cummings and Conner; and several visits 
were made to the Florida Hospital, where Mr. Cummings represented himself as an 
employee of Florida Hospital, acting in his capacity as an officer of Florida Hospital, i.e., 
as a potential customer of Bank One. [Kurtyka:2000, pp.7-13].  This system was not 
included in the prior art presented to the U.S patent office.  
4.5.1.1 Overview 
 
[BankOne:1989] was a proposed 1989 Medical Payment System. The system was an 
electronic, comprehensive, and integrated medical payment system for health care 
providers. Participants included providers, patients, employers for enrollment, and 
insurance companies, with the Bank providing a clearinghouse function, Features 
included adjudication, utilization, reimbursement claims processing, payment, data input 
terminal, swipe cards, and electronic transmitting funds. Medical information included 
diagnosis, procedures, treatments, using ICD and CPT codes. Drug codes were 
contemplated for pharmaceutical adjudication. Support for obtaining second opinion, 
making referrals, and utilization review was included. The system did not instruct the 
release of payment until there was confirmation that the review has been obtained. To 
some extent it also provided a vision,  but during 1992-193 substantial parts had been 
implemented at a Wisconsin health care site [Kurtyka:2002]. 
 
 
We will now compare the asserted limitations with the proposed Bank One system. If one 
assumes the Allcare claims construction of the limitations where the preamble is not a 
limitation (i.e., the system need not be comprehensive), the system does not have to be 
completely automated, and that many of the `smart system` functions may be performed 
manually with human intervention, then I hold the following opinions.  
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4.5.1.2 Invalidity and Anticipation of asserted claims 
 
It is my opinion that  
the Bank One system includes the limitations of [CCL-Input Means] by the feature of 
data input terminal.  
 
the Bank One system includes the limitations of [CCL-Patient ID] by the presence of a 
swipe card. 
 
it that Bank One system was designed to allow inclusion of [CCL-DB-Treatments-
UR], and enabled its implementation  by a person of ordinary skill in the art by facilitate 
ICD, CPT, and utilization review.  
  
the Bank One system includes the limitations of [CCL-Payment Means] sense 1 by 
construction.  
 
the Bank One system includes the limitations of [CCL-Symptoms] by construction.  
 
the Bank One system includes the limitations of [CCL-Proposed Treatments] sense 3 
by construction.  
 
the Bank One system includes the limitations of [CCL-Indicia] sense 2 by construction.  
 
the Bank One system includes the limitations of [CCL-Prevent Payment] sense 1 by 
construction.  
 
the Bank One system includes the limitations of [CCL-Provide Ancillary Service] 
sense 2 by example of a referral.  
 
it is obvious that Bank One system could be extended to include limitation [CCL- 
Indicia-Treatments Ancillary Service] by one of ordinary skill in the art by example of 
referral. 
 
it is obvious that Bank One system could be extended to include limitations [CCL-DB 
Medical History] by one of ordinary skill in the art by construction, ICD, and CPT.  
 
it is obvious that Bank One system could be extended to include limitations [CCL-DB 
Physical Profile] by one of ordinary skill in the art by simple extension.  
 
the Bank One system includes the limitations of [CCL-Data Input Terminal] by 
construction.  
  
the Bank One system includes the limitations of [CCL-Responsive Data Input 
Terminal] by construction.  
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it is obvious that Bank One system could be extended to include limitations [CCL-
Verify Authenticity] sense 2 by one of ordinary skill in the art by simple extension of 
known processes.  
 
the Bank One system includes the limitations of [CCL-Eligibility] by construction.  
 
it is obvious that Bank One system could be extended to include limitations [CCL-
Manual Keyboard] by one of ordinary skill in the art by simple extension of known 
technology.  
 
the Bank One system includes the limitations of [CCL-DB-Treatments-Second-
Opinion] by construction. 
 
the Bank One system includes the limitations of  [CCL-Data Processor] by 
construction.  
 
the Bank One system includes the limitations of [CCL-Data Bank Memory] by 
construction.  
 
it is obvious that Bank One system could be extended to include limitations [CCL-
Identify Preventive Health Routines] by one of ordinary skill in the art by simple 
extension of treatments.  
 
it is obvious that Bank One system could be extended to include limitations [CCL-DB-
Patient Data] by one of ordinary skill in the art by simple extension of technology.  
 
it is obvious that Bank One system could be extended to include limitations [CCL-DB-
Terminal-Patient-Data] by one of ordinary skill in the art by simple extension of 
technology. 
 
the Bank One system includes the limitations of [CCL-Payer Data] by construction. 
 
the Bank One system includes the limitations of [CCL-Data Representing Treatment] 
by CPT. 
 
it is obvious that Bank One system could be extended to include limitations [CCL-DB-
Personal Health Profile Data] by one of ordinary skill in the art by simple extension of 
technology.  
 
Recall that we are assuming that the Allcare claims construction of the limitations where 
the preamble is not a limitation (i.e., the system need not be comprehensive), the system 
does not have to be completely automated, and that many of the `smart system` functions 
are performed manually with human intervention, then the following opinions can be 
expressed.  
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I hold the opinion that the asserted claims [1, 2, 4, 5, 6, 7, 8, 9, 12, 16, 17, 19, 20, 21, 22, 
23, 24, 27, 34, 35, 36, 37, 38, 39, 43, 52, 53, 54, 55, 56, 57, 58, 59, 60, 63, 67, 68, 69, 70, 
71, 72, 73, 74, 75, 78, 80, 85, 86, 87, 88, 89, 91, 93, 95, 102] of the `105 patent are 
invalidated by the Bank One system because the limitations are either included or 
obvious by one of ordinary skill in the art, if one uses the Allcare claims construction.  
 
I hold the opinion that the asserted claims of the `105 patent are anticipated by the Bank 
One system if one uses the Allcare claims construction because all asserted claims are 
invalidated.  
 
 
4.5.2 Blue Max  
 
Blue Max ([Bluemax:1990], [Medicalis:1986], [Medicalis:1986a]) was a Medical 
office automation system built by Health Management Corporation in association with 
Blue Cross and Blue Shield of Virginia in the 1986 time frame. This was a practice 
management system: "a unified financial, clinical and office automation healthcare 
network". 
 
Areas covered (with respect to the `105 patent) on the topic of computer systems and 
hardware included a micro-based computer system on the desktop. Financial areas 
included payment (debit or carrier), insurance forms, payment information, flexibility in 
billing, patient or account information, charge slips, bank deposit slips, practice's billing 
requirements, monitoring of year-to-date and lifetime benefits and deductible amounts for 
each type of insurance plan, payment adjustments, monthly financial reports, accounts 
receivable aging, and electronic reimbursement claims. Areas discussed about the 
medical patient chart included medical records, patient information (names, addresses, 
phone numbers), patient identification code, diagnosis, prescriptions, notes, treatment 
plans, rule-outs, test results, last visit date, clinic rounds report, and treatment plan. There 
was encoding of services and diagnosis, pre-authorization, and report generation. The 
system contained an On-line Electronic Index and Dictionary. 
 
There is a list of procedures that require pre-authorization from the insurance company. 
Each patient may have a treatment plan. "System VI brings up an easy-pick list of pre-
authorized procedures from the patient's treatment plan. Then, just select the item ... ". 
The system includes electronic claims submission and keeps track of referral sources 
from other doctors. Authentication of the provider is by password functionality.  
 
There is a list of 300+ proposed future features. They include: 
 
Item 16. Link Information from a self-administered patient history (SAPH) into an expert 
system database and print flow charts for diagnostic follow up (e.g. rule-outs, 
etc.). 
Item 35. Employer codes. 
Item 44. Print a group plan utilization report. 
Item 109. Add a frequency of diagnosis by provider report.   128
Item 110. Add a patient visits by doctor report. 
Item 121. Calculate patient visitation = number of patients over number of new patients. 
Item 122. Calculate office visit average. 
Item 123. Calculate case average.  
Item 125. Allow pre-verification before actual billing, making sure all needed info is 
there. 
Item 135. Add artificial intelligence "guardian agent" which are (monitoring) situations 
you define. If the system spots them, it will take appropriate action, e.g. warn you 
if a patient hasn't been in for over 6 months to verify the address, or any other 
situation.  
Item 140. Have the system automatically calculate the EOB of payments. 
Item 228. Have a documentation line (free-form, one line) that will appear whenever 
patient is accessed (for medical alerts, etc.). 
Item 248. Build more "smarts" into the recall (data-merge) system to warn patients when 
certain permanent diagnosis are pulled.  The system can generate special 
forms/reminders the patient should think of, including possible questions, things 
to bring, follow-ups, etc.  
Item 336. Let charge slips include all activities, not just pre-auths. 
  
4.5.3 LifeCard   
 
[LifeCard:1985]  is the brochure on the LifeCard system of Blue Cross/Blue Shield of 
Maryland dated 1985. 
 
LifeCard is a card-base system the size of a credit card. The card is a laser/optical 
memory card that can hold up to 800 pages of patient information. It requires use of a PC 
with a read/write unit and special software at the provider office. 
 
On the card, information is stored including health history, identification, an 
identification photo, diagnosis, treatment plan, hospital pre-admittance, insurance 
coverage information, the exact amount that will be covered, eligibility and medical 
coverage, lab work, blood type, current medications, prior cardiac episodes, seizures, 
discharge summary, images produced by EKGs, EEGs, X-rays, CATs, NMRs, operative 
procedures, results of diagnostic and therapeutic procedures, complete summary of all 
medicines prescribed, automatic reimbursement claim processing, pre-emergency 
information, follow up visits, drug allergies, security, authorization of usage, and 
confidential data security. 
 
The card has supporting systems to assist in the coding of diagnoses and DRGs (see 
Definition 3.4). The card will help reduce the problem of polypharmacy (prescription of 
drugs by more than one physician). 
 
The card will improve cost efficiency and the wellness of the subscriber. 
This card is also named "Health Management System". There is support for obtaining 
second opinions. 
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A person obtaining a LifeCard will obtain a free health review when they get the card. 
 
LifeCard is a trademark of Health Management Systems, Inc.  
 
 
4.5.4 Opti-Med  
 
Opti-Med [Andrusyshyn:2000] [Wellman:2000] or Optimed is a health care 
management system providing pre-certification and pre-authorization of requested 
treatment procedures and utilization review.  It is a commercial successor to work that 
was performed at the Health Data institute in Newton, MA, starting around 1987. Opti-
Med systems were sold to insurance carriers such as Blue Cross, Humana, and Chrysler 
for employee benefit support. The Opti-Med programs review the medical necessity, 
appropriateness of location (inpatient, outpatient, or physicians office), and 
appropriateness of length of stay of a given treatment regiment given diagnostic codes 
and other data. Opti-Med includes a complete set of clinical protocols. The system 
supports referrals and second opinions. The early system relied on telephonic 
communications between providers and the insurance companies that used it. The 
company was purchased by SHPS in 1997, and the software became a module of their 
health care support package. 
 
From [Holland:2002D] 
A. It was a product owned by the Health Data Institute and in 1990 the Health 
Data Institute was broken up and sold by the parent company, Baxter, and myself 
and two friends bought the Optimed Medical Systems. 
Q. And you say it was a phone-based system? 
A. Yes. It was made for nurses that sat at a terminal and read questions off the 
screen and doctors would call in and they would talk to the doctor and their staff, 
answer questions and then would produce a decision to pre-authorize, assign a 
length of stay. 
Q. What was the typical response time for that type of thing to happen? 
A. Typical phone call? 
Q. Yes. 
A. It was five to 12 minutes.  
[Page 105 Lines 1-22, Page 106 Lines 1-2] 
 
 
4.5.5 The Birmingham System  
 
[Wirtschafter:1975] was a Blue Cross reimbursement system by phone developed at the 
University of Alabama in Birmingham, Alabama, servicing patients and physicians with 
remote outreach. 
We are obtaining more information about this project. 
 
4.5.6 Metropolitan Life Insurance Company 
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Proposal for a claims system for the Metropolitan Life Insurance Company by Noble 
Lowndes International Inc. in the 1985 time frame. [MetropolitanLife:1985] 
 
This was a proposal to extend the existing Lowndes system for Metropolitan Life. The 
adjudication system was called Automated Claims Entry System (ACES). The integrated 
system included the features of claim history, patient identification, eligibility checking, 
pre-certification, benefits checking, per-cause limitations based on diagnosis, payment 
system, EOBs, on line claim entry, UB82 claim forms, authentication, and benefit 
verification. The system was for hospital and physician care with support for drug, 
medical, vision, and ancillary system. Information was encoded using ICD9, CPT4, and 
DRGs. The system uses IBM computers and databases. The system supported pre-
certification and referrals. Utilization review was done for cost effectiveness and included 
hospital length of stay. Claims could be placed in "pend" status. The system supports a 
"fast pay" mode where claims were paid and then post-adjudicated and adjusted.  
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4.6 Subsystems for Healthcare Functions 
As Kaliski insists, and Singer denies, Health Care information systems must be composed 
of many pieces of software and then interfaced to form a coherent whole. The healthcare 
enterprise is just too large and dynamic to allow one vendor or supplier to control it all. 
Cummings was aware of that: 
 
"Q:  And after these rules are developed, the rules are not finished at that point, 
correct? A: No, That – basically, medicine is always dynamic" [Cummings :2000 
III, p.323 l. 3-6] 
 
Most single system health care systems are no longer in operation because they could not 
adapt adequately to the variety of changes imposed by changes in financing, medical 
practice, and demographics. New concepts are typically innovated in distinct projects, 
and, if effective, eventually interfaced and perhaps integrated into the larger, compose 
systems. We will list the instances in approximately chronological order, although many 
of them had long gestation times, and the point of conception may not be known.   
 
The number of individual projects that comprise relevant prior art numbered in the 
hundreds at the time the patent was applied for.  The patent cited some, focusing on the 
use of `smart card' technology. We only mention ones cited or implied  - often misspelled 
- in the expert reports. 
 
4.6.1 Meditech  
 
Meditech commercialized the MGH developed MUMPS software technology in the 
middle 1960’s. This technology allowed operations on modest computers, easy 
programming, and a data file structure that was oriented towards medical information. 
Meditech provided the infrastructure for many subsequent innovations.  Among others it 
supported Beth Israel, Boston Brigham and Women's and related hospitals, as well as the 
Veterans Administration hospitals and other military care centers. See [Bleich:2000].  
 
4.6.2 Internist  
 
Internist [cited by Blevin] summarized in [Shortliffe:1990], is a large diagnostic 
program developed at the University of Pittsburgh School of Medicine in the early 
1970’s. It maps findings and disease manifestations into diseases. It tried to capture the 
depth of knowledge of Dr. Jack Mayers, one of the most renowned diagnosticians of our 
times. To each finding – sign or symptom - is assigned an evoking strength, a frequency 
weight, and an important number. Internist then used a scoring scheme to establish the 
differential diagnosis from a collection of such findings. Being based on the experience 
of a single expert, versus on committee deliberations, provides a great deal of consistency 
in quantifying the findings. In one 1982 study involving 19 different patients with 43 
diagnoses, Internist correctly identified 25. Originally Internist ran on a mainframe 
computer, but in the early 1980s the program was adapted to run on a microcomputer as   132
QMR (Quick Medical Reference). Although development is continuing, it has not yet 
reached a competence to serve in primary medical settings. 
 
4.6.3 DXplain  
 
DXplain [cited by Blevin] is a diagnostic decision-support system developed at 
Massachusetts General Hospital and was developed by Octo Barnett and his staff during 
1987 to 1990. One of the goals of DXplain is to generate a list of possible diagnoses from 
a group of clinical findings. Other information is available, such as the frequency that a 
symptom occurs in a particular disease, or the chance that a particular disease is present 
given a certain finding.  
 
A disease profile consists of a set of clinical findings the developers have decided are 
relevant. For each finding listed for a disease, three attributes are stored: term frequency, 
term-evoking power, and term importance. Term frequency quantifies how often a 
finding occurs in a disease, term-evoking power states how strongly the finding supports 
the diagnosis of the disease, and term-importance measures how consequential is the 
finding. DXplain also stores the disease prevalence for each disease or the baseline 
likelihood of a disease in the general population, or how consequential the disease is.  
 
DXplain generates a list of possible diagnoses using a pseudo-probabilistic algorithm. It 
first evaluates the term importance and term-evoking strength of each finding-diagnosis 
pair and then calculates a summary score for each disease. A disease score is most 
influenced by positive findings that have high term-evoking strength. Findings with 
intermediate evoking strengths and high term importance contribute moderately to the 
summary score. After DXplain evaluates each clinical finding, it displays the highest 
ranked diagnoses divided into "common diseases" and "rare or very rare diseases."  
 
DXplain is currently used by many individuals and institutions around the world. 
Because of concerns that proper interpretation of its output requires medical knowledge, 
DXplain is available only to physicians. 
 
4.6.4 Mycin  
 
Mycin is the most cited rule-based system in Medicine. It is employed only when a 
diagnosis of Meningitis has been reached and provides advice on which of 5 alternate 
antibiotics to employ before clinical laboratory testing has determined which one tests to 
be the most effective.  A rule-based approach is reasonable here because: 
1. a diagnosis exists. 
2. the number of alternatives treatments is small.  
3. all the treatments have little risk, they only differ in effectiveness. The treatment 
advice is only valid for the few days needed to obtain the laboratory report. 
4. the actual medication decision is made by the patient's physician. [Cummings II:2000, 
p. 186 l. 17-21]. 
Mycin was developed by Dr. Shortliffe at Stanford University during 1975-1980 
[Shortliffe:1976].   133
 
4.6.5 Oncocin  
 
Oncocin [cited by Blevin xxx] is a system for Clinical Oncology Data Management, 
intended to assist physicians in collecting appropriate data for making good decisions for 
ongoing treatment. All patients have already been diagnosed and treatments have been 
prescribed.  It was developed by Shortliffe et al. during 1984-1986 in part due to the 
frustration of having inadequate data available from routine data for rule-based systems 
of the Mycin style (q.v.). 
 
4.6.6 Acid-Base Disorders [Bleich:1969] 
 
With the advent of electronic computers (in the 1969 time frame) that operate in the time-
sharing mode, it has become possible to develop an automated system that can assist a 
physician in solving clinical problems. In the present study a Teletype terminal has been 
linked to a time-sharing computer which has been programmed to evaluate clinical and 
laboratory information concerning patients with acid-base disorders. The program checks 
the data for evidence of internal consistency and requests additional information as 
needed to solve the acid-base aspects of the clinical problem. If sufficient information is 
provided, the program generates an evaluation note designed to review with the physician 
the pathophysiology of the disorder and to assist him in its management. If the input data 
are incomplete, the program draws the most useful conclusions possible based on the data 
provided, specifies the limitations which pertain to these conclusions, suggests further 
studies designed to circumvent these limitations, and while awaiting the results, suggests 
appropriate interim therapeutic measures.  
 
4.6.7 Ovid [Ovid:2002] 
 
Ovid offers a rich, inter-linked knowledge environment designed to deliver authoritative 
answers to questions quickly and easily. Ovid search software supports full text journals 
and bibliographic. Support for over 800 journals. Support for medical, nursing, and 
pharmaceutical reference textbooks from multiple publishers. Intended for working 
physicians, nurses, and pharmacists, Ovid delivers evidence-based summary information 
on clinical topics as well as clinical decision support and education resources, and drug 
information. 
 
4.7 Summary 
Predating the `105 patent is significant prior art. I hold the opinion that the Bank One 
system, a system containing the features described for AAMRS, the AHIS workbook, 
and the Three Generations HIS system all anticipate the asserted claims of the `105 
patent as construed by Allcare's claims construction chart when it is asserted that the 
preamble is not a limitation, the system does not have to be completely automated, and 
that many of the `smart system` functions are performed manually with human   134
intervention.  The anticipating references are only examples.  Further literature searches 
would greatly increase the number of anticipating references. 
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5. Reviews and Rebuttals of Plaintiff's reports and depositions 
 
Index by Author. 
 
  5.10   Barber et al., patent 4858121 August, 1989. 
  5.1   Cummings: [2000] and [2002]. 
  5.15   Deschenes et al., patent 3697693 October, 1972. 
  5.14   Doyle, Jr. et al.  4916611 April 1990. 
  5.6   Holland:2002 Report. 
  5.7   Holland's 2002 Deposition. 
  5.5   Kaliski:2002. 
  5.9   Krieger: Analysis of Prior Art by Paul Krieger. 
  5.8   Kurtyka, Expert Report.    
  5.16   Mohlenbrock et al. , patent 5018067 May, 1991. 
  5.12   Pritchard, patent 4491725 January, 1985. 
  5.17   Sinay, patent 4290114 September, 1981. 
  5.2   Singer:1990  Quality Assurance. 
  5.3   Singer:2000.  
  5.4   Singer: 2000 and 2002 Depositions.  
  5.13   Valentino, patent 4648037 March, 1987. 
  5.11   Watanabe, patent 4797543 January, 1989.  
 
Since the submitted material is voluminous, we reserve the right to append further 
comments and analyses to this Section.  
 
5.1 Cummings: [2000] and [2002] 
In the initial depositions [Cummings:2000] and the later following deposition 
[Cummings:2002], there are items which are presented clearly, and items where 
Cummings is not able to be precise.  Cummings presents high-level issues in health care 
clearly.  He is enthusiastic about the need for comprehensive health care. Cummings 
becomes vague and inconsistent when specific health care or computer system detail is 
probed. His professional focus has obviously been on marketing improved health care 
systems, not building or managing them.  
 
5.1.1 Vision  
 
Cummings presents a system that he never, even in part, could implement, or that he even 
contemplated implementing.  The disclosure ignores both the inability of current 
technology as well as organizational issues, namely that no single organization in the 
United States could be authorized to integrate all the required functions. 
 
 A. I just want to basically go back and reference that the background of the 
invention is really -- it states very clearly when it comes to medical issues that it's 
the total health care functions for an integrated -- for they have not integrated   136
important elements of the total care into the system, and that's really where he 
talks about -- that's the linkage of the medical treatment statement. 
Q. This is -- 
A. This is in the patent on column one.  It is line 36, I believe, however, such 
systems have not hitherto featured the total health care function for they have not 
integrated important elements of total health care.  That's all I wanted to make 
sure. 
Q. Why is that important? 
A. Because when we talk about medical treatment, that's the concept. He's talking 
about medical treatment. That's the concept.  It is not the concept of linking a 
payment system to a medical, to an insurer, because the payment system is only a 
portion.  It's a declared portion that is not -- it's out there, but it's the integration of 
the care model. 
Q. That's important in this context? 
A. Well, when Andy refers to -- when this statement refers -- the suggesting that 
the claims matter of this application which is directed to the aspects of medical 
treatment, I just wanted the medical treatment to be understood as not the 
payment of claims but the process of putting the care management, 
comprehensive care management system together. 
Q. Why is that important to the 105 patent?   
A. Because that's what Andy claims is in the background of the invention is the 
distinguishing factor. 
Q. Is that described anyplace else in the 105 patent? 
A. I think it's described in the vision.  I should say the abstract.  It's a fully 
integrated and comprehensive health care system that includes the interconnection 
and interactivity of patient health care provider.  Other financial insurance 
companies utilization reviewer and employer so as to include within a single 
system each of the essential participants to provide patients with complete 
comprehensive pretreatment, treatment, and post treatment health care and 
predetermined financial support thereof. 
Q. That's important to your invention? 
A. That's the comprehensive, the vision. 
Q. Is that what you mean by a health care management system? 
A. Where are you referring to now? 
Q. I'm not referring to anyplace.  You use health care management system all over 
this patent. 
 A. I have to be shown a specific -- because I think it takes the global view and 
then it breaks it down to preferred practice.  
[Cummings:2002, p. 127 l. 12-25, p. 128 l. 1-25, p. 129 l. 1-13]. 
 
Converting such a vision to an actual system is of course a difficult task and one not 
enabled by the specification. The specification of a future utopia and collecting all 
possible prior art seems impossible. The `105 patent does not provide any resolution.  No 
specific technological advance was specified in the application. It is no wonder that 
Singer, when investigating prior art, restricted himself to fully automated systems. 
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5.1.2 Symptoms are Distinct from Diagnoses 
The distinction between symptom and diagnosis is initially stated clearly, even though it 
critically effects the validity of the `105 patent. 
 
"Symptoms would be things that the patient tells a doctor' ...  `and physical 
manifestations that the doctor actually observes"  
 
`A diagnosis is the point at which you are able to say – categorize the symptoms 
within the Diagnostic Related Groups"  
 
C:`.... the government has put together or the CPT codes or the ICD-9 codes 
where you are able to code the problem, medical problem into an acceptable 
category' 
Q: `So the diagnosis is the conclusion of the doctor?'  
A: `Right'  Q: `So the symptom and the diagnosis are two different things?' A: 
`yes'  
Q: `But CPT, that's various procedures? A  Right.  Q: That's not a symptom, 
correct? A: `No, That's a treatment. That's a payment methodology and so forth. 
Basically, get it down to a diagnosis related group' <(DRG) used for billing>. 
`stomach ache' versus `ulcers' .  [Page `160]. 
 
Symbolic of symptoms does not mean symbolic of diseases. [Page 182]. 
 
Treatment is two steps removed from Symptoms [page 184]. 
 
The intermediate step is clearly obtaining a diagnosis, a task that Cummings here, but not 
in the patent, assigns to physicians. However, the requirements for diagnostic tests 
needed to produce signs and the role of the medical history in that process are not well 
elucidated: 
 
Identification of symptoms for diagnosis is a physical exam process.   
 
This statement, offered when going through the claims conflicts with his initial, correct 
explanation. See the definitions for Symptoms, Section 3.1 and Signs, Section 3.2.  
 
"Q: ... what's the difference between data symbolic of symptoms and symptoms for 
diagnosis?  
A: They're similar.  
Q: Are the same thing?  
 A: could be the same thing but not all – yeah." .... , but some are text statements. 
[p.311 l.17-21]. 
  
 
Actual systems require clear codes, typically ICD-9 based, for treatment advice and 
reimbursement decisions 
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5.1.3 Defining a Smart System 
The technology, role, and requirements of the `smart systems' that are hypothesized in the 
`105 patent to bridge the gap from Symptoms to treatment is not well understood. 
 
Q: `So the system of Claim 1 is a smart system, correct?'  
A: `It's part of the utilization. Right'. A: `yes',  
Q: `What is a smart system?'  
A: A smart system is capable of managed artificial intelligence or rules based'.  
Q: `What is artificial intelligence?'  
A: `Pattern analysis'.  
Q: `Okay. What is Pattern analysis?'  
A: `The ability to keep a system learning as you add more data'.  Insurance 
company sets the rules.  
[Cummings I:2000, pp. 161-162]. 
 
We have provided our definitions for `smart system' and `artificial intelligence' in Section 
3.15 and 3.17, concepts that an inventor in the field should be familiar with if he intends 
to teach others how to implement a system that he has not built himself. 
  
5.1.4 Smart Systems are Publicly Available 
To bridge the lack of understanding of smart systems, Cummings makes the assumption 
that they are publicly available. However, he has never attended a meeting, nor is a 
member of the society where researchers and developers work in that arena.  
 
"Q: Did you look for any kind of a smart system at the time, prior to filing the 
application?  
A: Basically, we did a search.  
Q" When you say, "we did a search, " who did a search?  
A: basically, I asked for a search to be done.  
Q: Asked who? Andy Haskell.  
Q: and he did a patent search; is that right?  
A: Yes. 
[Cummings II:2000, p.219 l. 10–18]. 
 
Cummings' knowledge seems limited to what is made available via marketing blurbs. 
In responding to a query about how to obtain `smart systems` he opines: 
 
A: Use experience, learning, factor analysis, literature review to create the smart 
system rules. Expect there would be plug-and-play resources, as from NIH. Use 
focus groups.  
Q: How much work is that?    
A: Work would NOT be significant. Use consensus.  
[Cummings:2000 II p.276, 277 ]. 
 
To substantiate that opinion, Cumming's mentions his experience in statistical education, 
working with doctors over many years.  
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250 doctors at Huguley.  
Medicine is dynamic.  
 
But none of that work involved building systems as envisioned in the patent. Cummings 
had involvement, although again, not in actually building systems that provide advice 
about healthy life styles.  There is quite a difference in scope and in risk from telling 
people how to behave versus determining medical interventions.  Reliability and 
correctness become issues, often requiring FDA certification.  
 
Q: how to test?  
A: Problem is compliance.  
[Cummings III:2000, p. 324-327]. 
 
The response indicates that the experience is based on creating advice for patient's 
behavior. When queried further the issue of liability arises, which is one of the reasons 
why research into health care computer systems involving medical practice is progressing 
slowly and requires much precision, care, and validation. 
 
Q: `When the system is implemented and it's at the hospital, does that system 
actually work at that point. You have created the rules.'  
A: `Sure, it works.'  
Q: `And have you ever seen such a system work, such a smart system?'  
A: `I have -- limited'.   
 
Cummings then mentions systems for pre-certification and pre-authorization, systems 
which existed prior to the application for this patent, and recognizes that there is a:    
 
A: `Liability issue. Big job, yes' 
 
By considering our definition, we can clearly see here that nothing was invented, nothing 
suitable had been built, and nothing was available to be integrated into a health care 
system.  
 
Kaliski [Kaliski:2002], in defending the validity of the `105 patent when faced with this 
issue is forced to state that `any computer system is smart' (see Section 5.5.3).   Such an 
opinion invalidates the patent, since now all computer systems in health care would be 
equally smart, and any of the many systems that included the steps claimed, becomes 
invalidating prior art. 
. 
5.1.5 Factor Analysis can be used 
 
Cummings claims that factor analysis (see Definition 3.21) can be used to drive `smart 
systems'. 
 
A: Yes, I knew how to do it. 
Q: Okay. How do you actually take symptoms and come up with a proposed 
mode of treatment?  How is that actually done?   140
A: Through pattern analysis. 
Q: How is pattern analysis done? 
A: Basically, where you have the best outcomes from an experience of employees 
and you’re able to factor-analyze what are the best outcomes for treating various 
conditions. 
Q: And you knew about pattern analysis when you filed the application? 
Pattern analysis? 
A: Yes. It’s statistical concept. 
Q: And you knew about that at the time you filed the application? 
A: It’s factor analysis, is what it is. 
Q: I guess you knew about factor analysis at the time you filed the application? 
A: I did. 
Q: And at the time you filed the application, the best way to come up with a best       
practice mode of protocol was to do factor analysis, correct? 
A: Right 
Q: That’s what you contemplated at the time you filed the application. 
A: Yes. 
Q: And how exactly would this factor analysis be conducted?  And, again, I’m 
talking about at the time you filed the application.  How did you contemplate 
actually doing this factor analysis to come up with this system to determine a 
proposed mode of treatment based on symptoms? 
A: Basically, through loading large databases of history into the computer and 
really doing an analysis process. 
Q: How would that analysis be done? 
A: The first step you’d do is focus groups with doctors on particular symptoms, 
finding out what they believe is the best, and utilizing literature and then 
comparing that to actual practice as you gathered the data. 
And – And keep refining that.  So that’s why the smart system. 
Q: So the best way of coming up with this system to determine proposed modes 
of treatment based on symptoms was to do factor analysis, to look at large 
databases, to get focus groups with doctors and to correlate the symptoms to 
proposed treatments, correct? Is that correct? 
A: It was a statistical process. 
Q: Statistical process. 
A: Right. 
[Cummings II:2000, p. 206, p. 207, p. 208 l. 4-7]. 
 
 
When deposed he realizes the difference of scale from his experience and the problem 
that would arise when deriving treatments from symptoms, or even just obtaining 
diagnoses from symptoms. 
 
A. It is far from routine. 
Q. It would be quite difficult? 
A. Yes, it would be difficult. 
[Cummings II:2000, p. 208 l. 19-22].    141
 
Increasing the number of symptoms to about 7,000, the number of diseases to about 
12,000, and considering the interaction of even two diseases, creates a computational 
problem, since the products of the symptoms and diseases forms the base.  More diseases 
that interact with each other further multiply the problem scope. Cummings is well aware 
that much of our population has multiple diseases, and terms that the "Floridization of 
health care." 
 
Q. If you can summarize your basic speech in a minute or so, would you mind 
doing that for us? 
A. Sure.  My basic speech is that we're facing a different era, which we've called 
the Floridization of the globe which, in essence, is in the year 2000 18 and a half 
percent of the people in Florida turned 65 or older.  That's the first time that's 
happened in a state or -- but it's going to happen around the world. What has 
happened is the Sandia Labs have called us the Floridization of the globe, and 
they show that Italy comes next, Japan next, and by the year 2023 all of the States 
will be in the same condition as Florida is today and Central Florida, 18 and a half 
percent over 65. What that does is change the health care equations.  It changes it 
from an acute care solution demand to a chronic disease demand, and this is 
illustrated in the rise of chronic disease affecting the costs of the delivery of care 
for Medicare patients which shows that -- the congressional record shows that 68 
percent of the people of -- the costs of Medicare is for people with five or more 
chronic conditions, and that is an escalating fact of aging. The difference between 
acute care, which was the medicine that brought us the solutions of moving the 
age expectancy in the first of the 20th century from 45 years to the end of the 20th 
century to 78 years was solving the contagious diseases.  Now we have the 
chronic diseases.  The contagious diseases can be solved with an episode or a 
vaccination or public health strategy, but the chronic diseases are lifestyle 
solutions, and you must create a care around the patient that supports them 
throughout a continuum. My father has diabetes, for instance.  You don't start 
managing him when he crashes in the emergency room, or you have huge costs.  
You manage him in the morning, what he eats, when he takes his medications and 
all that.  In that situation the core shifts because the problem that we had in 
managed care was a false assumption that all we need to do is change the 
incentives of the doctors by changing the way they're reimbursed, but, in fact, 
they didn't have the systems or the resources to manage and continuum of care. 
They only -- they've been trained episodically.  When the problem was episodic, 
they were really good.  When the problem is a continuum, they don't have the 
resources, they don't have the systems, and they don't have the solutions. What 
happens in the acute care model is the focus is on the physician and the staff.  The 
patient is just treated as an object.  You make them comply because you have total 
control.  In the new model of chronic disease, the patient gets more than 70 
percent of their own care.  They are their own primary care giver, so we call that 
the age of the pro-consumer where I'm my primary care giver, I'm my provider, 
and I consume specialty care.  In creating that continuum is what we think the 
future is about.   142
Q. In the context of your speech and what you think is going to be the future of 
health care, do you envision, you know, computerized systems that need to be 
developed to support that? 
A. Yes. 
Q. What kind of systems would they be? 
A. Basically, you know, where they are available. Point of care systems so you 
can provide the care at the point of need for the patient. 
Q. What do you mean by point of care system? 
A. Well, a system that provides you the information and the capabilities of 
delivering care in the setting that empowers the patient so you can integrate the 
care. Right now one of the huge problems we face is that a person who has ten 
chronic diseases or more has 49 prescriptions, 13 different doctors, and goes to 
those doctors 37 times a year on average.  The Gallop research shows those 
people tell us they get different -- on the same set of information get different 
conclusions about what their problem is, get overlapping tests, and get no 
coordination of care, so that has to be addressed. 
 [Cummings:2002, p. 19-21]. 
 
The effect of moving to the actual scale needed for healthcare is that the effort becomes 
many orders of magnitude larger, at least a thousand times.  To support such the 
computational problem would need quality data on a population that is larger than the 
population of the world. Even highly restricted analyses are immense 
[Framingham:2001]. 
 
If Cummings had actually tried to build such a system, he would have realized its 
impossibility. Now this solution is merely part of his vision. 
 
Q.    Do you know how to use factor analysis?    
A.    Yes.  I used factor analysis. 
Q.    Is that a statistical tool? 
A.    Yes. 
Q.    Do you know about P values? 
A.    Yes. 
Q.    What are P values? 
A.    Boy, you're sending me back to -- is this a test?  P values are probability 
values.   
Q.    Do you know about degrees of freedom?  Have you used that term? 
A.    Yes. 
Q.    What does that term mean to you? 
A.    Degrees of freedom is the amount of choice that you have with any given 
system.  It is the number of choices you have minus one.  For example, if I gave 
you a multiple choice question that had A, B, C, D, E choices, you would have 
four degrees of freedom.  If I gave you a question that said name the first 
president of the United States and there was only one right answer, you would 
have zero degrees of freedom.  That's my understanding.  Like I said, I'm not an 
expert.   143
Q.    If you were standing on or sitting in your car on a street corner at a stop light, 
how many degrees of freedom would you have then? 
A.    It depends if the light is red or green.  If the light is red, I would have only -- 
I would have zero degrees of freedom because I can only turn right, which is one 
option minus one. If the light is green, minus one, so I would have two degrees of 
freedom unless I could back up.  That might give me a little more. 
Q.    In the statistical sense do the degrees of freedom relate to variables? 
A.    I'm trying to think.  Are you talking factor analysis? 
Q.    No, just in general. 
A.    Do degrees of freedom relate to variables?  They can in a testing format.  
They will tell you if one of your variables is the right answer to a question.  Let's 
say one of your variables is you're producing a test and you've got an answer 
within that test and that becomes a variable, then there may be five right answers 
which would mean four degrees of freedom within that variable or there may be 
one right answer or zero degrees of freedom within that variable.  So it can have 
that influence, but, again, you really have me skating on territory that is -- wow, 
I'm digging hard to recall. 
Q.    When you did your dissertation, did it address any degrees of freedom or a 
statistical system with variables in it? 
A.    Yes. 
Q.    How many variables were involved in the topic for your dissertation? 
A.    I believe it was a matrix of 345 by 144, I believe.  It was 148, one of those.  
It was somewhere over 140. 
Q.    Three something by -- 
A.    So I had 345 variables on 148 or 49 subjects. 
Q.    What generally was the application for those variables? 
A.    That was a study of the factors of church growth among Caucasian churches 
in North America for the Seventh Day Adventist Church. 
Q.    Did you do any computerized analysis on those factors? 
A.    Yes. 
Q.    Was it a computationally intense study? 
A.    Very.  I mean, there was a lot of computations in the sense that the computer 
did them all, but it ground a long time to get them through.  It was basically factor 
analysis applied to those variables, boiling those variables down to factors. 
Q.    So you have some experience with multi-variable symptoms in factor 
analysis? 
A.    Yes. 
Q.    Now, when you compare the number of variables in your study for your 
dissertation to the number of variables to apply to a health care management 
system, what is the comparison there? 
A.    There's a lot more complexity in a health care management system. 
Q.    In order of magnitude maybe? 
A.    You know, there's a lot on the order of magnitude, yes. 
Q.    Ten times as much?  100 times as much? 
A.    You would have to get somebody to sit down who knows the field and 
suggests that.   144
Q.    Is it fair to say that in computing statistical systems that as the number of 
variables increases linearly the computation will increase exponentially? 
A.    I don't know if it's fair to say it increases exponentially.  I think it depends on 
the statistical tool you use to organize the variables. 
Q.    In your dissertation study what kind of statistical tool did you use? 
A.    I used multiple regression and factor analysis. 
Q.    What kind of computer processing system did you use? 
A.    I used the university's system. 
Q.    Which was the mainframe? 
A.    Yes, it was a mainframe. 
Q.    A mainframe is a fairly large computer? 
A.    Yes. 
Q.    Not like a PC? 
A.    Well, today our PC's would surpass the mainframe by tons.  It was a 
mainframe, but it was not a horse. 
Q.    How much data was used for your study? 
A.    Like I said, it was 145 subjects with 340 variables on each subject, so that 
was the size of the matrix.  But that's why we used factor analysis to organize      
the variables so that you could shoot vectors through the data to find out what 
correlated, and then you had to     interpret it because factor analysis is both a 
scientific process and an art, very much of an art. 
Q.    It took a long time for the computer to crank through the calculations that 
you needed? 
A.    It took a while. 
Q.    Have you ever built a system that was able to select proposed treatments 
based on symptoms? 
A.    I have basically been involved with disease management most recently.  Are 
you talking about -- put that in a time frame.  Are you talking about now? 
 Q.    Anytime. 
 A.    Basically been working on various things along that line.  One of them is 
disease management approach in which you basically -- the pattern of treatment 
that you put     together for, like, diabetes patients, and then you have -- you 
customize it to the particular patient.  [note, here the diagnosis is known] 
Q.    You're working on that now? 
A.    We actually implemented that and saw the results  of that kind of 
management when we were actually running a Medicare demonstration project. 
Q.    But that's management.  That's not generating a   treatment scenario based on 
an input of systems? 
A.    Well, it's chronic disease management, so it's   taking the conditions that the 
patient has and actually saying what's the best course of action to support them on   
and updating the symptoms, so you're able to gauge how they're making progress 
or whether they are in danger and needing intervention.  Disease management is a 
field that's really in need of that kind of best practice. 
Q.    Well, in that system that you're referring to,    what's it called? 
 A.    We don't have a name for it.  It's just our disease management program. 
[Cummings:2002, p. 141-146 l. 1].   145
 
This discussion of factor analysis, a method proposed to fill the discontinuity starts out 
with a nice example, but when some complexity are introduce that will arise when using 
this methods for comprehensive processing of symptoms, the responses reveal that 
scaling his technology from a thesis project or an HRA effort (see Section 3.21) to the 
level needed for comprehensive health care support not been addressed by Cummings. 
 
5.1.6 Health History  
 
Health history comes from the patient, includes medical history. 
 
A. Lifestyle elements and medical history, lifestyle risks.  
Q. What specific lifestyle elements and what specific medical history? 
A. I basically -- the lifestyle elements, things like I described before, like 
smoking, exercise, weight, the primary morbidity factors. 
Q. What are the primary morbidity factors beside weight, exercise -- 
A. Smoking. 
Q. -- and smoking? 
A. Stress, probably, is the other factor, depression. 
Q. Drinking? 
A. Could be, yeah. 
Q. Alcohol consumption? 
A. Right 
Q. And so at the time the application was filed, you thought the predetermined 
items of medical history that should be included for the system of -- the method of 
Claim 85 would be smoking, weight, stress, alcohol consumption, correct? 
A. (Nods head)  
Q. And what about for medical history? What are the items of medical history that 
you contemplated would be best included in the predetermined items of medical 
history for Claim 85? 
A. A lot - a lot of the normal medical history questions that you deal with of -- 
have you had, you know, prostate cancer? Have you been hospitalized? What 
medications are you allergic to? Those kinds of things.  
Q. Have you ever had diabetes? 
A. Right. 
Q. Have you ever been unconscious before? 
A. Yeah. 
[Cummings:  2000, p. 277 l. 23-25, p. 278, p. 279 l. 1-11]. 
 
5.1.7 Manual processing steps are covered by the patent.    
 
The author of the `105 patent presumes that his patent also covers manual processing 
[Cummings:  2002, pages 142-145]: 
 
"Well, I think if you read through it, it also says it could be manual. So there is 
manual capabilities, as well as automated capabilities.     146
Q: Okay, Well --   
A: Or automated --  
Q: So Claim 1, to you, covers both manual systems and automated systems, 
correct?  
A: Right.  
Q: Okay. And a manual system does not have electronic communications between 
the patient, health care provider, bank or other financial institution, insurance 
company, utilization reviewer and employer, correct?  
A: I think it's -- that's a technical decision I think that, you know, the telephone is 
a manual system, but it can be utilized with some automated properties. So it can 
be technically -- so I’d say that with that qualification, fax, telephone, those 
require certain manual -- whereas a computer's all automated. " ;  
 "In the patent process, there is data sending and there is human intervention" 
responding to "do you envision that possibly being done with people talking to 
each other on the phone": "In a primitive situation if necessary. Could be. I don't 
really -- the vision is to get all electronic"  
 
Since the vision is broad, and could indeed encompass any prior or current healthcare 
system that we must take specifics from the claim section.  However there is no 
indication of manual processing in the claims, nor in the prosecution history, nor in the 
prior art provided. 
5.2 Singer:1990  Quality Assurance 
Dr. Charles Singer is a consultant to Allcare in Health Care Information Technology. 
We received material provided by Mr. Singer on Quality Assurance [Singer:1990]. 
These documents describe fairly the need for quality assurance and provide in more detail 
a vision congruent with that presented by Cummings in the specifications of the `105 
patent. Quality assurance is the central goal of Utilization review. Singer also had a role 
when the `105 patent was being developed in assuring Allcare and, indirectly, 
Cummings, that `105 patent did cover any prior art. 
 
[Singer:1990, pp. 12, 3, 58, 52]  defines Quality Assurance  as a process matching our 
use of Utilization Review  (see Definition 3.9); inputs include  diagnoses, laboratory tests 
- resulting in triggers (we use the term sign - see Definition  3.3). It is a retrospective 
function. Claims data are inadequate for that purpose. 
 
[Singer:1990, p 41] also describes `Utilization Management', the function that we call 
Cost- Effectiveness Review (See Definition 3.10) . `Utilization Management is defined as 
a distinct discipline from Quality Assurance, and focuses solely on lowering costs. 
An example of Utilization Management is pre-authorization of inpatient services. 
 
The term `Symptom' does not seem to appear in Singer’s work at all.  
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5.3 Singer Expert Report [Singer:2000]  
The expert report submitted by Singer in connection with the 1990 Allcare case vs. 
Cerner et al. [Singer:2000] describes fairly the disjointed state of the Health care delivery 
industry in 1990 -- a situation that has not improved much since. He recognizes that "the 
`105 patent was at the time a valuable contribution in establishing a vision and 
framework for improving the American healthcare system" [p.5]. He agrees further with 
the patent "that a reasonably complete record of the patient's medical and insurance 
history" is required. None of that section addresses the claims of the `105 patent.  In 
Section III Singer states his understanding of the law. In Section IV his report deals with 
prior art. 
 
5.3.1 HELP is not invalidating prior art.  
 
Singer's opinion is that the HELP system [Gardner:2000H] (see Section 4.4.1 ) is not a 
comprehensive system, as stated in the preamble of Claims 34 and 85, and that hence 
HELP does not represent valid prior art. Of course, a system containing only the elements 
in the body of Claim 34 or Claim 85 would not be comprehensive either.   
 
For instance, on page 8 he states that "the `105 patent envisions a more complete and 
comprehensive patient record, similar to the system Mr. Gardner hopes the HELP System 
will become".  I do not know when Reed Gardner's or his predecessor, Dr. Homer 
Warner's hopes started.  If we allow a vision to be patented, we should allow a hope to be 
prior art.  
 
No comparative claims chart is provided, Mr. Singer relies on the specification in the 
vision. 
 
Singer also faults the HELP system as not taking care of outpatients and not performing 
payment services. Other systems within the LDS systems obviously did perform those 
tasks.  If Allcare’s urged claim construction is adopted, then the HELP system (including 
the overall services at LDS) inherently should include all of the features of the claims.  
The ‘105 patent could not be built as a tightly integrated single system, as Singer claims 
is necessary to satisfy the `105 patent.  A hospital will always be disjoint from a bank.   
 
 If we were to accept that manual processes are covered by the `105 patent (see Section 
1.1.3), then we would have to revisit the systems at LDS, including the Help system.  
 
5.3.2 Beth Israel, Brigham and Woman's Hospital (BI) 
 
The Systems at Beth Israel, Brigham and Woman's Hospitals (BI) are not invalidating 
prior art. Singer’s opinion is that the BI systems [Bleich:2000] (see Section 5.3.2) is not a 
comprehensive system, as stated in the preamble of Claims 1, 4, 34, 52, 55 and 85, and 
that hence BI does not represent valid prior art. Of course, systems containing all 
elements of Claims 1, 4, 34, 52, 55 and 85 would not be comprehensive either.  No 
comparative claims chart is provided.     148
Singer notices specifically that no payment system is included. Reimbursement does 
occur at BI, of course, but it is performed by remote subsystems, interfaced, but not 
included in the systems that Dr. Bleich was asked to describe. The `105 patent, since it is 
a distributed system according to [Kaliski:2002] (see Section 5.5), allows communication 
with insurance companies at remote locations. This criticism violates the spirit of the 
integrating intentions of the `105 specifications (see Definition 3.22). Furthermore, if all 
systems need to be that tightly integrated, then the case against TRIGON would be void, 
since TRIGON interoperates with many other systems in carrying out its tasks. 
Singer deduces that the `105 patent envisions open interconnection, not proprietary 
communication. At the time the patent was drafted the Internet was not available, only in 
1993 were the domains .com, .org, and .net defined by NSF. The provider at that time of 
open services for the academic community, and commercial registration came later.    
All prior systems outside of academia at that time had to use proprietary technology, and 
TRIGON still uses proprietary communication, so by that distinction TRIGON systems 
do not infringe. 
 
Singer also faults BI for not having complete medical records available at all locations.  
We now fight the confusion of what a medical history contains (see Section 1.4).  The 
cited `105 claims, nor the specifications specify when a Medical History is deemed to be 
complete. Deriving such stringent requirements from the preamble term `comprehensive' 
will invalidate the `105 claims themselves. Singer further faults BI's Medical History 
system in that the outpatient Medical History is only available for 15 months and lab 
reports only available for 6 months. Since the `105 system was never implemented, we 
can only guess how much of a patient's history would be included -- it is unlikely that 
many physicians would enter historical information beyond what is needed for 
reimbursement of claims. If BI fails Singer's test, so does the claims section of `105 and 
so does TRIGON.  There is no significant amount of patient's history included in the 
TRIGON system, it only has reimbursement claims data.  
 
Even though we object to much of Singer's reasoning, we would likely come to the same 
conclusion that the BI do not represent invalidating prior art, since the BI systems do not 
and cannot perform the miracle that is required to bridge the disconnect discussed in 
Section 1.1, and here required in Claim 1(d), Claim 4(e), Claim 34(d), Claim 52(c), 
Claim 55(d), and Claim 85(e) respectively.  If we were to accept the construction urged 
by Allcare, i.e., that manual processes are covered by the `105 patent (see Section 1.1.3), 
then we would conclude otherwise. 
 
5.3.3 The OPTIMED does not represent invalidating prior art.  
 
Singer's opinion is that the OPTIMED system [Wellman:2000] (see Section 4.5.5) does 
not have sufficient automation to qualify as relevant prior art. It used, at least at that time, 
telephones for communication, while "The preferred embodiment of the present invention 
includes the integrated connection and interaction of the patient, healthcare provider, 
bank and other financial institution, utilization review/case management ... " [page 11]  
such "electronic communication means as required by the patent".  This statement is in 
conflict with [Cummims:2000, pp 194-196].      149
 
Singer also notices that no payment system is included. OPTIMED is only a subsystem, 
purchased by companies as Blue Cross to carry out a specific task. Reimbursement of 
health care costs is their business, but it is performed by other interfaced subsystems. 
This criticism violates the spirit of the integrating intentions of the `105 specifications  
(See Section 3.22). Furthermore, if all systems need to be that tightly integrated, than the 
case against TRIGON would be void, since TRIGON interoperates with many other 
systems in carrying out its tasks. 
 
No comparative claims chart is provided.   
 
If we would be limited to reviewing only the OPTIMED subsystem, we would also come 
to the conclusion that this subsystem does not invalidate the comprehensive, if fictional, 
`105 system.  If we are to evaluate prior art in respect to a patent, as `105, that represents 
a vision of a comprehensive approach, then we'd obviously have to assess systems in 
which OPTIMED plays a role, not just the OPTIMED module itself. If OPTIMED's 
capabilities become an issue, then a comprehensive comparison will be needed. 
 
5.3.4 The Review Provided by Krieger is incorrect.   
 
Paul Krieger, an expert in Patent and Trademark law (in a prior action relating to the ‘105 
patent), reviewed o.a. [Gardner:2000H], [Bleich:2000], and [Wellman:2000], as 
described in Section 5.9.  Singer considers that the Pritchard patent [Pritchard:1985]  (see 
Section 5.12) reveals the Bank-One system, so that Krieger's contention that Bank-One 
should have been presented to the examiner is moot.  However, the Bank-One is a 
system, which can incorporate indeed the Pritchard and other patents.  We are here 
comparing systems, and when Singer seeks comprehensiveness, all of a system, not just 
an embedded novelty must be presented.   
 
There is again the question of missing functions in the Bank-One system versus the 
comprehensive intent of the `105 patent. Again, the Bank-One system operated in settings 
where all needed functionality was present, and cannot be faulted for not including 
capabilities of a system that was never built. 
 
Singer observes that `adjudication' is not the same as utilization review, faulting the 
Bank-One brochure for incorrectly characterizing `utilization review', a quality control 
process that singer is well familiar with, and matches our definition (see Definition 3.9). 
Adjudication refers to the cost-effectiveness review process carried out at insurance 
companies (see Definition 3.10).  However, utilization review was known as an adjunct 
to adjudication in an insurance company. 
 
5.3.5 Singer insists that the `105 patent requires full automation. 
 
Singer makes a strong point that systems that use of any manual steps are not invalidating 
prior art.  That point is consistent, in fact necessary, given his work at Allcare around 
1990, where he did a study searching for prior art. As stated in [Conner:2000,  pp.35-38],   150
Singer, according to Conner: 
 
... looked in all of the places that he felt, at the beginning of our relationship, such 
prior art might exist, if it did, and was  satisfied that it didn't. 
Singer, a knowledgeable expert, is likely to have been aware at that time of the efforts he 
is dismissing, say those nearby at Beth Israel (see Section 4.4.3), at LDS, at Optimed (see 
Section 4.5.5), as well as well publicized efforts at Technicon (TDS) -- see Section 4.4.5, 
at the Harvard Health Plan – see Section 4.4.2, and at the many sites ([Wiederhold:1976]  
lists over 100 efforts already at that time). 
 
The holder of the `105 patent claims not to have been aware of any of them, [Cummings 
VI:2000, p.126-129], stating that he fully relied on Conner  to check for prior art:  
 
Q: (Patent office) "just did searches of patents, did not do searches of what vendor  
systems there were or what other hospitals were doing, what insurance companies 
were doing, did they  
A. My background and assumption on that was Bill (Conner) was with the 
managed care side.  
Q. So you were relying on Bill Conner for the expertise to determine whether or 
not this was novel; is that correct?  
A: I was relying upon Bill and the way he worked with the patent attorneys with 
John and Andy to do that. and  when Bill asked for a search to be done, I assumed 
it was a literature search, because a couple of searches were done. So I assumed it 
included the literature as well.  But Bill's knowledge of the HMO systems and so 
forth was far – he had been in the business, so his knowledge of that and the 
technology people he had and, you know, the fact that he had brought in a guy 
from, you know, the Tandy organization and his relationship with that and 
American Airlines and those folks, that's really where I saw the contribution and 
the expertise that I relied on".  pp.130. l. 2-24 
 
and 
 
  "My role was to focus on the invention" p.131  l. 18. 
 
It is a bit hard to accept that an inventor should be innocent of all prior art except of 
patents retrieved during patent examination.  Note that all those patents are also limited to 
fully automated systems, even though their scope is much more limited than the `105 
specification. 
 
 
 
5.3.6 Singer expects open communications. 
 
If patients are to communicate freely, as is the intent of the `105 specifications, an `open 
network' is required.  
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The (`105) system envisions an environment in which many of the entities in 
healthcare would be able to inter communicate, in a manner similar to how the 
Internet has evolved to a more open environment [Singer:2000, p. 6]. 
 
Because of the risks to patient privacy and financial integrity, few health care systems 
have implemented open networks. Given the state of communication when the patent was 
applied for it would indeed be hard to find any open network that would qualify. The 
Internet was not yet `open' in 1990.  Trigon does not operate an open network. I believe 
only the Healtheon approach qualifies by that criterion.  
 
5.3.7 Summary of Singer:2000 Report 
Singer bases his understanding on full automation of the comprehensive vision presented 
in the specification. The vision he presented in his 1989 work is similar to Cummings, 
but focuses on Utilization Management, i.e., the reduction of heath care costs, the central 
focus of his consulting career [Singer:1990]. He finds fault with all prior submitted art 
because they failed to support that vision fully. Comparing an existing system with a 
vision will always favor the vision.    
 
Of course,  TRIGON does not support the full `105 vision either, it only arranges for 
reimbursement of the delivery of episodic care. For instance, Singer observes that the 
system contemplated in `105 includes a reasonably complete history of the patient's 
medical and insurance history, matching our definition (see Definition 3.7).   But if that 
must be the case, then TRIGON cannot infringe on `105, since TRIGON only stores 
reimbursement claims that it received for reimbursement, and hence has only a 
reimbursement claims history (see Definition 3.8). 
 
5.4 Singer:2000 and 2002 Depositions, and 2002 Report. 
 
5.4.1 Singer 2000 Deposition [Siunger:2000D] 
 
Cummings and Conner indicate that in the 1989-1993 time frame Singer did a search for 
prior art.  Singer obviously focused on the specifications instead of on the narrower 
claims: 
 
to be honest with you, I looked at the claims  probably spent – those charts, and 
probably spent 5 to 10 minutes on them, and then decided that I would prefer the 
language of the patent directly. I found the charts sometimes a bit confusing, 
harder to read, than just reading it directly (p.140 l.3-9). 
 
5.4.2 Singer takes an alternative approach 
 
In [Singer:2002. pp. 75-77] a new interpretation of the patent is presented; 
Instead of  symptoms leading to treatments, treatment entry leads to alternative 
treatments, and symptoms are ignored: 
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  ... my interpretation of this is that the physician or the person providing the care is 
entering the proposed mode of treatment. Q: Okay. All right.  ....  You described your 
understanding of this section to mean that the physician would – actually proposes "This 
is what I'm going to do," and the system might respond by saying, `Well you might want 
to also do theses other things.'  That's what you mean right?  A: Right. Q: Okay. And then 
I'm asking you, that would be different from the physician simply putting in the 
symptoms, say the patient's got a fever, complaining of stomachache, and then the system 
suggesting a proposed mode of treatment for that? ... A:  If your question is, if the 
computer diagnosing and deciding what to do, those systems are again extremely rare 
with the following caveat. A lot of times the physician will make a diagnosis and decide 
`I want to do a knee arthoscopy' or I want to do whatever ' and system may come back, 
because it has access to the patient history, and say, `Oh, by the way, the person's allergic 
to this. Do you want to do this instead' or whatever. So the issues is, is that the physician 
taking the first initiative, but the system may still suggest treatment, may suggest even 
diagnosis, but the key is that the physician start the process by entering a proposed mode 
of treatment. 
  
This interpretation conflicts with the specification and the claims of the `105 patent.  It 
also conflicts with statements made earlier in his deposition that, albeit rarely, an expert 
system would translate symptoms to diagnoses  
[p. 73].    153
 
5.4.3 Singer 2002 Report. 
 
Charles Singer submitted a brief letter in support of the Allcare Action Vs. Trigon. 
It provides a sketch which purports to define the match of the `105 patent and TRIGON 
operations. It is at such a high level that it can equally well apply to much of the prior art 
and current systems. 
 
 
Figure 3.  Singer Sketch comparing the `105 patent with Trigon's systems 
 
This sketch does not identify the matching `105 elements, and differs greatly from the 
figure provided in that patent. It should differ even more, since Singer fails to provide a 
Terminal for the Internal Medical MGMT performing utilization review.  They also 
initiate manually telephonic contact with the provider to help adjudicate payments. But 
such linkages would be in conflict with Singer's view that the `105 patent represents a 
fully automated system.  
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Figure 4.  The overall structure of the `105 patent system (Figure 1.) 
 
5.5 Kaliski:2002 
 
Professor Kaliski, of Cal State San Luis Obispo brings his knowledge of Computer 
Science to bear on this health care system. 
  
5.5.1. Kaliski draws specific conclusions from a generalization.   
 
Kaliski recognizes that the system sketched in the specifications is a `Distributed 
System': 
 
A person of ordinary skill in computers would have understood in 1991 that a 
distributed processing system is characterized by a set of interacting computers or 
databases situated at different locations. In such an environment, entry of 
commands or data in one computer can and does impact the data processing 
and/or storage activity of other computers within the distributed system 
[Kaliski:2002,  p. 4].   
 
We agree with that observation. Distributed Systems have been known in Computer 
Science for many decades, the classic text is [Tanenbaum:1981].  
 
Distributed systems can have an infinity of configurations. The claims in `105 are much 
more limiting. As detailed in Claim1, specifies  input of a patient identification, and 
Claim 2 augments that with input of symptoms. No other source of information is 
specified, outside of medical history (see Section 1.4 and loading of databank tables,  all 
claim elements dealing with communication). [Kaliski:2002, p .. pp].  Kaliski opines that 
since the system specified in `105 is a Distributed System that all general aspects of 
Distributed Systems can be assigned to this patent, [Kaliski 2002D: p.124], 
 
A.   Well, remember, this is in general a  distributive computing environment so it's very 
hard to say where the input's being done, where the part that's supported all of these three 
functions is physically located relative to that.   
 
 including at the medical director's site [p.84] . That such a generalized system then might 
infringe in TRIGON's operational systems is an unwarranted extrapolation 
 
For instance, it is stated in [Kaliski:2002, p. 11] that it is natural to have a printer and 
keyboard at the Insurance Company's Medical Director's site, but nowhere in the 
specifications or in the `105 claims is such a device specified at that location. There are 
printer, display, and keyboard devices specified, but they are all located in physician's 
office.   Specifically: 
1.  Figure 1 of  `105 shows a printer and (sic) moniter as being attached to the 
processing system as units 13 and 14.  In column 4, lines 14-21 the printer (13)   156
and monitor (14) are described as being in the physician's office `to facilitate 
observation and review'. 
2.  Figure 3 of  ‘105 shows units 11a-c referring to a terminal, unit 66 to be a high 
resolution display, repeats unit 13 to be a printer generating reports 66a, 66b, 66c, 
and a unit 61a to be a personal or mainframe computer.’  These devices are 
further described in the distributed environment section of the specification, 
column 7 lines 46 to 69. It states there also that the files need not be resident in 
the physician's office, indicating that the other units will be placed within the 
physician's office.  This placement covers specifically the terminal 11a-11-c.  The 
paragraph continues (line 55) with the costly, hence 'optional high-resolution 
display is preferably locate in the Physicians office to permit real-time display and 
visual review of relevant data, test results an the like.’  The printer unit 13 was 
already described as being located in the physicians office above. 
3.  Claim 1(a) refers to an `input means', possibly a terminal for entering the patient's 
identification in the physician's office. 
4.  Claim 1(d) informs the physician through communication means, possibly via one 
of the terminals in his or her office, of suggested treatments and indicating those 
that may require utilization review. 
5.  Claim 2, dependent in Claim 1, also provides for communication of indicated 
ancillary services to the physician. 
6.  Claim 4(a) refers to input means for entering the patient's identification and for 
entering patient symptoms, also in the physician's office. 
7.  Claim 4(e) repeats Claim 1(d). 
8.  Claim 6 adds to 4(a) adds the requirement for entering predetermined items of 
medical history, also in the physician's office.   
9.  Claim 7 adds to Claim 4 that "said data input terminal is responsive to inputs there 
to enter into one of said data banks data severally identifying said predetermined 
plurality of persons", still in the physician's office.  Kaliski [Kaliski:2002, p. 13] 
states: "Although there is no reference to a “data input terminal” per se in Claim 
4, it is my opinion that a person of ordinary skill in the art of computer science 
reading Claims 7 and 12 would understand that the reference to said data input 
terminal is a reference to the input means of Claim 4(a)."  We agree. 
10. Claim 11 (not asserted in this case) adds that "said data input terminal includes 
provision for data entry from a magnetically-encoded medium." Since this card is 
carried by the patient, this claim reinforces our understanding that the terminal is 
located in the physician's office. 
11. Claim 12 adds that "said data input terminal includes provision for data entry 
from a manual keyboard"' still in the physician's office. 
12. Claims 16(a), 16(d), 21, 22, 26, and 27 repeat the terminal issues of Claims 4(a), 
1(d), 6, and 7, 11, and 12. 
13. Claim 17 repeats Claim 5. 
14. Claim 19(a) and 19(e)  repeat Claim 4(a) and 1(d) 
15. Claim 31 (not asserted in this case) specifies entry of employer-derived 
information into a terminal at an unspecified location, possibly at an employer,  
"for entering data identifying each of a predetermined plurality of persons being 
on a payroll of an organization".   157
16. Claim 32 (not asserted in this case) specifies two terminals, one, as above, "at the 
location of a medical services provider for entering data identifying each of a 
predetermined plurality of persons being on a payroll of an organization; a second 
data terminal at the location of said organization" for (e) "for producing at the 
location of said second data terminal indicia indicative thereof and for permitting 
authorization for the excess to be made by said organization."  An authorization 
for absorbing the excess of what an insurance company will allow as 
reimbursement for a claim is the responsibility of a medical services provider, as a 
Physician or a hospital.  
17. Claim 33 includes a terminal for identifying patient's subject to workman's 
compensation. No location is specified. Such data is normally obtained from the 
patient in the physician's office or a hospital's emergency room. 
18. Claim 34(a), 34(d), 36, 37, 42 and 43 repeat the terminal issues of claims 4(a), 
1(d), 6, and 7, 11, and 12. 
19. Claim 47 (not asserted) in (a) repeats the input means of Claim 1(a), includes (g) 
"symptom input means", similar to Claim 4(a), (h) responsiveness, as Claim 7, 
approval of charges, similar to Claim 32, (k) payroll deduction, (l) access to 
results of utilization review.  The physical therapy services to be supported by this 
`105 claim can be provided by physicians, hospitals, or other ancillary medical 
services providers, but not by an insurance company.   
20. Claims 52(a), 52(c), 52(d), and 53 repeat Claims 1(a) and 1(d), and 5. 
21. Claim 54 adds providing indications of desired preventive health routines for the 
patient to the physician. No device is specified, but it seems reasonable that it 
would be located in the physician's office. 
22. Claims 55 (a) and 55(b) repeat Claims 1(a), and 6.  Claim 55 also specifies means 
for loading the program database tables, possibly for the claims processor 
programs. It does not specify if a terminal is used for this function. Any terminals 
needed can be located at the physician's office, since the specifications allow the 
files to be located remotely  (see point 2 of this list above).   
23. Claims 57, 62, 63 continue Claim 55 by repeating Claims 6, 11, 12. 
24. Claim 65 (not asserted) continues Claim 55  and repeats 1(d). 
 
There is no indication in the specification or any of the claims of `105 that any printer, 
monitor, display, or keyboard equipment is available for review in the premises of the 
medical director of an insurance company. We hence must assume that the patent 
intended the process of payment of reimbursement claims adjudication to be fully 
automated. Indeed, Kaliski in [Kaliski:2002, p.13] agrees that "In terms of what structure 
in the `105 patent supports the function of the input of data per the claims in suit, the 
Joint Statement shows that the parties agree that the structure is a ‘physician office 
terminal.’ ” We also agree with his further exposition about terminals, and their 
development. [Kaliski:2002, pp 13-15]. 
 
The fact that Kaliski is able to design a system that would include such facilities at other 
locations than the physician's office is due to his expertise, not based on an interpretation 
of the `105 patent.   
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Using a terminal, Trigon employees can communicate with the Trigon system. 
[Kaliski:2002, footnote on p. 11]. 
 
Kaliski is clear when he says that: 
 
the medical director in the insurance company should also have a terminal. 
Because that's what you'd expect from a distributed system. 
 
We agree that this is a requirement for a realistic system, and also a feature of the accused 
system.  But that is based on our expertise. However, the explanation of the figures in the 
`105 patent has all the equipment in the provider physician's office [`105: c. 4 l. 4-21].  
 
Hence, the patent must assume full automation at an insurance company, since no 
terminal facilities are provided there, only an interconnection to their computer systems.  
The `105 patent is also moot about any processing steps that are performed there, and 
cites all of the functionality in a single claims element, as in:  
 
1(d) means in communication with said input means responsive to input of data 
through said input means symbolic of symptoms of one of said predetermined 
plurality of persons for tentatively identifying a proposed mode of treatment for 
said one of said predetermined plurality of persons and, when said proposed 
mode of treatment includes one of said predetermined procedures requiring 
utilization review, for producing indicia indicative thereof and for preventing 
payment therefor by said payment means until said utilization review has been 
obtained and data indicative thereof has been entered in said system.  
 
This statement would lead a `person steeped in the art of building computer systems' to 
consider that all tasks are to be performed within a single system, and not to distribute the 
tasks among two or more independent entities: the patient's physician and the insurance 
company.  In no way can this claim sentence be expanded to include manual review at 
the insurance company. 
 
By placing multiple actual process steps into a single claim element the patent de-
emphasizes the difficulty of the problem being addressed.  
   
5.5.2. Kaliski must redefine comprehensive.  
 
On pages 10-11, Kaliski, using the statement from the preamble in many of the claims,  
states that `105 is a `comprehensive system'. But he noted earlier "Nowhere in the 
specification is comprehensive defined to have anything other than its ordinary meaning 
(see Definition 3.12). However, in reviewing the specification and the claims of the ‘105 
patent, it is clear that the prior art lacked a system possessing the “total health care 
function, [`105: c.  l. 37] to provide truly comprehensive medical care.” [`105: c. 1  l. 
49] " [Kaliski:2002, p. 8]. Here comprehensiveness in systems claims of `105 and 
comprehensive medical care are intertwined. The vision of comprehensive health care 
existed long before the patent was applied for [Kostrzewski:1976] . But a vision, just   159
like flying to Mars, alone cannot be patented.  To deal with the inconsistencies 
[Kaliski:2002, pp. 9-10] observes:  
 
However, different levels of comprehensiveness and integration are illustrated 
within the requirements of the different claims themselves. 
 
 and that  
 
It is also apparent that the most complete and fully inclusive apparatus claim of 
the `105 patent is not described as a “comprehensive” system at all; rather, Claim 
47, which has 14 different elements reaching as near to the description of the 
patent specification’s preferred embodiment, is described in the preamble as an 
`integrated health care management system,' harkening back to the description of 
the preferred embodiment as featuring `the integrated interconnection and 
interaction of the patient, health care provider, bank or other financial institution, 
utilization reviewer/case management and employer so as to include within a 
single system each of the essential elements to provide patients with complete and 
comprehensive health care and payment therefor.' [Kaliski:2002, pp. 9-10]).   
 
Here the loose integration of such systems becomes clear, while Singer [Singer:2000] 
insists that it should be a single, i.e., tightly coupled system to qualify for the `105 patent 
(see Definition 3.22). Footnote 3 expands further on the limited comprehensiveness  
observed in the actual `105 claims.  Having to  
 
`harken(ing) back to the description of the preferred embodiment'  
 
to include capabilities not included in the claim is again an unwarranted extrapolation, 
especially since the specification is an all encompassing vision of health care services, 
not a description of a built or buildable system. 
 
5.5.3. Kaliski notices that a `smart system' is needed.   
 
Kaliski notices the discontinuity in the `105 claims and the fact that the specification 
indicates that a `smart system' is needed.  He [Kaliki:2002, pp. 4-7] lists instances where 
the patent requires a `smart system' and concludes that there must be `different kinds of 
smart systems'. He then uses his expertise to suggest various implementations for such a 
`smart system'.  Again, nowhere in the specifications or in the claims of the patent is the 
actual implementation of such a `smart system' specified.  It cannot have been clear to a 
person `versed in the art of computing in 1990' how such a smart system might be 
implemented.  The definition partially cited in support of the generality of the term reads 
in full [Kaliski:2002, exhibits section, page 348 from [Webster's 1988] ]:  
 
smart: Having some computational ability of its own. Smart devices usually 
contain their own microprocessor or microcomputers.  
 
This definition clearly refers to devices, not to entire data processing systems.    160
Subsequent entries cite "smart card", "smart machines", and "smart terminal" in that 
sense, but do not include `smart system'. We also noted that later editions 
[Websters:2000] no longer define "smart" as a distinct entry, but still contain the three 
examples of smart devices. Data processing systems always embody computational 
abilities, and by Kaliski's generous interpretation all computer systems would be smart 
systems; we know better.   
 
The patent applicant however uses the attributes associated with being `smart' to 
differentiate the system proposed in `105 from earlier systems [Cummings II:2000, p. 220 
l. 4-15], in the sense of being intelligent.  Note that the author of the `105 patent himself 
(see Section 5.1) describes a smart system as one possessing artificial intelligence (See 
3.17). 
 
means (physician office terminals) as follows: “any of various conventional 
methods for connecting the input means of claim element l(a) with the data bank 
memory. Such memory may be part of the terminal that provides the input means 
(such as physician file Fig. l(44) and discussion at 6:44-54) or part of one or more 
remote systems to which it may be connected in any of various distributed 
processing environments (14:53-54), and accessible to it by any number of 
conventional communication paths (Fig. 1 (1 2)) to the processing system (Fig. 1 
(1 0)), which is in turn connected to the database in question (represented by 
arrows to and from the databases linking Fig. 1 (1 0) to Fig. 1 (1 6-22, and 44)).” 
Thus, it is my opinion that the nature of the connection includes an input means 
connected to a processing system where the database in question resides. 
Regarding whether one of the databases in question includes an identification of 
predetermined procedures requiring utilization review, I have reviewed and am in 
agreement with the Expert Report of Dr. Holland, pp. 28-29, that certain of the 
databases that are used by 
 
Kaliski, by even considering that systems with business rules are smart [Kaliski:2002, p. 
7], in effect overturns the arguments made in [Cummings I:2000, p. 162 l. 4-14], that the 
`105 patent presented an advance in the state-of-the-art by being smart. Systems with 
business rules had been in use, including in health care reimbursement systems, for many 
years prior to the application of this patent [Wirtschafter and Mesel, in Alabama]. 
 
When referring to Trigon's implementation, however, Kaliski considers the methods 
being used `algorithms' [Kaliski:2002, p. 50], a term that is used to distinguish common 
computing methods from smart systems (see Definitions 3.15 and 3.16).      
 
5.5.4. Kaliski does not distinguish Symptoms from Diagnoses.  
 
For the interpretation of these medical terms he relies on Holland, specifically pages 33-
44, and 35-40 (at [Kalinski:2002, p.18, and footnote 18 on page 32].   While Kaliski 
states throughout [Kaliski:2002. pp.18 - twice, 19, 20, 32 -- twice, 34, -- thrice, 35, 36, 
38, 39-40, 40 - twice, 50,] that he agrees with [Holland:2002], he cannot do so with 
authority. [Kalisky:2002, p.87].   161
 
Maternity is a condition, and recognizing that condition conveys information 
[Kaliski:2002, pp. 34-35, p. 38 . Holland:2002 pp. 8-9, pp. 41-42], and shown as an 
alternative to surgical and medical intervention, and neither a symptom of disease nor a 
diagnosis.  The condition of maternity is misused in [Kaliski:2002: p. 34, p. 38] to 
explain the possible workings of the `105 patent, variously as an example of a symptom 
and as an example of a disease.  
 
5.5.5 Only Claims data are available to Trigon.   
 
Kaliski recognizes that the medical history in most claims in `105 (see Definition 3.7) 
must come from the database, and that the TRIGON database only contains 
reimbursement claim information, and as such is what we define to be a reimbursement 
claims history (see Definition 3.8) [Kaliski:2002, p. 47].  Kaliski cites [Holland:2002] in 
arriving at his definition of a medical history. 
 
5.6 Holland:2002 Report 
Stephen Holland is a physician by training and has experience in health care 
management. Dr. Holland specializes in Long Term Care Underwriting Criteria and 
Underwriting Processes. 
 
5.6.1 Medical History. 
 
Holland cites Allcare's definition of "Medical History" from the Internet.  He also 
provides the description of medical history from a well recognized textbook -- a `learned 
treatise' [Noble:2001]  [Holland:2002, pp. 29-30]. These two definitions are conceptually 
similar, and match our simpler definition (see Definition 3.7).  
 
Prior to those citations Holland opines that medical histories are stored in some of the 
databanks memories at TRIGON, and:  
 
that each of these databank memories is accessible on the automated health care 
management system that is used by TRIGON [Holland:2002, p. 22].  
 
This reasoning is continued on page 31, and Holland states that:  
 
TRIGON has elected in advance to store “predetermined items of medical 
history,” in a database.   
 
That reasoning may make medical sense, but in practice TRIGON has no control over 
what items of a medical history it can obtain.  TRIGON only receives information 
relevant to reimbursement and hence can only collect a limited reimbursement claims 
history (see Definition 3.8). While Holland has found references in TRIGON'S systems 
that refer to a `Medical History', this is an insurance carrier's misuse of the term, since the 
items displayed are limited to the reimbursement claims history. If information from a   162
proper medical history is needed for reimbursement claims adjudication in the TRIMID 
portion of TRIGON, the medical officer must contact the provider's office by telephone. 
 
TRIGON does archive its reimbursement claim history and keeps it available for 
subsequent statistical analysis relevant to aggregate cost management.  The insurance 
company's auditors and actuaries are the primary users of the system.   
 
5.6.2 Symptoms are mischaracterized. 
 
While Holland cites a `learned treatise' for Medical History, no equivalent definition is 
provided for the critical term "Symptom" (see Definition 3.1). Instead Holland uses as 
examples citations from “The Wisconsin Upper Respiratory Symptom Survey 
(WURSS)” [Barrett:2002]. This study was unique in that it did not try to determine a 
diagnosis nor provide treatment.  Half of the study subjects had the flu, and the objective 
of the study was to test what Barrett termed an "illness-specific quality of life 
instrument." i.e. a measure of discomfort due to flu or the proximity to people having flu 
symptoms. This study was so unique that it actually found its way into the 11 March 
2002 New Yorker Magazine [not cited].  Using this quality-of-life study as a basis for 
equating symptoms with diagnoses is an imaginative stretch that is inappropriate to costly 
issues in the practice of health care. 
 
We encoded the terms claimed by [Holland:2002, pp. 37-39 ] to be symptoms that are 
used for diagnosis in Appendix 7, and find that all of them require elaboration by a 
clinician. None of these terms given would be approved for claims reimbursement unless 
accompanied by a proper diagnosis.  There are indeed some symptoms that are 
pathognomonic and are members of both the symptom and diagnostic class (see 
Definition 3.1). But no realistic system could restrict itself to such diseases, which likely 
comprise less than 5% of the healthcare expenditures we incur.    
 
5.7  Holland's 2002 Deposition 
In his deposition [Holland:2002D] provides his view of the TRIGON systems [pp. 54-55] 
as depicted by his sketch.   163
 
 
Holland does not consider himself an expert in reading patents, and focuses on the 
concepts presented in the specification. He also assumes throughout that the patent is   164
valid, and uses his health care expertise to mold the vision presented in the `105 patent 
into structures that are realistic and feasible. 
 
I understood the concepts pretty easily. The language of the patent is language I'm 
not familiar with and so it did -- I had to understand how claims were laid out, I 
had to understand the concepts of background and the embodiment. These are just 
not concepts I deal with every day, so it was very interesting. [p. 28 Lines 10-17] 
 
 
Since the specification describes a vision, a vision some medical experts will find very 
sympathetic, the weaknesses in the patent are minimized. Holland describes the business 
rules well that precede human adjudication of any claim that might be denied at Trigon 
(See Section 2.2.2.6 on Trimed). 
 
Business rules. Those business rules may be related at the highest level, whether 
this is an eligible patient or not, is the person a member of Trigon Blue 
Cross/Blue Shield, for instance.  The eligibility level it may say, determining 
whether the insurance is in force at the time the bill was generated, the service 
was provided. Other business rules may apply, is this a coverage service, so there 
are business rules that are based on the benefit plan that this eligible member then 
has purchased and that benefit plan, those business rules, whether perhaps a 
liposuction is called cosmetic and that procedure and that is not covered, a 
covered service, those sorts of benefit-based business rules. There will be other 
business rules on the provider, what is the provider and what fee schedule or what 
type of payments should they get for the service. If it's a certain type of service 
such as a referral or in-patient admission, one of those business rules would be to 
check for pre-authorization or pre-certification, yes or no, is it there and is it a 
legitimate code perhaps.  That is another business rule.  Finally, at the end of this 
adjudicatory process and in each one of those things is the diagnosis correct and 
acceptable, is it valid, there will be validity edits as well as business rules apply.  
And if everything is correct and payment can be made, then there'll be further 
business rules, such as are there any co-pays or deductibles that the patient is 
responsible for, and at that moment that everything has been applied and 
everything has gone correctly through -- and I believe that Trigon calls that a 
clean claim, meaning that all the business rules have been met, that has been 
automatically adjudicated, it is ready for payment. [p. 62 Lines 1-22, p. 63 Lines 
1-21]   
 
But the important aspect, that human medical directors, possibly informed during 
telephonic conversations with the patient's provider, are required to perform the steps that 
cannot be automated, is ignored. Moving to the actual patent: 
 
I described the adjudication that was going on here within the diagram.  The '105 
patent speaks to adjudication. It teaches to it in Column 13, Lines 31, 32, so 
Figure 8 is really the, shows in box, I believe, 202 the act of adjudication 
procedure, that the patent itself speaks of a variety of claims processing systems   165
in its background and assumes that there'll be various methods and means of 
adjudication. In the patent itself in Column 13, Line 32 talks about the 
adjudication procedures activated as notated on Rectangle 202, so within that 
there are business rules. It isn't really specific about what those business rules are, 
but really it was intending to say that they're part of this comprehensive healthcare 
system, could be a variety of claims payment systems that adjudicative 
procedures. 
 
Q. And still on Figure 8, is the Box 201 or claim codes accurate part of the 
adjudicative procedure? 
A. Yes. Those are usually validity checks. 
[p. 66 Lines 2-22, p. 67 Lines 1-3] 
 
Holland's insight of what a comprehensive health care system should contain has 
expanded the `105 patents visionary elements in Figure 8 with his beliefs and 
assumptions, rather than restricting them to the claims. 
 
When the patent mentions symptoms, Holland automatically assumes that diagnosis is 
intended, because that is the only thing that makes sense to him. 
 
A. The process of utilization review in the patent is shown in Figure 6, Boxes 127, 
128 and really is sort of embodied in 5-C of the patent. The data is entered into 
the system. The system data is symbolic of symptoms and tentatively identified a 
proposed treatment such as admitting the patient to the hospital for pneumonia. [p. 
69 Lines 20-22, p. 70 Lines 1-6]. 
 
Pneumonia is clearly a diagnosis, see the second table in Appendix 7.1. Symptoms that 
the patient presented may have included a cough, coughing up stuff, fever, sweats, chills, 
plugged ears, or chest congestion, see the first table in Appendix 7.1. It is the physician's 
role to establish a diagnosis from the presented symptoms and other signs, say the results 
of a sputum test. Then convert them to a diagnosis. Since the `105 patent proposes `smart' 
and `expert systems'  (see Section 1.1) it also recognized that a process step was required 
to convert one from the other. Since Holland does not know of any systems that can 
perform diagnosis automatically, he is forced to continue with that confusion. 
 
The ICD-9 code becomes the symbolic code of symptoms, maybe cough, fever, 
hemotatis(sic), which is bleeding from the lung. [p. 70 Lines 6-9] 
 
Cough is a symptom, fever is a sign implicating a host of possible diseases and clearly 
not a diagnosis that a physician would submit to obtain reimbursement, while Hemostatis 
is indeed a diagnosis, requiring interaction with the patient to determine the source of the 
blood produced.  Later similar mixed terminology arises at: 
 
Q. How is the proposed mode of treatment arrived at? 
A. The practice -- the system is designed for a physician to be able to enter that 
information in. The proposed mode of treatment may be a -- the diagnosis code   166
may be angina, which is a symptom, chest pain. The procedure code may be 
coronary artery bypass graft, which is a proposed treatment. [p.140 Lines 8-17] 
 
and later  
 
If it's a surgery or upper quadrant pain, a symptom, a procedure called a 
cystectomy, that procedure will be in the predetermined procedure requiring 
utilization review which will then pend and produce indicia indicative thereof. 
Q. So the provider must enter data symbolic of the procedure? 
A. Symptoms and procedure, yes.  The ICD-9 codes are -- yes. 
[p. 163 Lines 16-22, p. 164 Lines 1-3] 
 
When having to deal directly with the definitions no clarification ensues: 
 
A. Yes. There would be -- there would be, the vast majority of them would be 
symptom codes. There could be some purely diagnostic codes that could imply 
symptoms. Obviously, chronic cholecystitis is a disease but it's also a symptom.  
 
Few patients would so presumptuous to present the term `cholecystitis' as a symptom of 
their illness to their doctor.  See Appendix C if you wish to use it.  
 
There are symptoms associated with or symbolic of that, of right upper quadrant 
pain, fever, nausea and vomiting.  Internal derangement of the knee is a diagnosis 
but it has all sorts of symptoms associated with it, swelling, clicking, 
immobilization, pain. 
Note that none, nor all of those symptoms is adequate for the diagnosis. 
Q. That sounds to me like those symptoms were different than the diagnosis. 
A. No, they are the diagnosis.  They are synonymous with the diagnosis even 
though they're also in and of themselves ICD-9 codes for pain, for vomiting, for 
effusion, knee effusion. 
 
See Appendix C for encodings of symptoms. 
 
Q. Well, how do you define a symptom? 
A. A symptom is any state other than normal. 
 
No, that's an illness.  See Section 3.1 for the correct definition of symptom. 
 
Q. And how do you define a sign? 
A. Something I see or feel other than normal. 
Q. That's a medical definition? 
A. Yes.  Sign is something that you see or feel. 
 
No, that's a symptom.  See Section 3.2 for the correct definition of sign. 
 
Q. How do you define a diagnosis? 
A. Pathological condition other than normal.  I guess that's redundant, 
pathological condition.  Sorry.    167
[p. 174 Lines 11-22, p. 175 Lines 1-18] 
 
We show definitions and ICD-9 encoding of these terms in Appendices B and C, and note 
again that the terms used here are a mix of symptoms and diagnosis.   None of them are 
pathognomonic. 
 
In other testimony we find shortcuts. 
 
If it's a maternity request, request for maternity admission, information is put into 
the system after the patient is identified and patient admission for maternity is 
requested.  Data symbolic of the patient. [p. 71 Lines 7-12] 
 
An initial report of maternity does not lead to hospital admission, until delivery or if 
complications arise.  The speaker realizes that: 
 
If it's a normal delivery for maternity, it's going to have an ICD-9 code for labor, a 
symptom and normal delivery procedure. [p. 163 Lines 13-15] 
 
Maternity is actually not a symptom, sign, nor a disease; it is a condition that does have 
many medical implications, including provision of supportive medical services. It has 
been assigned many ICD-9 codes (see the second table in Appendix C). Even here 
clinical expertise comes into play, to determine date of conception, likelihood of 
complications due to personal and familial history, and the success of previous births.  
Approval of specific treatments will require specific diagnosis codes (ICD-9), attached to 
the maternity condition.    
 
How the `105 process is stated remains unclear in Holland's understanding 
 
Q: ... data symbolic of patient symptoms for tentatively identifying a proposed 
mode of treatment when, as I understand your explanation, the entry of the 
patient's symptoms and the proposed mode of treatment was by the doctor and the 
entry of the patient's symptoms was not for the purpose of tentatively identifying 
a proposed mode of treatment 
A.  Oh, it absolutely is.  The proposed mode of treatment is hospitalization or, as 
in a referral, it's a referral to another specialist for care. That is what I consider 
proposed treatment, so it is absolutely proposed treatment. [p. 143 Lines 1-15] 
 
As a physician, Holland just can't see that input of patient symptoms could ever work. 
Cummings, who is a marketing oriented inventor, having read a bit about expert systems 
can assign this task as a Miracle to a computer.  And a real-estate specialist, helping him 
define the patent language, Conner, certainly can.  But here, Holland's expertise forced 
him to an extrapolation not warranted by the text of the `105 patent. 
 
What I'm saying is that the doctors entering some data symbolic of a patient's 
symptom and as a means leading to a proposed treatment, i.e. hospitalization, 
surgical procedure, a delivery in the case of maternity or a referral to a specialist 
in the case of the pre-authorization system, and that proposed treatment is based   168
on the data symbolic of a patient's symptoms. And that based on that information 
is what is actually reviewed or criteria are applied to that by the Trigon system 
automatically and at times will either give an authorization the indicia indicative 
thereof producing a decision or producing a pend, meaning that it can't be decided 
and, therefore, has to go off for medical review. If you don't put that data in, it 
will not do anything, it will not produce a decision. 
Q. You don't think that the use of the word "for" implies a cause and effect in that 
clause? 
A. No, no. 
Q. Why doesn't the claim just say entering both data symbolic of symptoms and a 
proposed mode of treatment? 
MR. HILL:  Objection to the extent it calls for speculation. 
A. I didn't write the patent.  I don't know.  I just think that one leads to -- you 
know, I might put gas in my car so I can go for this task or that, but whether I do 
that or not is not a cause and effect. It basically means leading to or corresponding 
to. That's how I interpret that.  [p. 144 Lines 3-22, p.145 Lines 1-16] 
 
Now it becomes obvious that something miraculous is needed: 
 
Isn't it true that the patent describes a smart system which does operate in the 
cause-and-effect mode as set forth in this limitation 55-D? 
A. It does definitely describe the smart system, as a system with criteria rules, but 
that, I believe, is separate from the statement earlier of what the physician does.  
The physician is, has certain requirements and has to put in going to the system, 
select an in-patient admission or in-patient surgical procedure, put in data 
symbolic of patient's symptoms as a means of identifying a proposed mode of 
treatment which then goes against the smart system for a cause and effect, you 
know, that leads to a cause and effect of saying providing authorization or pend.  
That is how utilization review works.  It's criteria-based, putting in information, 
that information is evaluated and a decision that indicia indicative is provided 
back to the physician.  That is the basis of utilization review. [p. 145 Lines 17-20, 
p. 146 Lines 1-17] 
 
This is really not pre-certification.  This paragraph, to my opinion and my 
knowledge, does not speak to 52-C but, rather, 64, 65 and 66.  This is sort of a 
diagnosis assistance type system.  It's not pre-certification. It's a system that's 
designed to assist the physician in making a diagnosis and using patterns of 
treatment protocols, not currently in the pre-certification system of Trigon.  [p. 
147 Lines 7-16] 
 
Holland now assigns the hard tasks to the provider, not to the accused system at Trigon. 
 
This system is supposed to help the physician, assist the physician in correlating 
the observed patient's symptoms and test results to help identify the cause, so this 
really is not being addressed by 52-C. This is really what is described in Claims 
64, 65 and 66. It's an assistive device for making of diagnosis and treatment 
planning. I envision this was envisioned to be some sort of a program that would   169
help doctors make diagnoses and this is not what 52-C refers to, in my opinion. 
[p. 147 Lines 17-22, p.148 Lines 1-6] 
 
... most appropriate treatment protocols. 
A. This is not pre-certification. It's not referral management.  This is something 
very different. I think it's important that we draw a distinction. This is a diagnosis 
assistance device. There are programs outside like Ovid and things that physicians 
use to help them make a diagnosis where you put in symptoms and you're getting 
back potential diagnoses, and then maybe you should use this drug or that drug or 
this test or this test. This is not what is envisioned in 55-D. This is really what was 
envisioned in 64, 65 and 66.  [p. 149 Lines 17-22, p. 150 Lines 1-8] 
 
Maybe the mechanism of inputting data is similar between the two, but the 
outcomes, the output and all the other things inside is not 55-D. I'm passionate 
about that because this is not pre-certification, which I believe <claim> 55-D 
speaks to the utilization management. This is diagnosis assistance. This performs 
doc in a box. [p. 151 Lines 4-11] 
    
The manual steps currently performed in the adjudication process to bridge the gap are 
again ignored. See Definition 3.18 for the term `doc-in-a-box'. 
 
Holland also employs his expertise in interpreting other portions of the patent: 
 
A. The background Column 1, Line 36, talking about the total healthcare system, 
they talk about the review of the necessity of implementing selected procedures. 
They then provide some, including lifestyles, the obtaining of second opinions, 
utilization review and case management and other functions contemplated by total 
health management such as ancillary services.  So in a sense, the patent is 
teaching that utilization review is the review of the necessity for implementing 
selected procedures. 
Q. So then, according to this passage, ancillary services is not included in 
utilization review; is that correct? 
A. No. It says "and other functions contemplated."  So I took that to mean that 
that would be part of utilization review because ancillary services are, in large 
part can be considered procedures or treatments.  [p. 73 Lines 2-22, p. 74 Line 1] 
 
and later 
 
Q. But it doesn't say anywhere in here that optional pre-certification is utilization 
review, correct? 
A. No, but in 1990 and today, pre-certification is commonly a component of 
utilization review. 
Q. But that's not set forth here in this patent, correct? 
A. I interpret it to be so, but that's my interpretation. 
Q. On the basis of the paragraph Column 1, Line 36? 
A. Yes. 
Q. But that doesn't refer to pre-certifications, does it?   170
A. What?  Excuse me again. 
Q. The paragraph that starts on Column 1, Line 36. 
A.  Yeah, that is, it's the review of the necessity for implementing a selected 
procedure is pre-certification. That is the definition of pre-certification, is the 
review of necessity for a procedure. That is commonly held. If you ask somebody 
what is pre-certification, they're going to say reviewing the necessity of a selected 
procedure. That procedure could be an admission to the hospital, could be a 
referral, it could be a referral to a specialist. [p. 75 Lines 4-22, p. 76 Lines 1-11] 
 
Holland's expertise expands on what the patent teaches. It does match what is required in 
practice and performed at TRIGON.  He is well versed on the origins and use of rules that 
aid a company as TRIGON in approving treatments automatically, and so lessening the 
load on Trigon' medical experts, and on the providers that must respond to telephone calls 
from Trigon's medical directors when unresolved reimbursement requests arise.  
 
Holland makes reference to a component system that performs that function, and makes 
clear the difference between medical utilization review (See Definition 3.9) and the cost-
effectiveness review carried out at insurance companies such as Trigon (See Definition 
3.10). 
 
Q. So under your definition of "system," was the AMS and the claims processing 
system together one system? 
A. Yes. They were separate entities that came together to produce a system, yes.  I 
wouldn't call it a comprehensive healthcare management system, but I would call 
it a system, a claims payment system. You could call it a smart claims payment 
system. 
Q. And did that smart claims payment system perform utilization review? 
A. It performed a form of utilization review. To a claims manager, what it did, i.e. 
claim edits that were attempting to look for inappropriate care, inappropriate 
claims, redundant claims, that is a form of utilization review in a claims 
environment. But a medical manager, i.e., a physician, a medical director or a 
nurse working in the medical management department of health care, of a 
healthcare, health plan, would not consider that utilization review, so you have to 
understand that terms were used interchangeably and some were embraced by 
different departments.  But utilization review could mean a claims edit.  It could 
mean some of the adjudicatory processes.  It would be called a retrospective claim 
edit because it's a post-claim.  There's pre-payment and post-payment, but those 
were considered in those days a form of utilization review. I don't think today 
they would be considered that. Moreover, however, that term "utilization review" 
was quickly applied in 1985 to pre-certification, concurrent review and discharge 
planning and that started around 1985, although it started in more nascent ways in 
the Medicare or Medicaid populations a few years before that. But one of the very 
first utilization review programs was Private Healthcare Systems and that first 
started in 1985 here in Dedham, Massachusetts, and they would say the pre-
certification and definitely pre-certification, concurrent review and discharge 
planning were all part of utilization review. [p. 101 Lines 21-22, p. 102 Lines 1-
22, p. 103 Lines 1-22, p. 104 Lines 1-2]   171
 
Holland' had expressed his views.  He was associated with OptiMed.  But all of this 
information goes way beyond what the patent teaches. 
 
The components were prior art, and the question now arises if the `105 patent requires 
their tight integration (see Definition. 3.22  for integration) or a looser distribution. 
 
If the requirement of `105 is a single, tightly coupled system  
 
include within a single system each of the essential participants to provide 
patients with complete and comprehensive pre-treatment, treatment and post-
treatment health care and predetermined financial support therefor. [`105: 
abstract]  
 
then the prior art cited by Holland is indeed a mere subset. This interpretation makes 
TRIGON, not being tightly integrated, but having many components, some operated by 
other organizations according to their rules, (for example the accused subsystems  
Bon Secours Health Systems, Columbia/HCA, and Provider-based Practice Management 
Systems) not a system that infringes. 
 
If the `105 patent is not that strictly interpreted, considering statements as: 
 
It is still another object of the invention to provide an integrated health care 
management system including interactive participation with patients' employers 
and banks. [`105: c. 2 l. 11-14] 
 
or following Kaliski's [Kaliski:2002] reasoning (See Section 5.5), then a wide collection 
of actually integrated and integratable prior art  should be included.  If the patent would 
still be valid, then TRIGON as of today might be an infringer, but TRIGON's 
predecessors might be valid prior art. This argument excludes the execution of the 
miracle (see Section 1.1), which Holland cannot perceive, because he is steeped in actual, 
realized, and operating components of Health care reimbursement systems 
. 
Those systems, at the time relied also on manual communications: 
 
[p. 105 Lines 1-22, p. 106 Lines 1-2] 
planning module. In 1993 or '94, a referral management module was added to the 
system. 
Q. But the other components were present in 1990? 
A. Yes. They were actually present in 1985,  '86. 
Q. When you say -- 
A. It was a product owned by the Health Data Institute and in 1990 the Health 
Data Institute was broken up and sold by the parent company, Baxter, and myself 
and two friends bought the Optimed Medical Systems. 
Q. And you say it was a phone-based system?   172
A. Yes. It was made for nurses that sat at a terminal and read questions off the 
screen and doctors would call in and they would talk to the doctor and their staff, 
answer questions and then would produce a decision to pre-authorize, assign a 
length of stay. 
Q. What was the typical response time for that type of thing to happen? 
A. Typical phone call? 
Q. Yes. 
A. It was five to 12 minutes. 
 
In summary, Holland is an expert trying to make sense of the patent, often by glossing 
over issues that would be problems for someone who has to rely on the patent to 
understand what is intended. We cite an example of the attitude:   
 
[p. 209 Lines 10-19] 
A. In this, I believe -- excuse me.  In my opinion, preventing payment therefore is 
based on the fact that something required utilization review, produced an indicia 
indicative thereof, meaning a pend status until said utilization review has been 
obtained, and data indicative thereof has been entered into the system, thereby 
allowing payment to go through. That's the way I read it. How else could you read 
it? 
 
We learn much from this deposition.  When the expert becomes merely confused, we find 
serious problems.  Maybe we could repair the `105 patent problems as well, but that is 
not our task here.   173
5.8  Expert Reports by Kurtyka,  
 
5.8.1   Bank One System  [Kurtyka:2000]. 
Gerald Kurtyka provided an extensive description of the background and functionality of 
the Bank One system (occasionally cited as the Banc One System), early interactions 
with allcare principals, and the actual implementation of some of the envisaged 
functionality at a site in Wisconsin [Kurtyka:2000].  He entered the field from a banking 
background, so that payment management aspects of the system developed at Bank One 
under his guidance are particularly strong.  Health care input was mainly through relevant 
banking customer interaction, including large employers with concerns about managing 
their growing healthcare expenses. The concepts were developed in the 1988-1989 
period. Technical support was provided by a Services Corporation, associated with Bank 
One, including a Mr. Lyons, who participated in some of the subsequent meetings. The 
documentation, generated in 1989, presages all of the claimed functionality of the `105 
patent, with the exception for course of expert systems capability and entry of Symptoms 
[BankOne:1989].  The bank functions as a central clearing house, and electronic linkages 
are to be provided to providers and hospitals, insurance companies, employers, and 
patients for copayments. In the Bank One systems Diagnosis codes (ICD) are to be 
entered by the providers, as well as treatment codes (CPT) and eventually drug codes for 
prescriptions.    
Utilization review is to be performed by the insurance companies or equivalent payers. 
 
The Bank One system was shown to Cummings at an AHA meeting in May 1990, where 
"Mr. Cummings was very excited and stated "I've been working on exactly the 
same thing!".   
Kurtyka met Cummings and Conner subsequently a number of times. Kurtyka discussed 
implementation at Florida Hospital where Mr Cummings was employed hoping for an 
implemetation there of the Bank One system. Kurtyka visited Cummings at Florida 
Hospital on several occasions.  Mr. Cummings always represented himself as an 
employee of Florida Hospital and to be acting in his capacity as an officer of Florida 
Hospital.  Kurtya was puzzled by Conner's role and Conner's request to sign a non-
disclosure agreement with Allcare.  Since the Bank One documents we have seen 
preceded those meetings there was no information flow from Allcare to Bank One. 
 
Kurtyka publicized and shared the information about Bank One's Medical Payment 
System freely at meetings in his quest to find customers for AllCare..  
  
5.8.2  Kurtyka 2002 Deposition [Kurtyka:2002] 
A second deposition, in November 2002, largely validated the earlier deposition, 
although Kurtyka here stated that Cummings' vision largely overlapped the Bank One 
approach, but included additional medical capabilities. Kurtyka considers the 
specifications as part of the patent, even when not substantiated by any of the claims 
(p.176, 177). For instance, the Bank One system itself does not do adjudication, while the 
`105 system specifies that function.  However, when `seen from the 50 000 foot level' the 
systems that include Bank One as front end does match the `105 patent.  Kurtyka clearly   174
understands that financial responsibilities in health care financing are and should be 
partitioned over distinct organizations.  
  
When reviewing Trigon he opines clearly that Trigon is a payment system, and not a 
comprehensive health care systems as defined in the `105 patent specification. 
 
 
5.8.3 Trigon System Architecture.  
Figure 1 of [Kurtyka:2002] (presented in Section 2.1 of this report)  summarizes the 
TRIGON system. The label of this figure is "Trigon Medical Payments System". It is 
interesting that the figure omits showing terminals for the Medical Directors of TRIMED, 
the TRIGON module for reimbursement claim payment adjudication.  It appear that since 
the `105 patent omitted such terminals, it was convenient to forget about their existence 
in TRIGON. 
 
5.9 Barber et al., patent 4858121 August, 1989. 
 
This `121 patent shows a great deal of overlap with the Allcare patent. Some initial 
figures are nearly identical. It appears to represent an actual implemented system, by the 
Assignee, MPS.  The intent of this patent seems indeed to protect existing intellectual 
property. 
 
The `121 system is a payment system, focusing on patient insurance and treatment 
information. It does not require entry of symptoms for automation of the claims process. 
When required for a claim, the diagnostic codes and treatment codes are entered. The 
system collects the information and verifies eligibility. It does not carry out utilization 
review nor cost-effectiveness reviews, but forwards verified information to the actual 
insurance carriers for further processing.   
 
The patent is well described, and a person conversant with state of the art in 
communicating financial systems would be able to create functional systems from the 
specification. 
  
The operations described in `121 are quite similar to the operations of the front-end of the 
TRIGON system.  
 
The patent distinguishes itself from the `105 patent by its intent, realism, and 
specificness. 
5.10 Watanabe, patent 4797543 January, 1989. 
 
The `543 patent describes a 'smart card' containing a processor and memory. It is an 
important aspect of some claims of the Cummings `105 patent system, but not of any that 
Allcare is asserting versus TRIGON. It is also relevant to the Barber `121 patent. 
   175
5.11 Pritchard, patent 4491725 January, 1985. 
 
The `725 patent teaches the use of a 'smart card', as invented in `543, to verify medical 
insurance eligibility. It is conceptually a subset of the Barber `121 patent.  It is not 
relevant to this case since Allcare is not asserting any claims involving smart cards versus 
TRIGON.   It is significant only to the extent that this technology was incorporated in the 
Bank-One System (see 4.5.1), and the related argument by [Singer:2000, p.12] (see 
Section  5.3).  
 
5.12 Valentino, patent 4648037 March, 1987. 
 
The `037 patent describes remote access for employees to their insurance and other 
information. It focuses on the operation of central terminals, kept available to all 
employees for that purpose.  The security code - password - is the employees Social 
Security Number! The patent predates the ubiquity of terminals. It is not very relevant to 
the modern world or to the `105 patent. 
 
5.13 Doyle, Jr. et al., patent 4916611 April 1990. 
 
The `611 patent expands on Pritchard's `725 patent by including more up-to-date records 
and including the coverage rules of the CORBA legislation.  Since it also relies on a card 
for patient identification it is not relevant to this case since Allcare is not asserting any 
claims involving smart cards versus TRIGON.  
 
5.14 Deschenes et al., patent 3697693 October, 1972. 
 
The `693 patent describes a mechanical terminal for reading credit card and amount-to-be 
charged information, as well as a system which receives that information in real time and 
provides an authorized or reject response. It is not relevant to the `105 patent or the 
TRIGON systems. 
 
5.15 Mohlenbrock et al., patent 5018067 May, 1991. 
 
The `067 patent teaches the use of diagnostic codes (ICD), combined with some patient 
information as sex and age, in order to predict items of concern in costing of medical 
care, as length of stay in a hospital and other resources. It warns providers when resource 
use exceeds or fails to meet expectation significantly, in that sense providing some 
utilization review.  
 
The prediction is based on an extensive analysis over many pages. It factors in the 
problem of having multiple diagnoses for a patient by simply counting them, and admits   176
it cannot provide as good a prediction when the situations gets that complex. To 
maximize benefits to a hospital, it groups diagnoses into the diagnostic DRG groups that 
are used for government-supported reimbursement. 
 
Of note to the `105 patent are: 
 1. No 'smart system' is used, but rather statistics, and the limitation of statistical based 
prediction is well understood. 
 2. The starting point is diagnoses, not symptoms as in `105. 
 3. There is no attempt to predict required treatments, only aggregate factors as length of 
stay and total resource consumption.   
 
If a `105 system would ever be implemented some of its features would likely be 
modified, as implied by [Holland:2002] and [Kalinski:2002].  In that case, such an 
implementation might infringe on this `067 patent. 
5.16 Sinay 4290114 September, 1981. 
 
The `114 patent teaches how to use symptoms and signs encountered by a paramedic in 
order to provide a list of appropriate treatments and a diagnoses. A simple look-up 
program is described. I believe that this patent is naïve and would not be used in practice. 
Its use could create grave risks to patients, even though the setting where it is deemed 
applicable is when no qualified physicians are available. A demonstration of a table 
lookup for a few simple cases is not adequate to prove its generality.  Note that I could 
not access the images.  
 
The patent does define diagnosis in a responsible manner: As used below, diagnosis 
means the determination of the patient's malady based on an evaluation of a set of 
symptoms and findings.  
 
The proposed setting differs from the one contemplated in the `105 patent and the actual 
one at TRIGON. If a system as this would have reached operational state, it could be an 
argument that the methods needed for the `105 patent are feasible. It could also have 
saved much money for the U.S. government, which has, and continues to, spend many 
millions in improving the diagnostic processes in medicine. 
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Appendices 
There are currently 4 appendices: 
A.  My vitae and a reduced biography (submitted separately) 
B.  Symptoms Misused as Diagnoses in Plaintiff Testimony  
C.  Definitions of Medical Terms used in the report and in relevant testimonies 
D.  Claims clusters to structure the `105 patent   186
Appendix A. Gio Wiederhold's CV (attached) 
Appendix B. Symptoms Misused as Diagnoses in Plaintiff Testimony  
In this appendix we list 32 terms cited by [Holland:2002] in his argument that equates 
symptoms to diagnoses. Only Diagnoses, encoded by an ICD-9-CM code are admissible 
in the TRIGON system for reimbursement, while the `105 patent is based on entry of 
symptoms. ICD-9-CM is the most current version of ICD-9 and includes many additions 
since ICD-9 was introduced about 20 years earlier. We hence list for each of those 32 
terms the ICD-9 code or "none", as determined by a professional coder, Pat Russo, for 
reimbursement health claim using a program called the AutoCoder. As she expresses her 
doubts about the ability of ICD9  to encode these terms, she says : 
 
" ... I am not confident the AutoCoder output is what the requestor is seeking. 
Autocoder is little more that a data base of codes and their descriptions.  The 
codes it houses are ICD (International Classification of Diseases) codes, CPT 
(Current Procedural Terminology) codes, and HCPCS (Health Care Finance 
Administration Common Procedure Coding System) codes. A user can enter a 
code and get the text description or enter a word or phrase and get in return a list 
of codes, which contain or are related to the word or phrase entered.  It is not an 
intelligent system.  In other words, it cannot take two or more diagnoses or 
procedures and determine primary, secondary diagnosis or determine how the 
case should be coded." 
 
Only 12 of the 32 symptoms have a representative encoding. Observe that none of these 
encoded Symptoms are adequate to determine treatment, changes in lifestyle, or ancillary 
services, the objectives of the claims in `105. In summary: 
 
•  The symptom "COUGH INTERFERING WITH SLEEP" had no encoding. 
•  The symptom "PLUGGED NOSE" had no encoding. 
•  The symptom "FEELING “RUN DOWN”" had no encoding 
•  The symptom "PLUGGED EARS" identified a procedure code. 
•  The symptom "RUNNY NOSE" had no unique encoding. (6 candidates) 
•  The symptom "RUNNY NOSE" closest ICD-9 match was chronic sinusitis. (not 
chronic) 
•  The symptom "SINUS PRESSURE" was encoded as "RUNNY NOSE". (not 
identical) 
•  The symptom "SINUS PAIN" was encoded as "Other diseases of nasal cavity and 
sinuses " (not a disease) 
•  The symptom "COUGH" was encoded as "other chest symptoms" and excluded 
several different kinds of cough. 
•  The symptom "COUGHING UP STUFF" was encoded as "COUGH" (not identical) 
•  The symptom "SORE THROAT" was encoded as acute or viral. (not the same) 
•  The symptom  "SCRATCHY THROAT" was encoded as "SORE THROAT" (not 
identical)   187
•  The symptom "HOARSENESS" was encoded as "Other Symptoms involving head 
and neck" (too vague) 
•  The symptom "STUFFY NOSE" was encoded as "Other diseases of nasal cavity and 
sinuses" (not a disease) 
•  The symptom "SNEEZING" was encoded as 784.9 other symptoms involving head 
and neck including Choking sensation, Halitosis, and Mouth breathing. (not the same) 
•  The symptom "LOSS OF APPETITE" was encoded as anorexia. (not the same) 
•  The symptom "IRRITABILITY" was encoded as other ill-defined and unknown 
causes of morbidity and mortality including Nervousness. (not the same) 
•  The symptom "EAR DISCOMFORT" did not have a unique encoding. (3 candidates) 
•  The symptom "WATERY EYES " was encoded as "Other disorders of lacrimal 
system" (too vague) 
•  The symptom "HEAD CONGESTION" was encoded as "SNEEZING". (not the 
same) 
•  The remaining 12 symptoms of LACK OF ENERGY, HEADACHE, FEVER, 
SWEATS, MUSCLE ACHES, CHILLS, FEELING DIZZY, FEELING TIRED, 
SWOLLEN GLANDS, EYE DISCOMFORT, CHEST CONGESTION, and 
HEAVINESS IN CHEST have representative encoding.  
 
Holland also cited MATERNITY. It does have an ICD-9 encoding, however, since it is 
considered a condition, rather than a symptom or a diagnosis, specific further information 
has to be provided to identify reimbursable events, as shown on the table below.  
 
This table was generated from information at The Philadelphia Medical Mall 
http://www.tpmm.com/services/ICD9/1TABULAR.HTM and from the AutoCoder.  
 
 
 
Symptom  suggested encoding followed by full text description 
COUGH 786.2 
786 Symptoms involving respiratory system and other chest symptoms  
786.2 Cough  
               Excludes: cough:  
                    psychogenic (306.1)  
                    smokers' (491.0)  
                    with hemorrhage (786.3)  
 
COUGHING UP STUFF  786.2 
786 Symptoms involving respiratory system and other chest symptoms  
786.2 Cough  
               Excludes: cough:  
                    psychogenic (306.1)  
                    smokers' (491.0)  
                    with hemorrhage (786.3)  
COUGH INTERFERING 
WITH SLEEP 
TERM NOT RECOGNIZED 
SORE THROAT  462 
462 Acute pharyngitis    188
          Acute sore throat NOS  
          Pharyngitis (acute):  
               NOS  
               gangrenous  
               infective  
               phlegmonous  
               pneumococcal  
               staphylococcal  
               suppurative  
               ulcerative  
          Sore throat (viral) NOS  
          Viral pharyngitis  
          Excludes: abscess:  
               peritonsillar [quinsy] (475)  
               pharyngeal NOS (478.29)  
               retropharyngeal (478.24)  
               chronic pharyngitis (472.1)  
               infectious mononucleosis (075)  
               that specified as (due to):  
                    Coxsackie (virus) (074.0)  
                    gonococcus (098.6)  
                    herpes simplex (054.79)  
                    influenza (487.1)  
                    septic (034.0)  
                    streptococcal (034.0)  
SCRATCHY THROAT  462 
462 Acute pharyngitis  
          Acute sore throat NOS  
          Pharyngitis (acute):  
               NOS  
               gangrenous  
               infective  
               phlegmonous  
               pneumococcal  
               staphylococcal  
               suppurative  
               ulcerative  
          Sore throat (viral) NOS  
          Viral pharyngitis  
          Excludes: abscess:  
               peritonsillar [quinsy] (475)  
               pharyngeal NOS (478.29)  
               retropharyngeal (478.24)  
               chronic pharyngitis (472.1)  
               infectious mononucleosis (075)  
               that specified as (due to):  
                    Coxsackie (virus) (074.0)  
                    gonococcus (098.6)  
                    herpes simplex (054.79)  
                    influenza (487.1)  
                    septic (034.0)    189
                    streptococcal (034.0)  
HOARSENESS 784.49 
784 Symptoms involving head and neck  
784.4 Voice disturbance  
784.49 Other  
                    Change in voice  
                    Dysphonia  
                    Hoarseness  
                    Hypernasality  
                    Hyponasality  
RUNNY NOSE (473 = 
Chronic sinusitis) 
1.  UNSPECIFIED SINUSITIS (CHRONIC) 
2.  CHRONIC MAXILLARY SINUSITIS 
3.  CHRONIC FRONTAL SINUSITIS 
4.  CHRONIC ETHMOIDAL SINUSITIS 
5.  CHRONIC SPHENOIDAL SINUSITIS 
6.  OTHER CHRONIC SINUSITIS 
“ENTER A NUMBER FOR YOUR SELECTION” 
1.  473.9 
2.  473.0 
3.  473.1 
4.  473.2 
5.  473.3 
6. 473.8 
PLUGGED NOSE  TERM NOT RECOGNIZED 
STUFFY NOSE  478.1 
478 Other diseases of upper respiratory tract   
          478.0 Hypertrophy of nasal turbinates  
          478.1 Other diseases of nasal cavity and sinuses  
               Abscess of nose (septum)  
               Necrosis of nose (septum)  
               Ulcer of nose (septum)  
               Cyst or mucocele of sinus (nasal)  
               Rhinolith  
               Excludes: varicose ulcer of nasal septum (456.8)  
SNEEZING 784.9 
784.9 Other symptoms involving head and neck  
               Choking sensation  
               Halitosis  
               Mouth breathing  
HEADACHE 784.0 
784.0 Headache  
               Facial pain  
               Pain in head NOS  
               Excludes: atypical face pain (350.2)  
                    migraine (346.0-346.9)  
                    tension headache (307.81)  
FEVER 780.6 
780 General symptoms  
780.6 Fever    190
               Chills with fever  
               Fever NOS  
               Hyperpyrexia NOS  
               Pyrexia NOS  
               Pyrexia of unknown origin  
               Excludes: pyrexia of unknown origin (during):  
                    in newborn (778.4)  
                    labor (659.2)  
                    the puerperium (672)  
SWEATS 780.8 
780.8 Hyperhidrosis  
               Diaphoresis  
               Excessive sweating  
MUSCLE ACHES  729.1 
729 Other disorders of soft tissues  
729.1 Mylagia and myositis, unspecified  
               Fibromyositis NOS  
FEELING “RUN DOWN”  TERM NOT RECOGNIZED 
LOSS OF APPETITE  783.0 
783 Symptoms concerning nutrition, metabolism, and development  
783.0 Anorexia  
               Loss of appetite  
               Excludes: anorexia nervosa (307.1)  
                    loss of appetite of nonorganic origin (307.59)  
CHILLS 780.9 
780.9 Other general symptoms  
               Amnesia (retrograde)  
               Chill(s) NOS  
               Generalized pain  
               Hypothermia, not associated with low environmental temperature 
               Excludes: hypothermia:  
                    NOS (accidental) (991.6)  
                    due to anesthesia (995.89)  
                    of newborn (778.2-778.3)  
                    memory disturbance as part of a pattern of mental disorder  
FEELING DIZZY  780.4 
780.4 Dizziness and giddiness  
               Light-headedness  
               Vertigo NOS  
               Excludes: Ménière's disease and other specified vertiginous 
syndromes (386.0-386.9)  
FEELING TIRED  780.79 
780 General symptoms  
780.7 Malaise and fatigue  
               Asthenia NOS  
               Lethargy  
               Postviral (asthenic) syndrome  
               Tiredness  
               Excludes: debility, unspecified (799.3)  
                    fatigue (during):    191
                         combat (308.0-308.9)  
                         heat (992.6)  
                         pregnancy (646.8)  
                    neurasthenia (300.5)  
                    senile asthenia (797)  
IRRITABILITY 799.2 
799 Other ill-defined and unknown causes of morbidity and mortality  
799.2 Nervousness  
               "Nerves"  
SINUS PAIN  478.1 
478 Other diseases of upper respiratory tract   
          478.0 Hypertrophy of nasal turbinates  
          478.1 Other diseases of nasal cavity and sinuses  
               Abscess of nose (septum)  
               Necrosis of nose (septum)  
               Ulcer of nose (septum)  
               Cyst or mucocele of sinus (nasal)  
               Rhinolith  
               Excludes: varicose ulcer of nasal septum (456.8)  
SINUS PRESSURE  GIVES SAME LISTING AS  
“RUNNY NOSE” 
SWOLLEN GLANDS  785.6 
785 Symptoms involving cardiovascular system 
785.6 Enlargement of lymph nodes  
               Lymphadenopathy  
               "Swollen glands"  
               Excludes: lymphadenitis (chronic) (289.1-289.3)  
                    acute (683)  
PLUGGED EARS  TERM IDENTIFIES A PROCEDURE 
EAR DISCOMFORT  1.  OTALGIA, UNSPECIFIED 
2.  OTOGENIC PAIN 
3.  REFERRED OTOGENIC PAIN 
“ENTER A NUMBER FOR YOUR SELECTION.” 
1.  388.70 
2.  388.71 
3. 388.72 
WATERY EYES  375.89 
375 Disorders of lacrimal system 
375.8 Other disorders of lacrimal system  
               375.81 Granuloma of lacrimal passages  
               375.89 Other  
EYE DISCOMFORT  379.91 
379 Other disorders of eye  
379.9 Unspecified disorder of eye and adnexa  
379.91 Pain in or around eye  
HEAD CONGESTION  784.9 
784.9 Other symptoms involving head and neck  
               Choking sensation  
               Halitosis  
               Mouth breathing    192
CHEST CONGESTION  514 
514 Pulmonary congestion and hypostasis  
          Hypostatic:  
               bronchopneumonia  
               pneumonia  
          Passive pneumonia  
          Pulmonary congestion (chronic) (passive)  
          Pulmonary edema:  
               NOS  
               chronic  
          Excludes: acute pulmonary edema:  
               NOS (518.4)  
               with mention of heart disease or failure (428.1)  
HEAVINESS IN CHEST  786.59 
786 Symptoms involving respiratory system and other chest symptoms  
786.5 Chest pain  
786.59 Other  
                    Discomfort in chest  
                    Pressure in chest  
                    Tightness in chest  
                    Excludes: pain in breast (611.71) 
LACK OF ENERGY  780.79 
780.79 
780 General symptoms  
780.7 Malaise and fatigue  
               Asthenia NOS  
               Lethargy  
               Postviral (asthenic) syndrome  
               Tiredness  
               Excludes: debility, unspecified (799.3)  
                    fatigue (during):  
                         combat (308.0-308.9)  
                         heat (992.6)  
 
 
In the Holland deposition [Holland:2002D] several more terms, either symptoms or diagnosis, 
were mentioned. Here is their ICD-9-CM encoding. 
 
Term ICD-9-CM  Encoding 
PNEUMONIA  480 Viral pneumonia  
480.0 Pneumonia due to adenovirus  
480.1 Pneumonia due to respiratory syncytial virus  
480.2 Pneumonia due to parainfluenza virus  
480.8 Pneumonia due to other virus not elsewhere classified  
Excludes: congenital rubella pneumonitis (771.0)  
influenza with pneumonia, any form (487.0)  
pneumonia complicating viral diseases classified elsewhere (484.1-484.8)  
480.9 Viral pneumonia, unspecified  
481 Pneumococcal pneumonia [Streptococcus pneumoniae pneumonia]  
Lobar pneumonia, organism unspecified    193
482 Other bacterial pneumonia  
482.0 Pneumonia due to Klebsiella pneumoniae  
482.1 Pneumonia due to Pseudomonas  
482.2 Pneumonia due to Hemophilus influenzae [H. influenzae]  
482.3 Pneumonia due to Streptococcus  
Excludes: Streptococcus pneumoniae pneumonia (481)  
482.30 Streptococcus, unspecified  
482.31 Group A  
482.32 Group B  
482.39 Other Streptococcus  
482.4 Pneumonia due to Staphylococcus  
482.8 Pneumonia due to other specified bacteria  
Excludes: pneumonia complicating infectious disease classified elsewhere 
(484.1-484.8)  
482.81 Anaerobes  
Gram-negative anaerobes  
Bacteroides (melaninogenicus)  
482.82 Escherichia coli [E. coli]  
482.83 Other gram-negative bacteria  
Gram-negative pneumonia NOS  
Proteus  
Serratia marcescens  
Excludes: gram-negative anaerobes (482.81)  
482.89 Other specified bacteria  
482.9 Bacterial pneumonia unspecified  
483 Pneumonia due to other specified organism  
483.0 Mycoplasma pneumoniae  
Eaton's agent  
Pleuropneumonia-like organisms [PPLO]  
483.8 Other specified organism  
484 Pneumonia in infectious diseases classified elsewhere  
Excludes: influenza with pneumonia, any form (487.0)  
484.1 Pneumonia in cytomegalic inclusion disease  
Code first underlying disease, as: (078.5)  
484.3 Pneumonia in whooping cough  
Code first underlying disease, as: (033.0-033.9)  
484.5 Pneumonia in anthrax  
Code first underlying disease (022.1)  
484.6 Pneumonia in aspergillosis  
Code first underlying disease (117.3)  
484.7 Pneumonia in other systemic mycoses  
Code first underlying disease  
Excludes: pneumonia in:  
candidiasis (112.4)  
coccidioidomycosis (114.0)  
histoplasmosis (115.0-115.9 with fifth-digit 5)  
484.8 Pneumonia in other infectious diseases classified elsewhere  
Code first underlying disease, as:  
Q fever (083.0)  
typhoid fever (002.0)  
Excludes: pneumonia in:    194
actinomycosis (039.1)  
measles (055.1)  
nocardiosis (039.1)  
ornithosis (073.0)  
Pneumocystis carinii (136.3)  
salmonellosis (003.22)  
toxoplasmosis (130.4)  
tuberculosis (011.6)  
tularemia (021.2)  
varicella (052.1)  
485 Bronchopneumonia, organism unspecified  
Bronchopneumonia:  
hemorrhagic  
terminal  
Pleurobronchopneumonia  
Pneumonia:  
lobular  
segmental  
Excludes: bronchiolitis (acute) (466.1)  
chronic (491.8)  
lipoid pneumonia (507.1)  
486 Pneumonia, organism unspecified  
Excludes: hypostatic or passive pneumonia (514)  
influenza with pneumonia, any form (487.0)  
inhalation or aspiration pneumonia due to foreign materials (507.0-507.8)  
pneumonitis due to fumes and vapors (506.0)  
487 Influenza  
Excludes: Hemophilus influenzae [H. influenzae]:  
infection NOS (041.5)  
laryngitis (464.0)  
meningitis (320.0)  
pneumonia (482.2)  
487.0 With pneumonia  
Influenza with pneumonia, any form  
Influenzal:  
bronchopneumonia  
pneumonia  
487.1 With other respiratory manifestations  
Influenza NOS  
Influenzal:  
laryngitis  
pharyngitis  
respiratory infection (upper) (acute)  
487.8 With other manifestations  
Encephalopathy due to influenza  
Influenza with involvement of gastrointestinal tract  
Excludes: "intestinal flu" [viral gastroenteritis] (008.8) 
MATERNITY  NORMAL DELIVERY, AND OTHER INDICATIONS FOR CARE IN 
PREGNANCY, LABOR, AND DELIVERY (650-659) 
The following fifth-digit subclassification is for use with categories 651-
659 to denote the current episode of care:    195
0 unspecified as to episode of care or not applicable  
1 delivered, with or without mention of antepartum condition  
2 delivered, with mention of postpartum complication  
3 antepartum condition or complication  
4 postpartum condition or complication  
650 Normal delivery  
Delivery requiring minimal or no assistance, with or without episiotomy, 
without fetal manipulation [e.g., rotation version] or instrumentation 
[forceps] of a spontaneous, cephalic, vaginal, full-term, single, live-born 
infant. This code is for use as a single diagnosis code and is not to be used 
with any other code in the range 630-676.  
Use additional code to indicate outcome of delivery (V27.0)  
Excludes: breech delivery (assisted) (spontaneous) NOS (652.2)  
delivery by vacuum extractor, forceps, cesarean section, or breech 
extraction, without specified complication (669.5-669.7)  
651 Multiple gestation  
Requires fifth digit; valid digits are in [brackets] under each code. See 
beginning of section 650-659 for definitions.  
651.0 Twin pregnancy  
[0,1,3]  
651.1 Triplet pregnancy  
[0,1,3]  
651.2 Quadruplet pregnancy  
[0,1,3]  
651.3 Twin pregnancy with fetal loss and retention of one fetus  
[0,1,3]  
651.4 Triplet pregnancy with fetal loss and retention of one or more 
fetus(es)  
[0,1,3]  
651.5 Quadruplet pregnancy with fetal loss and retention of one or more 
fetus(es)  
[0,1,3]  
651.6 Other multiple pregnancy with fetal loss and retention of one or 
more fetus(es)  
[0,1,3]  
651.8 Other specified multiple gestation  
[0,1,3]  
651.9 Unspecified multiple gestation  
[0,1,3]  
652 Malposition and malpresentation of fetus  
Requires fifth digit; valid digits are in [brackets] under each code. See 
beginning of section 650-659 for definitions.  
Code first any associated obstructed labor (660.0)  
652.0 Unstable lie  
[0,1,3]  
652.1 Breech or other malpresentation successfully converted to cephalic 
presentation  
[0,1,3] Cephalic version NOS  
652.2 Breech presentation without mention of version  
[0,1,3] Breech delivery (assisted) (spontaneous) NOS  
652.3 Transverse or oblique presentation    196
[0,1,3] Oblique lie  
Transverse lie  
Excludes: transverse arrest of fetal head (660.3)  
652.4 Face or brow presentation  
[0,1,3] Mentum presentation  
652.5 High head at term  
[0,1,3] Failure of head to enter pelvic brim  
652.6 Multiple gestation with malpresentation of one fetus or more  
[0,1,3]  
652.7 Prolapsed arm  
[0,1,3]  
652.8 Other specified malposition or malpresentation  
[0,1,3] Compound presentation  
652.9 Unspecified malposition or malpresentation  
[0,1,3]  
653 Disproportion  
Requires fifth digit; valid digits are in [brackets] under each code. See 
beginning of section 650-659 for definitions.  
Code first any associated obstructed labor (660.1)  
653.0 Major abnormality of bony pelvis, not further specified  
[0,1,3] Pelvic deformity NOS  
653.1 Generally contracted pelvis  
[0,1,3] Contracted pelvis NOS  
653.2 Inlet contraction of pelvis  
[0,1,3] Inlet contraction (pelvis)  
653.3 Outlet contraction of pelvis  
[0,1,3] Outlet contraction (pelvis)  
653.4 Fetopelvic disproportion  
[0,1,3] Cephalopelvic disproportion NOS  
Disproportion of mixed maternal and fetal origin, with normally formed 
fetus  
653.5 Unusually large fetus causing disproportion  
[0,1,3] Disproportion of fetal origin with normally formed fetus  
Fetal disproportion NOS  
Excludes: that when the reason for medical care was concern for the fetus 
(656.6)  
653.6 Hydrocephalic fetus causing disproportion  
[0,1,3]  
Excludes: that when the reason for medical care was concern for the fetus 
(655.0)  
653.7 Other fetal abnormality causing disproportion  
[0,1,3] Conjoined twins  
Fetal:  
ascites  
hydrops  
myelomeningocele  
sacral teratoma  
tumor  
653.8 Disproportion of other origin  
[0,1,3]  
Excludes: shoulder (girdle) dystocia (660.4)    197
653.9 Unspecified disproportion  
[0,1,3]  
654 Abnormality of organs and soft tissues of pelvis  
Requires fifth digit; valid digits are in [brackets] under each code. See 
beginning of section 650-659 for definitions.  
Includes: the listed conditions during pregnancy, childbirth, or the 
puerperium  
Code first any associated obstructed labor (660.2)  
654.0 Congenital abnormalities of uterus  
[0-4] Double uterus  
Uterus bicornis  
654.1 Tumors of body of uterus  
[0-4] Uterine fibroids  
654.2 Previous cesarean delivery  
[0,1,3] Uterine scar from previous cesarean delivery  
654.3 Retroverted and incarcerated gravid uterus  
[0-4]  
654.4 Other abnormalities in shape or position of gravid uterus and of 
neighboring structures  
[0-4]  
Cystocele  
Pelvic floor repair  
Pendulous abdomen  
Prolapse of gravid uterus  
Rectocele  
Rigid pelvic floor  
654.5 Cervical incompetence  
[0-4] Presence of Shirodkar suture with or without mention of cervical 
incompetence  
654.6 Other congenital or acquired abnormality of cervix  
[0-4] Cicatricial cervix  
Polyp of cervix  
Previous surgery to cervix  
Rigid cervix (uteri)  
Stenosis or stricture of cervix  
Tumor of cervix  
654.7 Congenital or acquired abnormality of vagina  
[0-4] Previous surgery to vagina  
Septate vagina  
Stenosis of vagina (acquired) (congenital)  
Sricture of vagina  
Tumor of vagina  
654.8 Congenital or acquired abnormality of vulva  
[0-4] Fibrosis of perineum  
Persistent hymen  
Previous surgery to perineum or vulva  
Rigid perineum  
Tumor of vulva  
Excludes: varicose veins of vulva (671.1)  
654.9 Other and unspecified  
[0-4] Uterine scar NEC    198
655 Known or suspected fetal abnormality affecting management of 
mother  
Requires fifth digit; valid digits are in [brackets] under each code. See 
beginning of section 650-659 for definitions.  
Includes: the listed conditions in the fetus as a reason for observation or 
obstetrical care of the mother, or for termination of pregnancy  
655.0 Central nervous system malformation in fetus  
[0,1,3] Fetal or suspected fetal:  
anencephaly  
hydrocephalus  
spina bifida (with myelomeningocele)  
655.1 Chromosomal abnormality in fetus  
[0,1,3]  
655.2 Hereditary disease in family possibly affecting fetus  
[0,1,3]  
655.3 Suspected damage to fetus from viral disease in the mother  
[0,1,3] Suspected damage to fetus from maternal rubella  
655.4 Suspected damage to fetus from other disease in the mother  
[0,1,3] Suspected damage to fetus from maternal:  
alcohol addiction  
listeriosis  
toxoplasmosis  
655.5 Suspected damage to fetus from drugs  
[0,1,3]  
Excludes: fetal distress in labor and delivery due to drug administration 
(656.3)  
655.6 Suspected damage to fetus from radiation  
[0,1,3]  
655.8 Other known or suspected fetal abnormality, not elsewhere 
classified  
[0,1,3] Suspected damage to fetus from:  
environmental toxins  
intrauterine contraceptive device  
655.9 Unspecified  
[0,1,3]  
656 Other fetal and placental problems affecting management of mother  
Requires fifth digit; valid digits are in [brackets] under each code. See 
beginning of section 650-659 for definitions.  
656.0 Fetal-maternal hemorrhage  
[0,1,3] Leakage (microscopic) of fetal blood into maternal circulation  
656.1 Rhesus isoimmunization  
[0,1,3] Anti-D [Rh] antibodies  
Rh incompatibility  
656.2 Isoimmunization from other and unspecified blood-group 
incompatibility  
[0,1,3] ABO isoimmunization  
656.3 Fetal distress  
[0,1,3] Abnormal fetal:  
acid-base balance  
heart rate or rhythm  
Fetal:    199
acidemia  
bradycardia  
tachycardia  
Meconium in liquor  
656.4 Intrauterine death  
[0,1,3] Fetal death:  
NOS  
after completion of 22 weeks gestation  
late  
Missed delivery  
Excludes: missed abortion (632)  
656.5 Poor fetal growth  
[0,1,3] "Light-for-dates"  
"Placental insufficiency"  
"Small-for-dates"  
656.6 Excessive fetal growth  
[0,1,3] "Large-for-dates"  
656.7 Other placental conditions  
[0,1,3] Abnormal placenta  
Placental infarct  
Excludes: placental polyp (674.4)  
placentitis (658.4)  
656.8 Other specified fetal and placental problems  
[0,1,3] Lithopedian  
656.9 Unspecified fetal and placental problem  
[0,1,3]  
657 Polyhydramnios  
[0,1,3]  
Requires fifth digit; valid digits are in [brackets] under each code. See 
beginning of section 650-659 for definitions.  
Use 0 as fourth digit for category 657  
Hydramnios  
658 Other problems associated with amniotic cavity and membranes  
Requires fifth digit; valid digits are in [brackets] under each code. See 
beginning of section 650-659 for definitions.  
Excludes: amniotic fluid embolism (673.1)  
658.0 Oligohydramnios  
[0,1,3] Oligohydramnios without mention of rupture of membranes  
658.1 Premature rupture of membranes  
[0,1,3] Rupture of amniotic sac less than 24 hours prior to the onset of 
labor  
658.2 Delayed delivery after spontaneous or unspecified rupture of 
membranes  
[0,1,3] Prolonged rupture of membranes NOS  
Rupture of amniotic sac 24 hours or more prior to the onset of labor  
658.3 Delayed delivery after artificial rupture of membranes  
[0,1,3]  
658.4 Infection of amniotic cavity  
[0,1,3] Amnionitis  
Chorioamnionitis  
Membranitis    200
Placentitis  
658.8 Other  
[0,1,3] Amnion nodosum  
Amniotic cyst  
658.9 Unspecified  
[0,1,3]  
659 Other indiciations for care or intervention related to labor and 
delivery, not elsewhere classified  
Requires fifth digit; valid digits are in [brackets] under each code. See 
beginning of section 650-659 for definitions.  
659.0 Failed mechanical induction  
[0,1,3] Failure of induction of labor by surgical or other instrumental 
methods  
659.1 Failed medical or unspecified induction  
[0,1,3] Failed induction NOS  
Failure of induction of labor by medical methods, such as oxytocic drugs  
659.2 Maternal pyrexia during labor, unspecified  
[0,1,3]  
659.3 Generalized infection during labor  
[0,1,3] Septicemia during labor  
659.4 Grand multiparity  
[0,1,3]  
Excludes: supervision only, in pregnancy (V23.3)  
without current pregnancy (V61.5)  
659.5 Elderly primigravida  
[0,1,3]  
Excludes: supervision only, in pregnancy (V23.8)  
659.6 Other advanced maternal age  
[0,1,3]  
Excludes: elderly primigravida (659.5)  
659.8 Other specified indications for care or intervention related to labor 
and delivery  
[0,1,3]  
659.9 Unspecified indication for care or intervention related to labor and 
delivery  
[0,1,3]  
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Appendix C. Definitions of Medical Terms Cited 
This appendix contains definitions for other medical terms used in the report and 
testimonies from Stedman's Medical Dictionary. Especially [Holland:2002D] used 
several medical terms in his deposition. Here are their definitions as found in 
[Stedman:2000]. 
 
Angina: The definition of Angina in Stedman's Medical Dictionary [Stedman:2000] is 
"1. A severe, often constricting pain, usually referring to a. pectoris. Where a. pectoris is 
defined as, severe constricting pain in the chest, often radiating from the pericardium to a 
shoulder (usually left) and down the arm, due to schema of the heart muscle usually 
caused by coronary disease." 
 
(Chronic) Cholecystitis: The definition of (Chronic) Cholecystitis in Stedman's Medical 
Dictionary [Stedman:2000] is "(chronic) inflammation of the gallbladder, usually 
secondary to lithiasis, with lymphocytic infiltration and fibrosis that may produce marked 
thickening of the wall." 
 
Cough: The definition of Cough in Stedman's Medical Dictionary [Stedman:2000] is "1. 
A sudden explosive forcing of air through the glottis, occurring immediately on opening 
the previously closed glottis, excited by mechanical or chemical irritation of the trachea 
or bronchi or by pressure from adjacent structures." 
 
Cystectomy: The definition of Cystectomy in Stedman's Medical Dictionary 
[Stedman:2000] is "1. Excision of the urinary bladder. 2. Excision of the gallbladder 
(cholecystectomy). 3. Removal of a cyst." 
 
Dysphagia: The definition of Dysphagia in Stedman's Medical Dictionary 
[Stedman:2000] is "Difficulty is swallowing." 
 
Fever: The definition of Fever in Stedman's Medical Dictionary [Stedman:2000] is "A 
complex physiologic response to disease mediated by pyrogenic cytokines and 
characterized by a rise in core temperature, generation of acute phase reactants, and 
activation of immune systems." 
 
Hemoptysis: The definition of Hemoptysis in Stedman's Medical Dictionary 
[Stedman:2000] is "Spitting of blood derived from the lungs or bronchial tubes as a result 
of pulmonary or bronchial hemorrhage." 
 
Joint Effusion: The definition of Joint Effusion in Stedman's Medical Dictionary 
[Stedman:2000] is "Increased fluid in synovial cavity of the joint." 
 
Labor: The definition of Labor in Stedman's Medical Dictionary [Stedman:2000] is "The 
process of expulsion of the fetus and the placenta from the uterus." 
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Liposuction: The definition of Liposuction in Stedman's Medical Dictionary 
[Stedman:2000] is "Method of removing unwanted subcutaneous fat using 
percutaneously placed suction tubes." 
 
Maternity: The definition of Maternity in Stedman's Medical Dictionary [Stedman:2000] 
is "Motherhood. Relating to or derived form the mother." 
 
Meningitis: The definition of Meningitis in Stedman's Medical Dictionary 
[Stedman:2000] is "Inflammation of the membranes of the brain or spinal cord." 
 
Nausea: The definition of Nausea in Stedman's Medical Dictionary [Stedman:2000] is 
"An inclination to vomit." 
 
Pathogonomic: The definition of Pathogonomic in Stedman's Medical Dictionary 
[Stedman:2000] is "Characteristic or indicative of a disease; denoting especially one or 
more typical symptoms, findings, or pattern of abnormalities specific for a given disease 
and not found in any other condition." 
 
Pathology: The definition of Pathology in Stedman's Medical Dictionary [Stedman:2000] 
is "The medical science, and specialty practice, concerned with all aspects of disease, but 
with special reference to the essential nature, causes, and development of abnormal 
conditions, as well as the structural and functional changes that result from disease 
processes." 
 
Pneumonia: The definition of Pneumonia in Stedman's Medical Dictionary 
[Stedman:2000] is "Inflammation of the lung parenchyma characterized by consolidation 
of the affected part, the alveolar air spaces being filled with exudate, inflammatory cells, 
and fibrin. Most cases are due to infection by bacteria or viruses, a few to inhalation of 
chemicals or trauma to the chest wall, and a small minority to rickettsiae, fungi, and 
yeasts." 
 
Sepsis: The definition of Sepsis in Stedman's Medical Dictionary [Stedman:2000] is "The 
presence of various pathogenic organisms, or their toxins, in the blood or tissues; 
septicemia is a common type." 
Vomit: The definition of Vomit in Stedman's Medical Dictionary [Stedman:2000] is "1. 
To eject matter from the stomach through the mouth."   203
 
Appendix D. Claim Clusters for the `105 Patent 
 
The `105 patent contains a collection of independent claims and their associated 
dependent claims forming claim clusters. Bold represents asserted claims.  
 
Independent Claim  Claim Clusters (Independent + Dependent) Claims 
1  1, 2, 3, 13, 14, 15 
4  4, 5, 6, 7, 8, 9, 10, 11, 12 
16  16, 17, 18, 28, 29, 30 
19  19, 20, 21, 22, 23, 24, 25, 26, 27 
31 31 
32 32 
33 33 
34  34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46 
47  47, 48, 49, 50, 51 
52  52, 53, 54 
55  55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66 
67  67, 68, 69 
70  70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81 
82 82 
83 83 
84 84 
85  85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96 
97  97, 98, 99, 100, 101 
102 102 
 